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SUMMARY 
This thesis records an investigation into the biosynthesis of the 
aranotins, a group of sulphur-containing dioxopiperazine metabolites 
produced by the fungi Aspergillus terreus and Amauroascus aureus. 
A series of analogues of the known aranotin precursor, cyclo-
(L-phenylalanyl-L-phenylalanyl), fluorinated on one or both aromatic 
rings, was prepared, both unlabelled and labelled with 14C• These 
compounds were fed to Aspergillus terreus, as were £-, ~-, and ~-fluoro­
phenylalanines, and their metabolism was followed by 19F n.m.r. 
spectroscopy of the extracts. A fluorinated bisdethiodi(methylthio)-
acetylapoaranotin was isolated from cultures which had been fed 
DL-~-fluorophenylalanine or cyclo-(L-phenylalanyl-L-~-fluorophenyl­
alanyl) • 
A new natural metabolite of A. terreus, cis-~,~'-di(methylthio)­
cyclo-(phenylalanyl-phenylalanyl), of unknown absolute configuration, 
was isolated and characterised. Several fluorinated analogues of this 
compound were detected spectroscopically in extracts which had been 
fed fluorinated precursors. 
cyclo-(L-Phenylalanyl-L-~-fluorophenylalanyl), stereospecifically 
monodeuteriated at the methylene group of the E-fluorophenylalanyl 
residue, was fed to A. terreus, and it was shown that neither the 3R-
nor the 3S-deuterium was lost obligatorily during the conversion of 
this compound into cis-~,~'-di(methylthio)-cyclo-(phenylalanyl-E-fluoro­
phenylalanyl), although there was a partial loss from each position. 
The natural product, cis-cA,c(' -di (methylthio) -cyclo-(phenylalanyl-
phenylalanyl), was synthesised as a racemate. The compound, labelled 
with 35S , was fed to A. terreus, and was not significantly incorporated 
into bisdethiodi(methylthio)acetylaranotin. The racemic epidisulphide, 
~,~'-epidithio-cyclo-(phenylalanyl-phenylalanyl), was synthesised. 
This compound, doubly labelled with 3H and 35S , was fed to A. terreus, 
and was incorporated into acetylaranotin and bisdethiodi(methylthio)-
acetylaranotin, with some changes in the isotopic ratios. An "inter-
mediate trapping" experiment confirmed the ability of the fungus to 
biosynthesise ~,~'-epidithio-cyclo-(phenylalanyl-phenylalanyl), of 
unknown absolute configuration, from L-phenylalanine. 
Abbreviations used ln the text 
n. m.r. = nuclear magnetic resonance 
p.p.m. = parts per million 
t.l.c. = thin layer chromatography 
u.v. = ultraviolet 
i.r. = infrared 
BDA = bisdethiodi(methylthio)acetylaranotin (40) 
~DAA = bisdethiodi(methylthio)acetylapoaranotin (41) 
DMF = N,N-dimethylformamide 
DMSO = dimethylsulphoxide 
LDA = lithium di-isopropylamide 
TIfF = tetrahydrofuran 
TFA = trifluoroacetic acid 
Phe = phenylalanyl 
Ala = alanyl 
Gly = glycyl 
Ser = seryl 
Trp = tryptophyl 
Tyr = tyrosyl 
Pro = prolyl 
Deuterium is represented by D. 
1 
CHAPrER 1 
INTRODUCTION 
1.1 General 
In 1936, Weindling and Emerson1 isolated a toxic compound from 
Gliocladium fimbriatum (Trichoderma viride) which they named gliotoxin. 
Its structure, finally determined in 1958 by Bell et al.~ contains 
the sulphur-bridged dioxopiperazine lI!oiety (2), which is a character-
istic of a number of fungal metabolites discovered since. There are 
now ca. 40 members of the family, containing either the sulphur-bridged 
ring (2) or the closely related cis-di(methylthio)-dioxopiperazine ring 
system (3). Some other metabolites appear to be the products of rearr-
angement of epidithiodioxopiperazines~,4,5 
~ ~(ye 
Cli o N'R 
SMeL. 
2 
(1 ) (2); X= 2, 3, or 4 (3) 
Several reviews have been published ccncerning the structures, 
chemistry, biosynthesis, and biological activity of these compounds?,7,8 
The biosynthetic studies up to 1980 have been reviewed by Kirby and 
Robins: and since this review, three new sulphur-containing dioxo-
3 4 10 piperazines have been reported.' , 
The toxicology of this class of compounds has been the subject of 
11 
much interest, and has been reviewed by Taylor. The epidi-, tri-, and 
tetra-sulphides show pronounced antiviral activity, and are also toxic 
to fungi, bacteria, and mammals. The di(methylthio)- cowpounds show 
2 
no toxicity. The mechanism of action of the epipolysulphidec is not 
known, but they are believed to interfere with DNA transcription. 
All the sulphur-containing dioxopiperazines isolated to date from 
natural sources have been found in fungi, and their biosynthetic 
procedures are discussed below (Section 1.2). There is another 
producer of these compounds, however, i.e. Homo sapiens~ and his methods 
are detailed in Section 1.3. 
~ Biosynthesis of sulphur-containing dioxopiperazines 
1.2.1 Biosynthesis of gliotoxin (1) 
Because gliotoxin was the first epidithiodioxopiperazine to be 
discovered, most of the earlier biosynthetic investigations were 
concerned with it. Examination of the structure of gliotoxin (1) 
suggests a derivation from two amino-acids, the "lower half" (C-10 -
C-12) resembling serine, and the "upper half" (C-1 - C-9) a modified 
aromatic amino- acid such as phenylalanine or ~-tyrosine. Accordingly, 
in 1958 Suhadolnik and Chenoweth12 fed DL_[1_14g phenylalanine and 
DL-[2-14C]Phenylalanine to T. viride and observed significant incorp-
orations into gliotoxin (8.4 and 12.4% respectively). Degradation of 
the metabolite obtained from feeding DL_[1_14C] phenylalanine located 
the label at the C-1 carbonyl group (82% of the total activity), 
confirming that the amino-acid was incorporated intact and without 
rearrangement. Similarly~3 DL-[1-14CJserine was incorporated (1.9%) 
COfi 
(4) 
3 
into gliotoxin, degradation showing that the label resided in neither 
the ~-methyl group nor the indole-2-carboxylic acid (4) derived from 
the phenylalanine portion. However, when DL{3-14CJserine was fed, the 
gliotoxin isolated contained activity (25% of the total) in the ~-methyl 
group. This is consistent with transfer of the serine methylene group 
to the C1 pool of the organism, and in agreement with this result, 
DL- [methyl-.. 14C] methionine was found to be a more efficient methyl 
source. This group also reported13 a large incorporation (44.3%) of 
D~-[U_3H]-~-tyrosine (5) into gliotoxin. Several attempts to repeat 
this observation have failed;4,1 5,16 and m-tyrosine is not now considered 
to be a precursor. 
HO 
Bose et al. 17 ,18 investigated the origin of the nitrogen atoms in 
the dioxopiperazine nucleus. It was demonstrated that r5NJ glycine, 
[15~ aspartic acid, and r5N] glutamic acid could all act as sources of 
the nitrogen atoms. Although DL-[1 5N]phenylalanine gave gliotoxin with 
a large proportion of the label in the expected position, when doubly 
labelled DL_[1_14C,1 5N] phenylalanine was used the 15N was diluted to a 
14 greater extent than the C label. These results suggest that deamin-
ation and re-amination of the amino-acid occur readily. When optically 
active phenylalanines were fed;8 it \'ias found that D-[ 1_14C] phenyl-
alanine was incorporated almost as efficiently as L_[1_14g phenylalanine. 
Thus it appears that inversion of the chiral centre of phenylalanine can 
take place easily, possibly by the deamination-reamination process 
4 
mentioned above. 
In 1975, MacDonald and Slater19 investigated the possibility that 
the cyclic dipeptide cyclo-(L-Phe-L-Ser) (6) was an intermediate on the 
biosynthetic pathway. However, on observing only a low incorporation 
of cycIO-(L-[1-14C]Phe-L-Ser) into gliotoxin by Penicillium terlikowskii, 
they concluded that the cyclic dipeptide (6) was not a free intermediate. 
Their results were not in accord with those of BulLock and Leigh~O who 
reported a high incorporation (21%) of activity from a mixture of cyclo-
(L-[Ar-3H]Phe-L-[1-14CJSer) and cyCIo-(L-[Ar-3H]Phe-D-[1-14C]Ser) into 
gliotoxin by Trichoderma viride. BulLock and Leigh proposed that the 
poor incorporation by P. terlikowskii could be explained by the large 
amount of cyclo-(L-Phe-L-Ser) fed to the organism. 
Kirby et al. 21 fed all four stereoisomers of [14C]-cyclo-(Phe-Ser) 
separately to T. viride (Gliocladium deliguescens), and found that only 
the LL- isomer was efficiently incorporated (48%). Feeding of cyclo-
(L_[41_3H]Phe_L_[3_14C]Ser) gave gliotoxin with conservation of the 
3H: 14C isotopic ratio, and hydrolysis gave inactive methylamine. These 
results suggest that cyclo-(L-Phe-L-Ser) (6) is metabolised to gliotoxin 
without separation of the two amino-acid residues, and that the 
methylene group of the seryl residue is not exchanged with the C1 pool 
(as it was with the free amino-acid). Also, an "intermediate trapping" 
experiment demonstrated the presence of cyclo-(L-Phe-L-Ser) in the 
organism; cyclo-(L-Phe-L-Ser) was added to the cultures, followed 2h 
later by L_[u_14g phenylalanine. The re-isolated cyclo-(L-Phe-L-Ser) 
(6) 
5 
contained 1.3% of the activity fed, showing that cyclo-(L-Phe-L-Ser) 
is synthesised ln the organism from L-phenylalanine. 
Following cyclic dipeptide formation, there remain at least three 
transformations necessary to produce gliotoxin, i.e. oxidative cyclis-
ation of nitrogen with the phenyl group, N-methylation, and intro-
duction of the disulphide bridge. The relative order of these steps is 
unknown. The S-methyl group of methionine has been shown to be incorp-
orated efficiently into gliotoxin~2 suggesting a relationship with 
?ther biological methylations. 
It is now fairly well established that m-tyrosine (5) is not a 
precursor for gliotoxin. Bu'Lock and Ryles14 fed DL~[2' ,3' ,4',5' ,6',-
D
5
]Phenylalanine to T. viride and found no significant loss of 
deuterium. Similarly, Johns and Kirby15 found that DL_[1_14c , 3,_3~_ 
phenylalanine was converted into gliotoxin by T. viride with no loss 
of tritium. The label was shown to be located equally at C-6 and c-8 
of gliotoxin by degradations. Also, the possibility that migration to 
a neighbouring carbon atom was taking place, followed by return to the 
original site with loss of hydrogen, was discounted by feeding DL-
[1_14C, 2,_3H]Phenylalanine and DL_[1_14C, 4,_3H] phenylalanine; these 
were incorporated into gliotoxin with no loss of tritium. 
At present, the most popular explanation of the formation of the 
cyclohexadienol ring system involves the intermediacy of an arene 
oxide which is opened by nucleophilic attack of nitrogen. Both 2' ,3'-
o~( - o 
OH 
(8) 
HO 
6 
and 3' ,4'- epoxides (7) and (8) are possible intermediates, although 
the 3',4' - arene oxide is not a suitable intermediate in aranotin bio-
synthesis (see below) and attack by nitrogen on this compound would be 
disfavoured by Baldwin's rules (5-endo-trig)~2 This mechanism accounts 
for all the experimental results except those where phenolic precursors 
have been incorporated, i.e. m-tyrosine (5)13and the gliotoxin deriv-
23 
atives (9) and (10). The weight of evidence in favour of an arene 
oxide intermediate must bring the validity of these results into 
question. 
Rastetter et ale demonstrated the feasibility of nucleophilic 
attack on arene oxides by amines in vitro~4 although the model co~pounds 
(11), (12), and (13) did not cyclise under their conditions~2 rearrange-
ment to the phenols taking place. 
OH x> 
( 
7 
In connection with this proposed mechanism, Hanson and 0'Leary25 
isolated two new metabolites (14) and (15), from Gliocladium deliques-
cens. They pointed out that the para- oxygen function could have arisen 
from a 3',4'- arene oxide, but not from a 2' ,3'-oxide. However, oxid-
ation of the aromatic ring in these compounds rray be unrelated to the 
oxidation ln gliotoxin biosynthesis. 
RO (14); R =H 
R=~ 
Little is known to date as to the mechanism of sulphur intro-. 
duction. Neuss et al. 26 found that L-[35SJmethionine gave a good 
incorporation of sulphur into gliotoxin by P. terlikowsii (10.2%) and 
T. viride (3.3%). When unlabelled L-cysteine was added in 1000-fold 
excess to cultures of T. viride fed L-[35SJmethionine, gliotoxin pro-
duction was more than doubled, and the incorporation of 35S was reduced 
to 0.1%, suggesting that cysteine can also act as a sulphur source for 
gliotoxin production. 
Unsaturated derivatives of cyclo-(Phe-Ser) such as (10) have been 
proposed as possible precursors to gliotoxin~ When phenylalanine, 
tritiated or deuteriated at the ~ethylene group, was fed27 to ~viride, 
(G. deliquescens) and incorporated into gliotoxin, there was a stereo-
(10) 
8 
selective loss of label, ~ tritium was lost from [3R-3H]Phenyl-
alanine but retained in [3S-3H]Phenylalanine. When [3-D2]phenylalanine 
was fed, the gliotoxin isolated contained, besides unlabelled material, 
mainly monodeuteriated compound. However, small amounts of dideuterio-
gliotoxin were present, eliminating olefinic derivatives (in the 
phenylalanine moiety) as obligatory intermediates. The predominance 
of the monodeuteriated species could be attributed to a stereospecific 
exchange of the 3R-hydrogen in L-phenylalanine, which was found to have 
taken place in the amino-acid recovered from the mycelial proteins~7 
Thus loss of the ': label could have occurred before formation of the 
cyclic dipeptide. 
Structural analogues of the natural precursors have been fed to 
G. deliquescens. cyclo-(L-Phe-L-Ala) (16) was incorporated with high 
efficiency (ca. 40%) into the gliotoxin analogue (17)~8 This indicates 
that the C-12 hydroxyl group is not involved in an essential part of 
the biosynthetic route. 
) ) 
( 16) 
Another analogue of cyclo-(Phe-Ser), cyclo-(L-Phe-L-a-amino-
butyryl) (18) was fed to G. deliquescens, and incorporation into three 
metabolites was observed~9 The structures of two of these compounds 
were tentatively assigned as the gliotoxin analogue (19), and the 
bisdethiodi(methylthio)-analogue (20). The third compound was assigned 
the structure (21), and this has been confirmed by synthesis of the 
racemate~O The isolation of this metabolite suggests that 
OH 0 . 
Me~" 
) (20) 
( 18) 
9 
biosynthetic introduction of sulphur occurs immediately after formation 
of the cyclic dipeptide, and before N-methylation or oxidative cyclis-
ation. 
In G. deliguescens, as in other dioxopiperazine-producing fungi, 
the bisdethiodi(methylthio)- derivative of gliotoxin (22) co-occurs 
with the epidisulphide~1 The relationship between the two was studied 
by Kirby et al.~1 who fed [14C]gliotoxin (derived biosynthetically 
from [u_14C]phenylalanine) to Go deliguescens, and observed a signific-
ant incorporation (8.6%) into bisdethiodi(methylthio)gliotoxin (22). 
A further 27.4% of the activity was recovered as gliotoxin. When 
[14C]bisdethiodi(methylthio)gliotoxin was fed, the incorporation into 
gliotoxin was negligible ( 0.2%), and 58% of the activity was recovered 
as unchanged (22). It was thus demonstrated that, in G. deliquescens, 
bisdethiodi(methylthio)gliotoxin (22) is formed by irreversible 
reductive methylation of gliotoxin; this result might also apply to 
the analogous metabolites in other fungi. 
A biosynthesis for gliotoxin that agrees with most of the evidence 
presented to date is given in Scheme I. N-Methylation could occur 
either before or after cyclisation of the aromatic ring with the amide 
nitrogen. 
Scheme I 
/ 
Ph 
o NH 
H'\\' 
(6) 
) 
~ ~. 0 
H~ 
o (,Me 
OH 
(9)32 
OH 
Ph 
HN) a --~) I~:r 
o ?,S NH 
H 
11 
1.2.2 Biosynthesis of hyalodendrin 
Hyalodendrin (24) was first isolated by Strunz et al. 33 from a 
species of ~yalodendron. Interestingly, a comparison of its circular 
dichroism curve with those of other epidithiodioxopiperazines33 
indicated that the configuration of the disulphide bridge in hyalo-
dendrin is antipodal to that of gliotoxin, the aranotins, and the 
sporidesmins. Strunz et ale also isolated the related bisdethio-
di(methylthio)hyalodendrin (25)}4 
(24) 
Related metabolites have been found in several other fungi. Dorn 
and Arigoni35 isolated gliovictin (26) from Helminthosporium victoriae, 
differing from bisdethiodi(methylthio)hyalodendrin (25) only in its 
absolute configuration. The same metabolite was isolated from 
Penicillium turbatum by Michel et al.~6 along with the hyalodendrin 
antipode (27) and the tetrasulphide (28). The enantiomer of this 
37 
tetrasulphide has been isolated from Hyalodendron by Strunz et al •. 
Ph Me~i:t0 
o ? NMe 
H OH H 
(26) (27) (28) 
12 
Hyalodendrin bears a close resemblance to gliotoxin, the only 
differences being the absolute configuration, the lack of oxidative 
cyclisation, and the ITethylation of the second nitrogen. Accordingly, 
Patrick38 and Pita39 investigated whether cyclo-(Phe-Ser) (6) is a 
precursor for this group of metabolites. Because of the growth 
conditions used, bisdethiodi(methylthio)hyalodendrin (25) was isolated 
from the cultures of Hyalodendron rather than the epidisulphide (24), 
but their conclusions should also hold for hyalodendrin. All four 
isomers of cyclo-(Phe-Ser) were fed (labelled with 14C),38 and only 
cyclo-(L-Phe-L-Ser) (6a) was incorporated to a significant degree (28%). 
Doubly labelled cyclo-(L-[4,_3H]Phe-L-[3-14C]Ser) was incorporated 
(42%) without significant change in the isotopic ratio, indicating that 
the cyclic dipeptide is transformed into (25) without return to its 
constituent amino-acids. Patrick also showed38 that the monomethylated 
cyclic dipeptide (29) was not incorporated into the hyalodendrin deriv-
ative (25). The intermediacy of cyclo-(L-Phe-L-Ser) (6a) is therefore 
Ph 
o NH 
H~ 
OH 
(6a) 
well established, and it may be that sulphur is introduced before 
N-methylation, as was suggested for gliotoxin. The fact that sulphur 
is inserted with retention of configuration in gliotoxin biosynthesis, 
but with inversion in the case of hyalodendrin, is unexplained, but 
might indicate a non-chiral intermediate, for example an imine such 
13 
as (A), or Ph the pyrazinediol (30) • 
R ~ ~ OH N~O HO~N ~ OH 
(A) (30) 
1.2.3 Biosynthesis of the sporidesmins 
Pithomyces chartarum produces a series of related metabolites; of 
which sporidesmin (31) is the most abundant. These compounds are 
implicated in facial eczema, a disease of sheep. Tryptophan and 
alanine seem strong candidates for progenitors of the carbon skeleton, 
~-I ~H 
and both have been shown to be incorporated into sporidesmin by 
o 
P. chartarum~O Activity from [14CJserine, [1_14C] glycine, and 
L_[methyl-14c ]methionine was also incorporated to a lesser extent, but 
DL-[3-14c]cysteine and L_[u_14C]Phenylalanine did not serve as pre-
cursors. 
Following the analogy of gliotoxin biosynthesis, Kirby and 
Varley41 tested cyclo-(L-Ala-L-Trp) (32) as a possible precursor. 
Cyclo_(L_[3_3H]Ala-L-[3-14C]Trp) was incorporated (2% of the 14C 
activity), but the 3H: 14C isotopic ratio was reduced to 51% of that of 
the precursor. This could be explained, either by breakdown of the 
cyclic dipeptides into the amino-acids and re-incorporation, or by 
loss of tritium from the methyl group of the alanyl residue. 
14 
Therefore the status of cyclo-(L-Ala-L-Trp) (32) as an intermediate is 
not yet clear. 
The cyclisation of the dioxopiperazine ring to the indolyl system 
in sporidesmin biosynthesis could take place by attack of nitrogen on 
an epoxide (33), in an analogous way to the proposed cyclisation 
mechanism in gliotoxin, but no work has been done on this possibility 
to date. 
QH 
1.2.4 Biosynthesis of the sirodesmins 
The sirodesmins constitute a family of epipolythiodioxopiperazines 
containing an unusual spiro-fused tetrahydrofuranone system, sirodesmin 
PL (34) being a typical example. The other members of the group have 
OH 
different stereochemistry in the side-group anq/or different numbers 
of sulphur atoms in the bridge (2, 3, or 4). 42 Ferezou et ale have 
investigated the biosynthesis of sirodesmin PL (34) in Phoma lingam. 
L-[u-14CJSerine and L-[u_14CJtyrosine were both incorporated into 
15 
sirodesmin PL, although at a rather low level (0.3 and 0.5% respect-
ively). A much better incorporation (12.5%) was observed on feeding 
14 C -Labelled phomamide (36), the 
dimethylallyl ether of cyclo-(L-Tyr-L-Ser), which occurs naturally in 
Phoma lingam, was incorporated to an even greater extent (25.5%). By 
HO 
_ .. Jl 0 
HN O~/NH H'''~ OH 
feeding [1-14C]acetate and r,2-13C2]acetate it was established that 
the "isoprenyl" unit of the tetrahydrofuranone ring was indeed derived 
from mevalonate, and a biosynthesis was proposed in accord with the 
results (Scheme II). 
Scheme II 
(36) ) ) 
} 
OH t 
"'~ 0< < a '~ "II~ 
I J 'L.-.. 
~ 
..:-
Once again, the cyclisation of the amide nitrogen to form a pyrrol-
idine ring could take place via an inter~diate epoxide, as suggested 
for sporidesmin (see above). 
1.2.5 Biosynthesis of the aranotins 
43 44 In 1968, Neuss et ale ' reported the isolation of five new 
metabolites from cultures of Arachniotus aureus (Eidam) Shroeter. 
16 
Three of these compounds, aranotin (37), acetylaranotin (38), and apo-
aranotin (39) are epidisulphides; the other two are bisdethiodi(methyl-
thio)acetylaranotin (BDA) (40) and bisdethiodi(methylthio)acetylapo-
aranotin (BDAA) (41). In the same year, Miller et ale reported the 
(37); R = H (38); R = Ac 
(40) 
isolation of two metabolites from Aspergillus terreus cultures. These 
two compounds, which they named LL-S8~ and LL-S8~, proved to be 
identical to acetylaranotin (38) and BDA (40) respectively. X-Ray and 
circular dichroism studies46 ,47 confirmed that the aranotins had the 
same configuration as gliotoxin (1) at the disulphide bridge. 
The first biosynthetic experiments on the aranotins were carried 
out by Neuss and coworkers~6 who fed a range of amino-acids to 
A. aureus. Both D- and L-phenylalanines were incorporated into BDA 
17 
(2.42 and 3.15% respectively), as was L-[ methyl_14g methionine (6.46%)0 
Isolation of the methyl iodide produced by Zeisel degradation of BDA 
from the last experiment showed that 96% of the activity from the 
labelled methionine was in the S-methyl groups of BDA. When a mixture 
of L_[35S] methionine and L-[methyl-3H]methionine was fed to ~. aureus, 
the tritium label was incorporated with greater efficiency (11.3%) 
than the 35S (2.77%), indicating that the methylthio- group of meth-
ionine was not transferred intact to BDA. DL-[3-14~Serine and 
DL_[3_14C] tryptophan were also incorporated into BDA, though at a 
much lower level (0.76 and 0.67% respectively). Here, Zeisel degrad-
ation again located much of the label in the S-methyl groups (73 and 
84% respectively). Unfortunately, BDA from the phenylalanine feeding 
experiments was not similarly degraded. 
Feeding experiments by Brannon et al. 16 established that DL-
[3_14c]Phenylalanine was incorporated into BDA (40) much more effic~ 
iently (6.64%) than DL-[2-14C]-m-tyrosine (0.46%) or DL-3',5'- [2_14c]_ 
dihydroxyphenylalanine (0.18%) by A. aureus. When a mixture of DL-
[3_14C] phenylalanine and DL-[2,_3H] phenylalanine was fed, both isotopes 
were incorporated (7.04 and 5.67fo respectively) into BDA, showing that 
there was little loss of tritium from the ortho- position of phenyl-
alanine in its transformation to the aranotin ring system. 
This research group also investigated the fate of the other 
hydrogen atoms in Phenylalanine. 16 When fully C-deuteriated (D8) 
DL-phenylalanine was fed to A. terreus, mass spectrometry of the 
isolated acetylaranotin (38) revealed large amounts of[D~and[D14J 
species. This result suggested that [D8]Phenylalanine contributed to 
both halves of the aranotin molecule, and that only one deuterium atom 
was lost as an obligatory step, probably from the ~- position of the 
18 
phenylalanine fed. Some further loss of deuterium had evidently 
occurred, however, Slnce there were substantial abundances of [D6 J and 
[D13 J ions. Johns et al. 27 showed that this loss was from the methylene 
group of phenylalanine by feeding DL-[3,3-D2, 1_14CJphenylalanine to 
Aspergillus terreus; mass spectrometry of the isolated acetylaranotin 
showed substantial loss of one deuterium atom. This loss could be 
explained by the stereospecific exchange of the methylene hydrogens ln 
phenylalanine which was shown to take place in Gliocladium deliguescens, 
and thus might be unconnected with dioxopiperazine biosynthesis. 27 
The comparison of the aranotins and gliotoxin (1) suggested the 
cyclic dipeptide cyclo-(L-Phe-L-Phe) (42) as a possible aranotin 
precursor. Accordingly, Kirby et al. 48 fed cyclo-(L~U-14~Phe-L-Phe) 
to cultures of A. terreus and observed a high incorporation (19.9%) in 
into BDA (40) (which was produced in preference to acetylaranotin (38) 
under their growth conditions). A mixture of CYC1o-(L-[1-14C]Phe-D-Phe) 
(42) 
and CyC1o-(D-[1-14C]Phe-D-Phe) was not significantly incorporated 
(0.5%). To establish that the cyclic dipeptide (42) was incorporated 
without dissociation into its constituent amino-acids and recombin-
ation, the doubly labelled cyclo_(L_[15N]Phe_DL~[1_13~ Phe) was synth-
esised and fed. The one-bond coupling between 15N and 13C creates a 
symmetrical doublet in the 13C n.m.r. signal of the amide carbonyl, and 
comparison of the intensities of the 13C n.m.r. amide carbonyl signals 
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In the isolated BDA with those of the precursor demonstrated that a 
minimum of 90% of the LL-precursor was transformed intact into BDA. 
It was also of interest to determine the fate of the methylene 
hydrogen atoms in cyclo-(L-Phe-L-Phe) (42).39 A mixture of cyclo-
(DL-[3,3-D2]Phe-DL-[3,3-D2)Phe) and CYC1o-(L-[U_14C]Phe-L-Phe) was fed 
to A. terreus, and the deuterium content of the BDA produced was 
determined by mass spectrometry. Some [D4] species were detected, 
indicating, as did the experiments of Brannon et al.~6 that deuterium 
loss from the methylene group is not obligatory; but overall the results 
suggested a loss of ca. 20% of the total deuterium label. 
After cyclic dipeptide formation, several transformations are 
required to obtain the aranotin metabolites. The mechanism of sulphur 
introduction has not been investigated; it is probable that this takes 
place in a similar manner to the analogous conversion in gliotoxin 
biosynthesis, and that the di(methylthio)- compounds (BDA and BDAA) are 
derived from the appropriate epidisulphides. Neuss et al. 43 have 
advanced a plausible explanation for the formation of the unusual 
oxepin rings (Scherr.e III); the existence of members of the aranotin 
family having a cyclohexadienol ring system (acetylapoaranotin and 
EDAA) suggests that this mechanism might also operate in gliotoxin 
biosynthesis. 
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Further work concerning aranotin biosynthesis is described ln this 
thesis (Discussion). 
1.2.6 Summary 
All the metabolites investigated to date have amino-acid biogen-
eses, and all appear to have simple cyclic dipeptides as intermediates 
in the biosyntheses. Interestingly, all the known sulphur-containing 
dioxopiperazines have at least one moiety which appears to be derived 
from one of the aromatic amino-acids (phenylalanine, tryptophan or 
tyrosine). The other amino-acid residue in the dioxopiperazine ring 
can be derived from phenylalanine, serine, alanine, or glycine. 
The origin of sulphur and the mechanism of its introduction are 
not fully determined for any metabolite. The presence in some fungal 
extracts of epitrisulphides and epitetrasulphides is intriguing, and 
although there is some suggestion that these might be artefacts,49 
their wide occurrence 9 and the mildness of the isolation procedures -
argue against this possibility. The finding that, in gliotoxin bio-
synthesis, the bisdethiodi(methylthio)- derivative is formed irrevers-
ibly from the epidisulphide, may apply to other sets of metabolites in 
different organisms. Although the mechanism of cyclisation of nitrogen 
to the amino-acid side-chains has not been determined, the intervention 
of arene oxides is an attractive possibility in several cases. 
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~ Synthesis of sulphur-containing dioxopifkrazines 
More than 30 years elapsed between the isolation of gliotoxin and 
the first synthesis of an epidithiodioxopiperazine. This was achieved 
in 1968 by Trown,50 who prepared the epidisulphide (46) from sarcosine 
anhydride (43) by the 
ReJjEtOR 
) o 
) 
SH 
~o 
NMe 
route given below. 
Br 
MeN~ oA(Me 
(44) 
KSAc 
(H:OS-l 
) 
SAc 
Me~ 
o NMe 
) 
(46) 
Most syntheses of sulphur-containing dioxopiperazines have intro-
duced sulphur into the preformed dioxopiperazine ring by the above 
method, i.e. by displacement of bromide with a sulphur nucleophile. 
In particular, Kishi and coworkers51 have used this approach for the 
syntheses of gliotoxin (1),51 ,52 dehydrogliotoxin (9),51 ,53 spori-
desmin A (31),54 and hyalodendrin (24).51 Kishi's strategy was to 
introduce sulphur at an early stage, and elaborate the protected 
sulphur-containing dioxopiperazine before removal of the sulphur 
protecting groups to give the desired product. 
In the synthesis of gliotoxin,51 ,52 the key intermediate was the 
, 
dithioacetal (50), which was prepared by an extension of Trown's 
method, as shown below. 
22 
Me OMe 
(48) 
t a CO/ BU ~C02Bu J 
l"j • "'II r s':: 
o ) OH ~ 
~CO/BU 
+ U OMe ~ N/ ( 
(49) 0 OH / 
Glycine sarcosine anhydride (47) was methoxymethylated with 
chloromethyl methyl ether and potassium t-butoxide. Sulphur was 
introduced by radical bromination with N-bromosuccinimide followed by 
displacement with potassium thiolacetate, giving a mixture of cis- and 
trans- isomers of the di(acetylthio)- derivative. After methanolysis, 
the dithiol was protected with ~-anisaldehyde and boron trifluoride 
etherate, and the methoxymethyl group was removed by acid hydrolysis. 
This gave a mixture of dithioacetals which was separated by selective 
N-benzoylation and ammonolysis. The diastereomer (48) reacted with 
the arene oxide-oxepin (49) in basic conditions, giving a mixture of 
isomers (50) and (51). 
The ester (50) was converted to the alkyl chloride (52) by a 
standard route. This comFound, on treatment with phenyl-lithium (3.2 
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equivalents) cyclised to glve a gliotoxin type pyrrolidine rlng, and 
the hydroxymethyl function was introduced by treating the anion with 
benzyl chloromethyl ether, followed by cleavage of the benzyl ether 
with boron trichloride. This gave the protected racemic gliotoxin (53) 
which was deprotected by treatment with m-chloroperbenzoic acid and 
perchloric acid. 
HO ) HO 
Optically active gliotoxin was obtained by conducting the sarre 
series of reactions on the resolved dithioacetal (48a), and its proper-
ties were identical to those of the natural product (1). 
H~~" 
"r ~~ 1111110" OMe O~ e -
(48a) 
(~)-Dehydrogliotoxin (9) was synthesised by a similar route. The 
N-aryl ~yclic dipeptide (54) was prepared by an Uhlmann-type reaction 
between glycine sarcosine anhydride (47) and 2-iodo-3-methoxybenzoic 
acid followed by esterification of the carboxyl group. After intro-
duction of the dithioacetal as before, both diastereoisomers were 
converted into the chloromethyl derivatives (55), which were treated 
with phenyl-lithium, cyclised, alkylated, and deprotected as in the 
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gliotoxin synthesis (see above). 
~ N ~{ 0 
HO ~ a ? Me 
OH 
) ) 
(±)-Sporidesmin A (31) was also synthesised by Kishi using this 
method. 
gH 
Mea 
(±)-Hyalodendrin {24) was prepared by a slightly different 
method;51 the protected derivative (56) was formed from the dithiol (45) 
(prepared by the procedure described above) on treatment with chloro-
methyl methyl ether and base. Alkylation of this compound using lithium 
di-isopropylamide (2.3 equivalents) followed by benzyl bromide and 
bromomethyl benzyl ether, then deprotection with boron trichloride and 
oxidation of the dithiol to the disulphide, gave racemic hyalodendrin 
(21). Alkylation was highly stereoselective, giving mainly the cis-
dialkyl compound (57). 
Me;Y° )Mly a ) ~NMe a Me a 
SCHpMe PhCHp 
(45) (56) (57) (24) (±) 
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Hyalodendrin was also synthesised by Strunz and Kakushima55 by an 
adaptation of Kishi's route using the anisaldehyde dithioacetal 
protecting group. 
A modification of this method was used by Kirby et al. 30 to synth-
esise the unnatural metabolite (21). Sulphur was introduced into 
di(methoxymethyl) glycine anhydride (58) by the usual method, and the 
dithiol was methylated to give (59). This compound was alkylated with 
benzyl bromide and ethyl iodide; treatment of the product with boron 
tribromide gave a mixture containing the di(bromomethyl)-compound (60) 
which was deprotected with aqueous sodium bicarbonate to give (21). 
/ 
( 
(60) 
Several other groups have used nucleophilic substitution of bromine 
as their method for sulphur introduction. Foisel and Schmidt
56 treated 
sarcosine anbydride dibromide (44) with a variety of sulphur nucleo-
philes and obtained the expected sulphenylated products. Olsen et al. 57 
treated the same compound (44) with several ~minal dithiols and 
obtained the sulphur-containing substitution products (61), but were 
not able to form epidisulphides from them. 
o 
(44) 
o NuSMe 
Me 
a ~Me 
SMe 
Me~1J: 
O~Me 
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Met:l~O 01. JMe HS ~AO HS):::Y) Me~ ~~y (61); Y = 0 CHCOPh (44: lr O~NMe 
NNHPh ( CH2Ph) 2 
NPh Me, t-Bu 
NEt 
Similar nucleophilic displacements of leaving groups other than 
bromide have been successful; Schmidt et al. 58 replaced hydroxyl and 
methoxyl groups with thiols using zinc chloride catalysis. 
) 
This method was also used by Yoshimura et al. 59 with methoxide as 
the leaving group. Ottenheijm and coworkers60 carried out a similar 
reaction on the dioxopiperazine (63). 
Me 
) 
Me 
""--~I""'" Me 
SH 
N 0 
~ /t:lMe 
, Me1\H 
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The second reaction above represents yet another means of sulphur 
introduction,. i.e. addition of a thiol (or hydrogen sulphide) across a 
double bond. 61 Machin and Sammes found that, under strongly acidic 
conditions, thiols added to the didehydro- derivative of proline 
anhydride (64) in the desired sense; cis-di(ethylthio)-cyclo-(Pro-Pro) 
(65) was obtained using ethanethiol and hydrogen chloride in methylene 
chloride, along with the monoaddition product (66). Thiolacetic acid 
gave only mono-adduct (67). 
+ 
(64) (66) 
Yoshimura et al. 62 found that addition of methanesulphenyl chloride 
and sulphur monochloride to dialkylidene dioxopiperazines took place in 
the opposite sense; ~ dimethylene sarcosine anhydride (68) gave the 
28 
derivative (69) with sulphur monochloride. 
o NMe 
) 
~-s 
(68) (69) 
The use of electrophilic sources of sulphur has been less 
frequent. Poisel and Schmidt63 ,64 treated proline anhydride (70) with 
lithium di-isopropylamide or sodamide in liquid ammonia, to give the 
anion which reacted with sulphur electrophiles yielding thiolate or 
alkylthio- derivatives. The thiolate derivative (71) could be treated 
) 
1 (70) 
) 
) ( 
with more base, then sulphur, giving an amorphous oligosulphide (72). 
Treatment of this compound with sodium borohydride in methanol gave a 
solution of the cis-dithiolate (73) which could be alkylated with 
~ 
alkyl halides to give the cis-di(alkylthio)- derivatives, or acidified 
and the resultant dithiol oxidised with potassium triiodide to the 
epidisulphide (62). When cyclo-(L-Pro-L-Pro) was used as the starting 
material, optically active disulphide (62) was obtained. 
) ) 
Williams and Rastetter65 ,66 used several sulphur electrophiles in 
their syntheses of (±)-hyalodendrin (24) and (±)-bisdethiodi(methyl-
thio)hyalodendrin (25). Formylation of sarcosine anhydride (43) gave 
the enol (74) which was sulphenylated with methanesulphenyl chloride in 
THF, giving the formyl methylthio- compound (75). Reduction to the 
alcohol and protection with ~-butyldimethylsilyl chloride was followed 
by a second 8ulphenylation with dimethyldisulphide and lithium di-iso-
propylamid,e at -78°C. This gave a mixture of diastereoisomers (76) 
which were not separated. Benzylation of this mixture took place in a 
highly stereoselective manner to give (±)-bisdethiodi(methylthio)-
M;(t MeN~O > ) o!x Me o NNe 
MeS (HO 
(43) (74) (75) 
SMe Ph?y'e ~ Me~ .' 0 Me MeN ~ ) ~t'lNe NMe ~e 0 H \'''SMe MeS OSiMe2tSu Me OSiMe2tBu 
(76) (25) (:iJ 
) 
30 
hyalodendrin (25) in 38% yield from sarcosine anhydride. 
On the other hand, sulphenylation of the benzyl compound (77) 
gave a mixture of C1S- and trans- isomers of (25) in the ratio 2:5. 
SMe 
MeN 0 
> O~NMe 
HO 
(78) 
(±)-Hyalodendrin was synthesised by a similar method. The 
protected compound (79) was converted into the thiol (80) by adding 
the enolate in THF to a solution of monoclinic sulphur, followed by a 
reductive work-up (sodium borohydride). The thiol was protected as 
the methyldisulphide (81); hydrolysis of the silyl protecting group 
gave the enol (82), and treatment of this compound with triphenyl-
methyl chlorodisulphide led to the doubly sulphenylated compound (83), 
as a mixture of cis- and trans- isomers in the ratio 1:2. Reductive 
( 
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deprotection with sodium borohydride followed by oxidation of the 
dithiol with potassium triiodide gave (±)-hyalodendrin in 12.% overall 
yield. 
-------~ 
Ph 
S Me o 
< 
OH 
(24) (±) 
Ph '~SSMe 
MeN'" Y O~ /~He 
-HOj'rsSCPh3 
Ph 
(83)1 
SH 
Coffen and coworkers67 used a related reaction in their synthesis 
of aromatic analogues of the aranotins. Treatment of the dienol (84) 
with sulphur monochloride in methylene chloride with pyridine as a 
base, gave the disulphide (85), or when excess sulphur monochloride was 
used, the trisulphide (86). 
(85); x = 2 
o (86); x = 3 
> 
(84) 
Sato and Hino68 introduced sulphur by decarboxylation of the 
dipotassium salt (87) in the presence of sulphur monochloride, 
obtaining a mixture of di-, tri-, and tetra-sulphides (88). 
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) Me~'1:'t° x ~ 2, 3, or 4 
O~Me 
(88) 
Sato and Hino also formed ethylthio- and phenylthio- derivatives 
of sarcosine anhydride by the above method with sulphenyl chlorides as 
electrophiles. In a previous paper69 they had reported the formation 
of the mono-, di-, tri-, and tetra-sulphides (90) from diethoxycarbonyl 
sarcosine anhydride (89). 
CO~t C02Et M;¢r0 S2C12 M$Ox ) a NMe = 1 , 2, 3, o Me 4 or 
C02Et C02Et 
(89) (90) 
Summary 
Syntheses of sulphur-containing dioxopiperazines have been 
performed using both nucleophilic and electrophilic sources of sulphur. 
In general, substitution with sulphur nucleophiles has been preferred 
for the syntheses of the naturally occurring compounds; the usual 
strategy has been to elaborate a relatively simple sulphur-containing 
dioxopiperazine nucleus by alkylation of anions at the 3- and 6-
positions. The use of sulphur electrophiles has been less widespread, 
but they seem to be more suitable for the sulphenylation of dioxopip-
33 
erazines already substituted at the 3- and 6- positions. Many of the 
naturally occurring sulphur-containing dioxopiperazines have been syn-
thesised, the major exceptions being the aranotins; the difficulties 
in constructing the oxepin ring system have probably deterred anyone 
from attempting this synthetic challenge. 
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1.4 The use of fluorinated analogues in biosynthesis 
The use of analogues in biosynthetic studies can be of assistance 
in elucidating pathways. The ability (or inability) of living systems 
to convert chemically modified precursors into analogues of their 
normal metabolites can throw some light on the enzymic transformations 
occurring. There is also the possibility that analogue substrates will 
be metabolised in an abnormal way, giving rise to new structural 
t,ypes. 
Fluorine has attracted attention as a replacement for hydrogen in 
precursors. Its properties are especially suited to this purpose; it 
forms a strong bond with carbon (ca. 460 kJ/moD, and thus is not 
readily displaced; its Van der Waals radius (1.35A) is comparable with 
that of hydrogen (1.20 A), and therefore its steric interactions with 
enzymes will be similar; many fluorinated compounds are readily avail-
able; the element is uncommon in living organisms, so is easy to 
observe in isolation; .and the transformations of fluorinated analogues 
can be traced using the sensitive technique of 19F n.m.r. spectro-
scopy. 
The first work on fluorinated compounds in biological systems was 
concerned with fluoroacetic acid (91). This simple compound was 
isolated from Dichapetalum cymosum (Gifblaar), a plant responsible for 
cattle poisoning in South Africa. Animals which were given fluoroacetic 
acid were found70 to have a markedly increased concentration of citric 
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acid in their organs, and this suggested some interference in the 
tricarboxylic acid pathway. Administration of fluoroacetic acid to 
kidney homogenates resulted in the production of (~)-erythro-fluoro­
citric acid (92). This compound was found to be a competitive 
inhibitor of the enzyme aconitase, but the inhibition was not suffic-
ient to account for all the biological effects. Later work71 showed 
that the site of fluorocitrate action is at the mitochondrial membrane; 
the compound is a potent inhibitor of citrate transport across this 
barrier. Evidence for the formation of two fluorocitrate-protein 
adducts was found, these being believed to be thiolesters. Fluorinated 
fatty acids and esters containing an even number of carbon atoms in 
the fatty acid chain were shown to be toxic~O but those with odd 
numbers of carbon atoms were relatively non-toxic. A possible explan-
ation for this observation is that the even-numbered chains are 
degraded to acetate and fluoroacetate, this being the ultima.te toxic 
principle. 
Recently, Prestwich and Phirwa72 prepared the fluorinated phyto-
sterol derivatives (93). These compounds were very toxic to insects, 
e 
R 
H 
3E 
and their toxicity was attributed to degradation of the steroid side-
chain, giving fluoroacetate. Insects are particularly susceptible to 
these compounds because they obtain their steroids by degradation of 
those in their food. 
The metabolism of 5-fluorouracil (94) ,an antitumour drug, has 
been studied in various systems. It is converted by Bacillus subtilis 
to 5-fluorouridine, by Brevibacterium ammoniagenes to 5-fluoro-
uridylic acid, and by Streptomyces cacaoi (var. asoensis) to 5-fluoro-
polyoxins. 73 
o 
B. subtilis 
HO OH 
R=H ,QrOH 
The degradation of 5-fluorouracil (94) in animals has also been 
studied, and various products have been isolated. 73 
) 
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Fluorinated analogues have been used in investigations of the 
shikimate pathway. (Z)-3-Fluoro-2-phosphoenolpyruvic acid (95) was 
prepared and was shown to be a substrate for several enzymes. 74 It 
was converted in the presence of erythrose-4-phosphate to (3S )-3-deoxy-
3-fluoro-arabino-heptulosonic acid-7-phosphate (96) by an enzyme from 
Escherichia coli, and this compound was further converted to (6S)-
fluoro-3-dehydroquinic acid (97) by dehydroquinate synthase. 
@XJJ(C02H CHO C02H I + HtOH I C=O F H H OH ) F H -po HO H 
CH2O® 
I 
( 95) :H H 
H H 
HQ (02H CH20® 
-. ",J-i 
0 . ®;: _~-Oe F (96) 
0 OH 6e .,. OH (97) 
An interesting study of squalene biosynthesis used fluorinated 
analogues. The rates of condensation of the E- and Z- trifluoromethyl 
analogues (98) and (99) of dimethylallyl pyrophosphate with isopentenyl 
pyrophosphate, mediated by pig-liver synthetase, were substantially 
lower than those of the normal substrates. 75 These decreases correlate 
well with the decreases in solvolysis rates of the corresponding 
methanesulphonate derivatives under SN1 conditions, but not under SN2 
conditions, when the fluorine substitution produced slight enhancement 
of the solvolysis rates. 2-Fluorogeranyl pyrophosphate (100) also 
acted as a substrate for the enzyme, giving 6-fluorofarnesyl pyro-
phosphate (101); again, the rate decrease was comparable to the 
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decrease in the SN1 solvolysis rate of the analogue methanesulphonate 
from that of the geranyl derivative. These results suggested that the 
Me 
Me 
(100) 
Me 
o~ 7M 
Me Me 
(101 ) 
Gondensation-elimination mechanism which has been proposed for this 
reaction (Scheme IV) was incorrect, since it involves SN2 displace-
ment of pyrophosphate. 
Scheme IV 
ofEP) > 
Enz.-X Me 
V 
M o(® 
R 
En2-X: 1 
M 
R o@) 
This group also showed that, in the presence of pig-liver synth-
etase, racemic 2-fluoroisopentenyl pyrophosphate (102) was converted 
into 2-fluorofarnesyl pyrophosphate (103). In the normal biosynthesis, 
MI ~ Ger~L-{)~ M~ 
~ ~O~ Me 
F 
o(® 
F 
( 103) 
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there is stereospecific loss of the pro-~ hydrogen atom from C-2 of 
isopentenyl pyrophosphate; therefore, if (2g)-2-fluoroisopentenyl 
pyrophosphate were attacked by an enzymic nucleophile, as in Scheme IV, 
the covalent intermediate might be incapable of eliminating EX, and 
thus the enzyme might be deactivated. No significant deactivation 
took place, and this gave further support to the authors' arguments 
against an SN2 mechanism involving a covalently enzyme-bound inter-
mediate; however, the possibilities were not excluded that the enzymic 
nucleophilic attack is reversible, or that the R- isomer of (102) is 
not a substrate for the enzyme. 
The metabolism of fluorinated precursor analogues by Gibberella 
fujikuroi has produced a number of fluorinated gibberellins and related 
compounds,76 e.g. the acid (104) was converted by G. fujikuroi into 
the gibberellin A4 analogue (105). An interesting feature of this 
work is the use of a suppressant of terpenoid biosynthesis, so that 
the only substances metabolised are the more advanced precursors such 
as (104). 
H 
Several simple fluorine-containing aromatic compounds have been 
incorporated into analogues of natural products, and some examples of 
these conversions are given below: 
(4_Fluorophenylthio)acetic acid (106) was used as the side~chain for a 
penicillin (107).77 
( 1(6) 
~-Fluorobenzoic acid was converted by a Pseudomonas species into 
3-fluorocatechol (108) and 2-fluoromuconic acid (109).78 
a F 
OH F 
DOH CC02H ~I ) I ~ F + ~ C02H 
(108) ( 109) 
Acetobacter vinelandii transforms benzoic acid into catechol via 
mediate hydroxylated compounds, as shown below. 79 m-Fluoro- and 
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inter-
£-fluoro-benzoic acids were also converted into the intermediate (110) 
analogues. 79 
') 
HO 
( F) 
I (110) 
OH AOH 
V 
Similarly, a Pseudomonas species, given £-fluorobenzoic acid as its 
sole carbon source, produces 4-fluorocatechol, 4-carboxymethyl-4-fluoro-
41 
but-2-enolide, and ~-fluoroacrylic acid. 80 Ultimately all the fluorine 
was released as F- ion. 
OH o 
OH 
F F 
Also, 4-fluorophenylacetic acid (111) was oxidised by a Pseudomonas 
81 species to the derivatives sho~n below. 
o 
> 
F 
OH 
OH 
F F 
H02C/yC02H 
-
F ~ 
[3-14CJ-~-FluorOPhenYlalanine (112) was incorporated by 
Scutellaria galericulata into [2_14C] -4'-fluorochrysin (113).82 
F 
F 
Tryptophan is metabolised by Pseudomonas aureofaciens to pyrrol-
nitrins (114) and (115),83 and the analogue 6-fluorotryptophan was 
F 
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converted to the fluoropyrrolnitrin (116).83 Similarly, 6-trifluoro-
) 
Cl + Cl 
( 114) 
----4) Cl 
F 
(116) 
methyltryptophan (117) was converted into the analogue (118), which 
has not been chlorinated on the benzene ring. 83 
) 
( 118) 
In contrast, 5-fluorotryptophan (119) was not incorporated into' 
. 84 
ergot alkaloids by Clav1ceps purpurea. 
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Leete et ale studied the conversion of 5-fluoronicotinic acid (120) 
into the 5-fluoro- analogues of the alkaloids nicotine (121)85 and 
anabasine (122).86 
Nicotiana tabacum F 
( 120) Nicotiana 
F 
(122) (±) 
Fluorinated compounds have been used in investigations of enzymic 
hydroxylations. Bird et al. 87 prepared a series of fluorinated 5~-
androstanones and compared their metabolism to that of the unfluorin-
ated compounds by Calonectria decora, Rhizopus nigricans, and Asper-
gillus ochraceus. These fungi hydroxylate the steroids in character-
istic positions, and it was found that substitution of fluorine for 
hydrogen did not alter these positions if the. fluorine was distant 
from the site of hydroxylation, e.g. 3,3-difluoro-5a-androstan-17-one 
(123) was converted into the 11~-hydroxy derivative (124) by 
A. ochraceus in 45% yield. 
( 123) ( 124) 
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However, hydroxylation was inhibited at or adjacent to carbons 
bearing fluorine. 
Several organisms can replace fluorine with a hydroxyl group, e.g. 
an enzyme preparation from Streptomyces antibioticus transforms 
4-fluoroproline (125) into 4-hydroxyproline (126).88 
) 
( 125) ( 126) 
Liver microsomes from several species of animals can convert 
~-fluorophenylalanine (112) into tyrosine. 89 
F HO 
) 
co;-
(112) 
Halide-substituted acetanilides have been used for studies of 
"" t" 90,91 hydroxylation by llver mlcrosome prepara lons. 4-Fluoro- and 
4-chloro-acetanilides were hydroxylated with loss of halogen to give 
4-hydroxyacetanilide. The 3-halo- compounds were hydroxylated in the 
4- position without loss of the halide substituent. 
O NHAC ONHAC I -~) I ~ ~ X HO Y NHAC yNHAC I -~) I ~ HO" ~ X X 
X F or Cl 
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In summary, fluorinated analogues of natural substrates have 
been metabolised by a wide variety of biological systems. In most 
cases, the fluorinated precursor analogues were transformed into 
analogues of the "normal" metabolites; this was nearly always true 
when the fluorine was remote from the sites of the transformations. 
Interestingly, some organisms have the peculiar ability to replace 
fluorine with a hydroxyl group, but apart from this the fluorine 
substituent is not normally lost in biological transformations. There 
are few examples of the utilisation of the chemical properties of 
fluorine substituents to alter the course of biosynthetic processes; 
the investigation of squalene biosynthesis using fluorinated analogues 
of the normal pyrophosphate precursors75 was an interesting demonstr-
ation of the deliberate use of fluorine's electronegativity to 
elucidate a biological mechanism. 
CHAPI'ER 2 
DISCUSSION 
2.1 Review of biosynthesis 
46 
The research described in the introduction (Section 1.3) has 
elucidated the earlier stages of the biosynthesis of sulphur-containing 
dioxopiperazines to a considerable degree. For many of these metabol-
ites, the amino-acid precursors have been determined, and in several 
cases it has been shown that cyclic dipeptides are intermediates on the 
biosynthetic pathways. Our knowledge of the transformations taking 
place after cyclic dipeptide formation is, however, rather limited. 
The feature common to all members of this metabolite family, apart 
from the dioxopiperazine ring, is the presence of sulphur, either as 
an epipolythio- bridge or as methylthio-groups; but when this project 
was begun, the timing and mechanism of sulphur introduction remained 
obscure. The cyclisation of the aromatic rings of the precursors onto 
nitrogen of the dioxopiperazine ring, with concomitant oxygenation, is 
a characteristic of many of the metabolites, ~ gliotoxin and the 
aranotins, but little is known of the biosynthetic pathways leading to 
these systems. The only relevant observations are that in gliotoxin 
and aranotin biosynthesis, no hydrogens are lost obligatorily from the 
aromatic ring of phenylalanine. This, coupled with the observed 
stereochemistry of the natural products, allowed Neuss to propose the 
intermediacy of arene oxides in the biosynthesis of these rr.etabolites 
(Introduction, Section 1.3), but it is unlikely that any such compounds 
would be stable enough to be tested as precursors by normal methods. 
There remains, however, the possibility of obtaining information on 
these biosynthetic transformations indirectly, by the use of analogue 
47 
precursors. These might be accepted by the fungi as normal precursors 
and be metabolised to give analogues of the natural products, or they 
might be metabolised abnormally to give new metabolite types, whose 
structures might reveal something of the nature of the processes 
required to form them. Furthermore, a late step in the biosynthesis 
might be inhibited by the structural change in the precursor, and 
thus, the analogue of a normally transient intermediate might accum-
ulate and be identified. 
~ Aspergillus terreus 
In all our feeding experiments, the fungus used was Aspergillus 
terreus, strain NRRL 3319. This fungus has been reported92 to produce 
acetylaranotin (38), but under our conditions the main metabolites 
were BDA (40) and BDAA (41), although a small amount of acetylaranotin 
was usually present. The change could be related to the higher temper-
ature in our growth room, as compared with the literature conditions 
(28°C rather than 25 0 C). Other than this, the growth conditions of 
Miller and Trown92 were followed. 
M eS~'\' L--...J... 
(41 ) 
AcO 0 
MeS"\\ ~--l 
(40) 
o 
o 
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Few problems were encountered with the growth of this fungus, but 
one significant requirement for the production of aranotin metabolites 
was normal daylight illumination. Continuous artificial lighting 
stopped the production of aranotins, and total darkness also had an 
adverse effect, although in this case some aranotin production contin-
ued. 
In the course of this work, a number of metabolites were isolated 
which had not been previously reported from this strain of A. terreus. 
The metabolite (127), previously found by Kiriyama et al. 93 in another 
strain of A. terreus (IFO 8835), was isolated from several of our 
extracts by preparative t.l.c •• Also, small amounts of orsellinic 
acid (128) and ergosterol (129) were found. A compound identified as 
ergosterol endo-peroxide (130) was also obtained from some extracts, 
although it is not certain that this was not an artefact. 
OH 
Me OH 
HO 
OH 
(128) 
e 
HO H 
(130) 
Me 
cyclo-(L-Phe-L-Phe) (42) was isolated for the first time from 
extracts of this fungus grown without added precursor, although it has 
been shown to be produced by A. terreus in an intermediate-trapping 
. t 48 T . experlmen • he lsolation of 
(131)94 is discussed in Section 
cis-di(methylthio)-cyclo-(Phe-Phe) 
2.6. 
Ph )y~SMe " () HN 
O~./NH ~S~Ph 
2.3 Preparation and feeding of fluorinated analogues 
2.3.1 Rationale 
48 It had already been demonstrated that cyclo-(L-Phe-L-Phe) (42) 
is an intermediate in the biosynthesis ofaranotins by Aspergillus 
terreus. Therefore, we thought that this compound would be a suitable 
subject for mimicking with analogues. The analogues which we chose to 
prepare were fluorinated on the aromatic rings of cyclo-(L-Phe-L-Phe); 
these were thought to be suitable for several reasons. 
i) The fluorine substituent, being of small size (Van der Waals 
radius ca. 1~ A) should not change the molecule sterically so much 
that it would no longer be accepted by the fungal enzymes. 
ii) A fluorine substituent on the aromatic ring should have a 
significant effect on the formation of arene oxides, but should be 
sufficiently removed from the site of sulphur introduction to have 
little effect on this process. Thus it was thought that there might 
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be produced metabolites containing sulphur, but with abnormally oxygen-
ated (or unoxygenated) fluorinated aromatic rings. 
iii) Since the only fluorinated compounds in the cultures would be 
derived from the materials fed, the unnatural metabolites would be 
easily detectable by 19F n.m.r. spectroscopy of fungal extracts or 
substances derived therefrom. 
Also, fluorinated analogues had been used successfully before in 
biological systems, as detailed in the Introduction (Section 1.4). 
2.3.2 Preparation of fluorinated analogues of cyclo-(L-Phe-L-Phe) 
We therefore set out to prepare a range of fluorinated analogues 
of aranotin precursors. The only such compound available commercially 
in radioactive form was DL-~-fluorophenylalanine, although DL-o- and 
m-fluorophenylalanines were available unlabelled. 
Our first objective was the preparation of cyclo-(L-Phe-L-£-Fluoro-
phe) (132). This was achieved by a standard peptide-type synthesis95 
from L-phenylalanine and DL-~-fluorophenylalanine, followed by separ-
ation of the 1: 1 mixture of LL- and LD- isomers by preparative t.l.c. 
(solvent system; chloroform: methanol: acetic acid, 9:0.5:0.5), but 
rather poor yields were obtained since only half of the product mixture 
was of use, and the t.l.c. separation was difficult; more than 20 mg of 
mixture per 20 x 20cm, 1 mm-thick plate caused streaking. We therefore 
thought it desirable to devise a synthesis of the single, LL- isomer. 
) 
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F 
H 
HN 0 
~ t.l.c. (13Z) NH ) o ." H -' " Ph 
DCC = dicyclohexylcarbodiimide 
It was known that aldehydes could be condensed with ~,N'-diacetyl 
cyclic dipeptides containing a glycyl residue (cf.the Perkin condens-
ation) giving alkylidene or arylidene derivatives. 96- 98 It was 
reasonable to suppose that this reaction could be carried out with 
substituted benzaldehydes and N,Nl-diacetyl-9yclo-(Gly-L-Phe) (133), 
and that the arylidene derivatives so produced (134) would be catalyt-
ically hydrogenated to give predominantly the cis- (LL) compounds 
(135);99 deacetylation would then give the desired analogues (136) of 
cyclo-(L-Phe-L-Phe). 
Ar A~>y ;zo ArCHO HN 0 Fdic HI'! ,.,H ° ~?c o , Ac Base HZ' MeOH o ." NAc 
H'" H'" 
Ph Ph Ph 
( 134) 
Ar?y~H 
.\, 0 
HN O?(H 
Ph 
(136) 
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Accordingly, we embarked on this route. 
cyclo-(~ly-L-Phe) (137)100 was prepared by the general method of 
Blaha. 95 It a t f . w s necessary 0 lnd a method of acetylation which would 
not cause racemisation of the cyclic dipeptide. Treatment with acetic 
anhydride under neutral or basic (pyridine or sodium acetate) conditions 
gave the diacetyl derivative (133),101 but with sUbstantial racemis-
ation. Interestingly, the L- enantiomer had a higher melting point 
(103-104°C) than the racemate (85-87°C), and crystallised separately 
f.rom solutions of the partially racemised compound (133). Acid-
catalysed acetylation (HC104) proceeded without racemisation to give 
the desired L-enantiomer in good yield. 
HN~O Ac20 >~o o~NH HC104 a " NAc 
H'~ H'" 
Ph Ph 
( 137) ( 133) 
Our first attempts at condensation of the diacetyl cyclic dipeptide 
(133) with aromatic aldehydes were conducted using 2,6-difluorobenz-
aldehyde. Gallina and Liberatori97 had found that activated aldehydes 
~ ~-nitrobenzaldehyde, would condense with N,N'-diacetyl-cyclo-
(Gly-Gly) in DMF in the presence of triethylamine, but that more 
unreactive aldehydes required a stronger base (potassium i-butoxide). 
Because of the necessity to avoid racemisation, we tried the weaker 
base, triethylamine, first. Reaction of N,N'-diacetyl-cyclo-(Gly-
L-Phe) (133) in DMF with 2,6-difluorobenzaldehyde and triethylamine 
took place over ca. 3 days at room temperature,giving the N-acetyl 
arylidene compound (134a) in reasonable yield. The acetyl group of 
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the glycyl residue was lost, in accordance with the mechanism proposed 
by Gallina and Liberatori,97 and z- geometry of the double bond was 
inferred by comparison of the chemical shift of the vinylic proton in 
the n.m.r. spectrum to those of known examples. 97 However, the 
considerable variation in optical activity of samples from different 
runs suggested that some racemisation was taking place, and this was 
confirmed by n.m.r. spectroscopy with the use of a chiral europium 
shift reagent; the ratio of L- to D- isomer in the sample of highest 
optical activity was ~ 2:1. An alternative method of preparation of 
(134), which would not cause racemisation, was therefore sought. 
Kanmera et al. 98 had used a ver~ similar route to our proposed 
method, in their asymmetric syntheses of ~-amino-acids. They condensed 
N,N'-diacetyl-cyclo-(L-Ala-Gly) with aldehydes, and after deacetylation 
of the product, catalytic hydrogenation gave predominantly the LL-
cyclic dipeptide, which was hydrolysed to its constituent amino-acids. 
The condensation was carried out using potassium t-butoxide at room 
temperature, and no racemisation was observed. We therefore tried 
potassium t-butoxide as the base in our reaction. Using one equivalent 
of base at aOc, the condensation of 2,6-difluorobenzaldehyde with 
(133) was virtually complete after 1 h, and n. m.r. spectroscopy of the 
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product (134a) using the chiral europium shift reagent did not detect 
any D- isomer. This method was therefore used to prepare the series 
of compounds (134a-f); all of these were obtained as oils. 
F 
AC~O O~AC 
Ar 
ArCHO, HNlyo 
F 
Ar=a) 1 ) d) -\ ) 
Ph 
DMF, KOtBu ) O~C 
H\"'~r 
Ph 
( 134) 
F F F 
b)-\ j-F e) ~ tF 
F F F 
c) ~ > f) -\ ) 
The nature of the aldehyde did not appear to have a great effect 
on the rate of the reaction. The reasons for the conservation of 
optical activity when potassium t-butoxide was used rather than tri-
ethylamine, are not clear, but one factor might be that the starting 
material is consumed much faster than in the reactions with triethyl-
amine; once the acetyl group is removed from the glycyl residue, the 
~-hydrogen of the phenylalanyl residue is likely to become much less 
acidic. 
Preliminary experiments showed that the products of deacetylation 
(138) of the arylidene compounds were very insoluble in most solvents, 
Ar) 
HN~O O~/NH 
- H""~ 
Ph 
( 138) 
98 
and this discouraged the use of the method of Kanmera et al. for the 
hydrogenation of the double bond. The N-acetyl arylidene compounds 
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(134) were much more soluble; catalytic hydrogenation of these, in 
methanol with a trace of acetic acid, was usually complete after 24 h. 
The N-acetyl cyclic dipeptides .(135) were not isolated; hydrazinolysis 
of the crude products of hydrogenation gave the cyclic dipeptides 
(136a-f), which were easier to purify. 
Ar Ar>y Ar H~~O HN*fa Fdic, H2 HN'> 0 H2NNH2 ~A( >~ MeOH o _>' NAc DMF > ?:cNH o . 
H" H"" 
Ph Ph Ph 
( 134) ( 135) (136) 
T.l.c. and n. m.r. spectroscopy gave no indication of the presence 
of any trans- isomers in the crystallised cyclic dipeptides, thus 
verifying that hydrogenation had taken place with virtually complete 
stereospecificity on the opposite face of the arylidene compound to 
the phenylalanyl side-chain. As a further demonstration that race mis-
ation did not occur at any stage, cyclo-(L-Phe-L-Phe) (42 = 136f) was 
prepared by the above method, and its optical rotation was comparable 
to that of material prepared by other methods or isolated from natural 
102 103 
sources. ' 
The symmetrical fluorinated analogues of cyclo-(Phe-Phe) (139a 
and 139b) were prepared by a similar method. Di-(E-fluorobenzylidene)-
piperazinedione (140a) was prepared by Sasaki's general method,96 and 
the preparation of di-(pentafluorobenzylidene) piperazinedione (140b) 
followed the method of Gallina and Liberatori. 9? Both compounds were 
catalytically hydrogenated in methanol-acetic acid to give exclusively 
the cis- racemic cyclic dipeptides (139a and b). 
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The radio-labelled compounds were prepared by the foregoing 
r,nethods, using [1-14C] glycine to prepare the intermediate cyclo-
C[1_14C]Gly_L_Phe); hence all the radioactive cyclic dipeptides used 
in the feeding experiments were labelled at the carbonyl of the fluor-
inated phenylalanyl residue. 
+ HN~* -3 CO2 ) ) 
2.3.3 N.m.r. spectra of cyclo-(Phe-Phe) analogues 
There has been considerable interest shown in the n.m.r. spectra 
f 1 · d . t . d . th t . . d h' 1 04-1 a; o cyc 1C 1pep 1 es W1 aroma 1C S1 e-c a1ns. In compounds 
such as cyclo-(Gly-Phe), the n.m.r. signal of one proton of the glycyl 
methylene group is shifted substantially upfield (by ca. 1 p.p.m. from 
the expected position at 6 ~. 4.0), and this is attributed to a 
tendency for the molecule to adopt a conformation where the phenyl 
group is lying over the dioxopiperazine ring; the aromatic ring then 
shields the cis- glycyl proton. In cyclo-(L-Phe-L-Phe) (42), the 
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H 
cyclo-(Gly-Phe) 
signals due to the protons of the methylene group are split into an 
ABX system; one of the methylene proton signals is to considerably 
higher field (&2.34) than expected from comparison with other phenyl-
alanine derivatives.(methylene signals at~ 3.1). This shift is again 
attributed to shielding by the aromatic ring of a benzyl methylene 
104-proton at the other end of the molecule; the side-chains might 
prefer to occupy positions such that one of the methylene protons is 
in the shielding region of the phenyl group of the other side-chain. 
0""" .. H H 
A 
The larger coupling constant to the a-proton associated with the 
. upfield methylene proton signal is consistent with a trans- vicinal 
relationship, in agreement with the postulate that this proton is 
preferentially located nearest to the distal benzyl group. 
Because of time averaging, the signals from both methylene groups 
in cyclo-(L~Phe-L-Phe) (42) are identical. It was noted by Liberek et 
al. 104 that in unsymmetrical dipeptides of this type, the methylene 
proton signals of the group with the more electron-rich aromatic ring 
were shifted less than those of the electron-poor ring. They inferred 
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that this was due to the electron-rich ring spending a greater fraction 
of the time over the dioxopiperazine, so that the dominant configur-
ation was that shown below (for the E-nitrophenyl analogue). 
o~o 
\ ~ ',,',', H 
H 
104-These workers located the signals for each residue by non-
stereospecific deuterium labelling of phenylalanine in the methylene 
group. Our synthesis of cyclo-(Phe-Phe) analogues, as described in 
Section 2.4, had potential for stereospecific labelling with deuterium; 
we could thus determine which proton was abnormally shielded. cyclo-
(L-Phe-L-E-Fluorophe) (136b) was chosen for this study, since one of 
the methylene protons was at exceptionally high field in the n.m.r. 
spectrum in TFA, (~ 2.07) • The arylidene compound (134b) was reduced 
with deuterium gas instead of hydrogen, and the product was deacetyl-
ated as before. The isolated cyclic dipeptide t136g) was stereospecif-
ically deuteriated at the ~-position and one of the methylene positions 
in the E-fluorophenylalanyl residue; the n.m.r. spectrum showed a 
collapse of the high-field doublet of doublets at & 2.07 to a broad 
singlet, and the disappearance of a one-proton signal at lower field 
(~ 3.01) • Assuming Z-geometry for the double bond in the arylidene 
compound, the pro-S hydrogen of the cyclic dipeptide (136g) should be 
replaced by deuterium; thus, the high-field n.m.r. signal is from the 
pro-R hydrogen of the fluorinated aromatic residue. 
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) 
( 134b) ( 136g) 
Similarly, when [formyl-D] -~-fluorobenzaldehyde was used to 
,prepare the arylidene compound (134h), hydrogenation and deacetylation 
gave the cyclic dipeptide (136h); in this case the high-field, pro-B 
proton signal was not observed. 
The proton n.m.r. spectra of these deuteriated compounds, together 
with that of the undeuteriated (136b), are illustrated in Figure 1. (on 
page 60). 
ACN~ 
OJ;/NAC 
H"l,Ph 
F 
) 
These data suggest a predominant configuration for (136b) as shown 
below, with the pro-~ hydrogen of the fluorophenylalanyl residue 
closest to the phenyl ring. 
F 
N--~ 
H 
IA'7~' \ 
Figure 1 1 H n.m.r. spectra of cyclo-(L-Phe-L-E-Fluorophe) and its 
deuteriated analogues (136g) and (136h) (methylene and 
methine signals) (in TFA). 
cyclo-(L-Phe-L-~-Fluorophe) (136b) 
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Because the geometry of the double bond of the arylidene compound 
(134b) was not absolutely certain, further confirmation of this result 
was obtained by reducing dibenzylidenepiperazinedione (140c)96 with 
deuterium; the configuration of (140c) is well established. 107 Again, 
the proton n.m.r. signals from the methylene group of cyclo-(L-Phe-
L-Phe) (42) were reduced to a broad singlet at5 2.30 in (±)-tetra-
deuterio-cis-cyclo-(Phe-Phe) (139c). Therefore the upfield methylene 
proton is once again pro-~ in cyclo-(L-Phe-L-Phe) • 
Ph 
o 
) 
(140c) (139c) 
2.3.4 Feeding experiments with fluorinated analogues 
Our first feeding experiments were conducted using DL-£-fluoro-
phenylalanine (112), an analogue of the natural precursor, L-phenyl-
alanine. When fed as a tracer to Aspergillus terreus, DL-[3-14CJ-
E-fluorophenylalanine was incorporated at a very high level (ca. 40%) 
into the total chloroform extract, and t.l.c. followed by radio-
scanning and autoradiograms of the t.l.c. plates showed that nearly all 
F 
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of this activity was in a compound whose t.l.c. properties were very 
like those of BDAA (41). Unlabelled DL-:Q-fluorophenylalanine was then 
fed at a sub-lethal dose (it was found to kill the fungus at 5 mM, but 
to be relatively innocuous at 05 roM), and the broth extract was 
subjected to n.m.r. spectroscopy. The proton-decoupled spectrum con-
tained a strong signal at & -123, and several other weaker signals 
clustered around & -115; the latter shift is characteristic of ,E-fluoro-
benzyl compounds, ~ cyclo-(L-Phe-L-:Q-Fluorophe) (136b). The signal 
at & -123 was also present in the spectra of extracts from cultures fed 
cyclo-(L-Phe-L-:Q-Fluorophe) (136b), and radioactivity from this comp-
ound was also observed to be incorporated into the BDAA-like metabolite 
(by autoradiography of chromatograms). Isolation of this compound 
proved difficult because of its similarity to BDAA, but it was event-
ually purified by repeated t.l.c. separation. The mass spectrum of 
this compound had a molecular ion at m/z 536, and the accurate mass 
of this ion gave the molecular formula as C24H25FN207S2' corresponding 
to a fluorinated BDAA. The next highest significant ion in the mass 
spectrum was at rrv'~ 489, produced by loss of [SMeJ from the molecular 
ion; this loss occurs in the mass spectra of BDA, BDAA, etc. The 
proton n.m.r. spectrum contained a set of signals attributable to an 
aranotin ring system, the chemical shifts and couplings being almost 
identical to those of the spectrum of BDAA. There were four other 
proton signals in the olefinic region; by selective decoupling experi-
ments the signals were shown to be consistent with a fluorocyclohexa-
dienol acetate system, with fluorine on the carbon adjacent to the 
carbon bearing the acetate group. All of the protons in the cyclo-
hexadienol ring were coupled to fluorine; these couplings were corr-
19 
elated by selective proton decoupling of the proton-coupled F n.m.r. 
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spectrum. The experimental data thus established the structure of the 
analogue metabolite as the fluoro-BDAA (141). 
F 
HN ~ O~/NH 
H\"~ 
Ph 
a 
The incorporation of cyclo-(L-Phe-L-:e-Fluorophe) into the analogue 
was not measured directly, because of losses of material on isolation, 
but 19F n.m.r. of the fungal extract using :e-fluorobenzoic acid as a 
standard gave an approximate incorporation of 1.8% into fluoro-BDAA, 
and a total incorporation of fluorine into the extract of 6.2%. This 
value is in fairly good agreement with the incorporation of 14C label 
into the total chloroform extract of 8.0%. 
It was of interest to determine the nature of the other fluorin-
ated metabolites present in the extract. On autoradiograms of 
extracts from cultures fed DL-~-fluorophenylalanine, spots were 
observed which corresponded to cyclo-(L-Phe-L-~-Fluorophe) and cis-
cyclo-(~-Fluorophe-~-Fluorophe) standards. Chromatographic separation 
of the extract and crystallisation of the material extracted from near 
the baseline, gave cyclo-(L-Phe-L-Phe) (42) with smaller amounts of 
cyclo-(L-Phe-L-~-Fl~orophe) (136b) and cis-cyclo-(~-Fluorophe-B-Fluoro­
phe) (139a) as determined by 19F n.m.r. spectroscopy and mass spectro-
metry. 
Activity on autoradiograms was also observed at a spot on t.l.c. 
E 
plates running with higher Rf than BDAA and the other aranotin metabol-
ites. Preparative t.l.c. allowed the isolation of a crystalline 
substance from this part of the extract; the compound could be obtained 
from both fed and unfed extracts. The structure (131) was assigned on 
the basis of its spectral properties. The highest significant ion in 
the mass spectrum was at ~z 339; this corresponds to loss of SMe from 
a di(methylthio)-cyclo-(Phe-Phe). The accurate mass measurement of 
this ion gave a formula of C19H19N202S, and a molecular ion of formula 
~20H22N202S2 was also observed. The 1H n.m.r. spectrum confirmed the 
presence of SMe groups, benzyl groups and NH protons. Since the meta-
bolite was optically active, the relative configuration must be cis-. 
This compound is the first reported sulphur-containing dioxopiperazine 
natural. product without substitution on nitrogen; its synthesis and its 
relationship with the biosynthesis of the aranotins are discussed in 
Section 2.5. 
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When the above compound (131) was isolated from extracts which had 
19 been fed DL-~-fluorophenylalanine, mass spectrometry and F n.m.r. 
showed it to contain small amounts of the analogues containing either 
one or two fluorophenyl rings (142) and (143) • Similar analogues were 
obtained from feedings of cyclo-(L-Phe-L-£-Fluorophe) (136c), cyclo-
(L-Phe-L-~-Fluorophe) (136d), cyclo-(L-Phe-L-E-Fluorophe) (136b), 
cyclo-(L-Phe-L-2',6'-Difluorophe) (136a), and (±)-cyclo-(E-Fluorophe-
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£-Fluorophe) (139a). The di(methylthio)- analogues were all isolated 
by co-crystallisation with the natural product (131), and were charac-
terised by 19F n.m.r. spectroscopy and mass spectrometry of the mixt-
ures. Of course, only the analogues containing one fluorinated ring 
were observed, except for the metabolite from (139a), where the 
precursor has two fluorinated aromatic rings. Spots corresponding to 
the analogue metabolites were also seen on autoradiograms when the 
radioactive precursors were fed. 
F F 
or 
,SMe 
", HN' 0 
~H o .' MeS"" Ph or antipode antipode 
F 
( 142) 
Apart from the detection of these. analogues, the feeding experi-
ments with fluorinated precursors have not been very fruitful. (±)-
cis-cyclo-(£-Fluorophe-£-Fluorophe) (139a) was fed to A. terreus, but 
the 19F n.m.r. spectrum of the extract had only three prominent 
signals, all of which were in the "aromatic" region (& ~ -115). Two 
of these signals may be assigned to the starting material (139a) and 
the di(methylthio)- analogue (143). A similar pattern was observed 
with cyclo-(L-Phe-L-E-Fluorophe) (136c) and.cyclo-(L-Phe-L-~-Fluorophe) 
(136d); three signals were present in the 19F n.m.r. spectrum in each 
case, and two of these were accounted for by the starting materials 
and the di(methylthio)- analogues (144) and (145). The amino-acids, 
DL-o-fluorophenylalanine and DL-m-fluorophenylalanine, gave a wider 
- -
range of fluorinated metabolites, but because the amino-acids were not 
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( 146) 
radioactive we were unable to isolate and characterise any of these. 
More interesting was cyclo-(L-Phe-L-2',6'-Difluorophe) (136a), 
which was metabolised to give a number of compounds, including some 
whose behaviour on t.l.c. was close to that of the aranotins. Unfort-
unately, because of losses on successive t.l.c. separations, only the 
starting material and the di(methylthio)-cyclo-(Phe~Phe) analogue (146) 
were detected with certainty. Similar problems were encountered with 
cyclo-(L-Phe-L-Pentafluorophe) (136e). The 19F n.m.r. spectrum of the 
fungal extract indicated the presence of several compounds, all of 
which possessed pentafluorophenyl rings as shown by the characteristic 
19F splitting pattern. However, none of these was isolated in a pure 
state, because of insufficient quantities. 
Finally, the "analogue" (±)-cis-cyclo-(Pentafluorophe-Pentafluoro-
phe) (139b) was fed to A. terreus. Not surprisingly, this compound 
19 
was not metabolised, and the signals in the F n.m.r. spectrum of the 
extract were those of the starting material only. 
The most interesting result was therefore the incorporation of DL-
E-fluorophenylalanine (112) and cyclo-(L-Phe-L-E-Fluorophe) (136b) 
into fluoro-BDAA (141). In this case, the modified precursor has 
evidently been accepted as a substrate by the aranotin-producing 
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enzymes, and has been oxygenated on the aromatic ring bearing fluorine. 
However, no compounds having fluorine in an aranotin (oxepin) ring 
were detected, so fluorine appears to prevent a second oxygenation of 
the aromatic ring from taking place. Also, the non-incorporation of 
cis-cyclo-(E-Fluorophe-E-Fluorophe) into ring-oxygenated metabolites 
may be significant; it might be necessary to oxidise one ring to an 
aranotin system before operations at the other end can commence. An 
interesting experiment related to this discussion was the observation 
?f the incorporation of cyclo-(L-E-Fluorophe-L-Ser) (147) into the 
fluorogliotoxin (148).108 
F 
HN 0 G. deliquescens 
O~NH 
OH 
( 148) 
There are several possible explanations for the failure of cyclo-
(L-Phe-L-E-Fluorophe) (136b) to give compounds fluorinated on an 
aranotin ring. Firstly, there might be two separate enzymes or enzyme 
active sites, one of which forms aranotin rings, and the other cyclo-
hexadienol rings. The former enzyme might then not accept the fluorin-
ated aromatic ring as a substrate. Alternatively, the fluorine 
substituent might affect the behaviour of the monooxygenated intermed-
iate, ~ (149) (A)~(B) in such a way that it is not oxygenated a 
second time. For example, the fluorinated oxepin (B) might not be an 
acceptable substrate for the enzyme performing the second oxidation; 
or, the fluorine substituent might alter the position of the equilib-
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rium between arene oxide and oxepin, so that oxygenation cannot take 
F 
o 
HN R 0 F 
oAPR'-~) ? . ~ F ~ ~ HN ~ 0 O~NR' 
R" ~ R" t - (B) (A) 
F 
place to any detectable extent because the oxepin is not present in 
sufficient amount; or, the fluorine substituent might increase the 
reactivity of the arene oxide (A), so that nucleophilic attack by 
nitrogen takes place before a second oxygenation can occur. In princ-
ipl~ a distinction between these alternatives might plausibly be made 
on the grounds of chemical reactivity. Unfortunately, though not 
surprisingly, there appear to be no examples in the literature of 
fluorinated arene oxides or, of course, the corresponding oxepins. 
After our first result, the failure of the 0- and m-fluoro- anal-
ogues (136c) and (136d) to be incorporated into aranotin-like 
compounds was somewhat unexpected, That the di(methylthio)-cyclo-
(Phe-Phe) analogues [(14~ and (145)J were detected is an indication 
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that the cyclic dipeptides were absorbed into the fungal cells, so cell 
walJ impermeability was probably not the cause of their non-incorpor-
ation. Moreover, introduction of sulphur into the molecules was not 
prevented by fluorine substitution, so it appears that fluorination had 
now inhibited even the first oxidation step. The 2' ,6'-difluoro- and 
pentafluoro- analogues (136a) and (136e) were converted into unnatural 
metabolites (detected by 19F n.m.r. and autoradiography) which might 
be related to aranotin biosynthesis, but further work is necessary to 
determine the structures of these compounds. 
2.3.5 Conclusions 
In at least some cases, fluorine substitution on aranotin precur-
sors had t~e predicted effect, ~ it inhibited oxygenation of the 
aromatic rings. Several fluorinated analogues of the natural metabol-
ites were detected, but isolation and characterisation was hindered by 
the low conversions of the precursors to metabolite analogues. The 
use of similar analogues in related biosynthetic systems, ~ the 
1 · . d' f Gl' 1 d' d l' 108 . ht g 10tox1n-pro uC1ng ungus 10C a 1um e 19uescens, ID1g prove 
to be enlightening. 
2.3.6 Feeding of deuteriated fluorinated analogues 
Several attempts have been made to establish whether the methylene 
hydrogens in precursors of sulphur-containing dioxopiperazines are lost 
during the biosynthesis (see Introduction). This is important since 
it is possible to envisage sulphur introduction by addition of thiols 
to unsaturated precursors such as (140q. This research has been 
hampered by various problems; enzymic exchange of the methylene 
K· 27· th' protons of phenylalanine was noted by Johns and 1rby, 1n e1r 
70 
investigations with gliotoxin, and Pita et ale 39 in their research 
- -_, on 
aranotin biosynthesis, had difficulty in interpretation of mass 
spectral data because of overlap of isotope (13C, 34S) peaks from 
natural, non-deuteriated BDA with the peaks arising from deuteriated 
BDA. However, the evidence gathered to date, as discussed in the 
Introduction, tends to support the view that there is no obligatory 
loss of hydrogen from the methylene groups of gliotoxin and aranotin 
precursors, although some experimenters have observed a small loss of 
deuterium and tritium label from these positions. 16 ,39 
Our isolation of a new, sulphur-containing metabolite, di(methyl-
thio)-cyclo-(Phe-Phe) (131) , along with its fluorinated analogues, 
gave us the opportunity to tackle this question in an unusual way. We 
had already prepared cyclo-CL-Phe-L-~-Fluorophe) stereospecifically 
labelled with deuterium at both the pro-g and pro-~ positions of the 
fluorobenzyl methylene group [C136g) and C136h)]. Feeding these 
compounds to A. terreus, isolation of the mixture of diCmethylthio)-
cyclo-(Phe-Phe) and the ~-fluoro- analogue (142), and mass spectrometry, 
should give a fairly accurate indication of how much deuterium is lost 
from each position during sulphur introduction. The advantage of this 
approach lies in the fact that., the mass spectral peaks for the fluorin-
ated products are, of course, shifted to higher mass, well clear of 
the isotope peaks of the natural metabolites. 
Firstly, the deuterium content at the methylene group of the 
precursor analogues had to be quantified. The cyclo-(L-Phe-L-(3R)-
[3-DJ-~-FluoroPhe) C136h) was unfortunately slightly contaminated with 
the dehydro-cyclic dipeptide (r~8h), because of incomplete hydrogen-
ation; however, the signals in the rrass spectrum due to this compound 
could easily be subtracted, and a minimum deuterium content at the 
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methylene group of 95% was calculated, in accord wl·th the proton m n. .r. 
spectrum which gave a similar value. The other analogue, cyclo-(L-Phe-
L-(3S)-[2,3-D2J-~-FluoroPhe) (136g) was similarly calculated to have a 
minimum deuterium content at the methylene group of 93%. Di(methyl-
thio)-cyclo-(Phe-Phe) (131) and the ~-fluoro- analogue (142) were 
isolated from cultures fed each deuteriated compound, and the intens-
ities of the ions in the mass spectrum corresponding to loss of a 
methylthio- group from the fluorinated analogues (i.e. the highest 
significant ions) were compared to the intensities in the undeuteriated 
analogue (142). In both cases, the most abundant ion was at ~~ 358, 
corresponding to the retention of one deuterium atom. By comparison of 
the intensities of the ions at m/z 357 to that of the ion at m/z 356 in 
the undeuteriated analogue (142), and taking into account the percent~ 
age deuteriation of each precursor, the loss of deuterium from each 
methylene group was calculated as 6% from the (3R)-[3-D]- compound 
(136h), and 11% from the (3S) -[3-D} analogue (136g). The only factor 
F F 
(0) 
\\,SHe 
.' 0 
o!s<HN H 
MeS"'" 
·Ph 
( 142) 
F 
HN o~. NH 
~" 
Ph 
whicp could invalidate these results would be a shift of the ~-deuter­
ium in (136g) to the ~-position in the sulphur-containing product, but 
this would appear to be unlikely. There is, therefore, a small but 
significant loss of deuterium label from both the R- and S-positions 
of the fluorophenylalanyl group, but clearly, obligatory loss of 
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a hydrogen atom during biosynthesis can be discounted. 
2.4 Feeding of 35S0112-
Radioactive sodium [35SJ sulphate was fed to cultures of A. terreus 
so that it would be possible to observe all sulphur-containing metab-
olites by autoradiography and radioscanning of chromatograms. As 
expected, most of the label was located in spots corresponding to BDA 
and BDAA, but other rretabolites were present, and there was significant 
~ctivity in the di(methylthio)-cyclo-(Phe-Phe) spot (Figure 2). 
Figure 2 T.l.c. autoradiogram (solvent system A) of total extract 
fed sodium [35S J sulphate 
,------t 
Di(methylthio)-cyclo-(Phe-Phe) (131) 
-t---- Unidentified metabolite 
--+----BDAA (41) and acetylaranotin (38) 
--+--- BDA (40) 
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~ Synthesis of sulphur-containipg dioxopiperazines 
2.5.1 General background 
The isolation of di(methylthio)-cyclo-(Phe-Phe) (131) from 
extracts of Aspergillus terreus (see Section 2.1.6) gave a hint as to 
how the biosynthesis of the aranotins might proceed from cyclo-(L-Phe-
L-Phe) (42). The fact that this compound did not have any structural 
changes from cyclo-(Phe-Phe) other than the replacement of the a-hydro-
gens with methylthio- groups suggested that introduction of sulphur 
could be the step immediately following cyclic dipeptide formation in 
aranotin biosynthesis. We did not believe that di(methylthio)-cyclo-
(Phe-Phe) was an intermediate on the pathway to the aranotins, because 
~-methylation was expected to take place after formation of the 
aranotin skeleton, analogously to gliotoxin biosynthesis; rather, the 
new metabolite was thought to be a product of reductive methylation of 
the epidisulphide (152), which might be the true intermediate. Of 
Ph 
cyclo-(L-Phe-L-Phe) 
HN~ O~ 
~~ 
- C:h ~ 
( 152) Aranotins 
course, it was-desirable to check these predictions by experiment; we 
therefore set out to synthesise the natural product (131) and the 
epidisulphide (152). 
There were no natural products recorded in the literature contain-
ing a secondary amide and an epidisulphide in the dioxopiperazine ring, 
except antibiotic A30641 , whose structure (153) 109 is in some doubt. 5 
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The only other example from natural sources of a dioxopiperazine with 
a sulphur-bearing carbon a- to a secondary amide nitrogen is the 
unnatural metabolite (21) isolated by Kirby et ale from Gliocladium 
deliquescens. 30 Neither have any epidisulphides with secondary amides 
Cl 
HO 
Ph Me 
Me ~e .' 0 HN NS 0 0:X:H 04NH MeS"/ Me Me 
(21) ( 154) 
been synthesised. Ottenheijm et al. 110 claimed that they had prepared 
the gliotoxin analogue (154), but that it was unstable. Unfortunately, 
no data were reported for this compound. Kishi's group, in their 
syntheses of gliotoxin (1) and sporidesmin (31) made use of the dithio-
acetals (48) and (155.), which were prepared by removal of an N-protective 
methoxymethyl group with concentrated hydrochloric acid in ethanol or 
trifluoroacetic acid. 
Cl 
MeG 
GMe OMe 
(48) 
At this time, 1n our laboratories, work was in progress to synth-
esise the unnatural metabolite (21) by an adaptation of Kishi's 
method. 30 The synthetic targets (131) and (152), however, seemed to 
lend themselves, by their symmetry and unreactive side-chains, to a 
shorter synthesis. 
2.5.2 Synthetic procedures 
One of the simplest methods that could be envisaged would be the 
addition of methanethiol or hydrogen sulphide across the double bonds 
of dibenzylidenepiperazinedione (140c), giving the di(methylthio)-
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compound in one step, or the epidisulphide (152) in two, after oxid- .. 
ation of the dithiol. Machin and Sammes61 had shown that under acidic 
( 140c) 
Ph~SR 
HN~O 
> n~NH 
\J RS~ 
Ph 
R= H orMe 
conditions, addition of thiols to double bonds in N-alkylated dioxo-
piperazines took place in the desired sense, with sulphur on the carbon 
(X- to the nitrogen (see Introduction, Section 1.3). Also, Ottenheijm 
60 
et ale had performed a similar reaction with hydrogen sulphide using 
zinc chloride catalysis. 
We therefore attempted the addition of methanethiol to dibenzyl-
idenepiperazinedione (140c) under similar conditions. Zinc chloride 
was prepared in situ by saturation of a suspension of zinc dust in 
methylene chloride with hydrogen chloride gas. Dibenzylidenepiperaz-
inedione (140c) was added, then methanethiol. The products isolated 
were found to be predominantly starting material, along with a very 
small amount of a compound tentatively identified as the mono-adduct 
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(156). No di(methylthio)- compound (131) was detected. A repeat of 
this reaction produced only starting material, so although it appears 
Ph ~SMe 
H~O 
o NH 
Ph 
( 156) 
to be feasible to introduce sulphur in this way, our attempts were 
abandoned because of the uncertainty of achieving the target compounds 
(131) and (152). 
Several research groups had reported the introduction of sulphur 
by generation of anions at C-3 and C-6 of the dioxopiperazine ring, and 
reaction of these with sulphur electrophiles (Introduction, Section 
1.3). For these reactions it was necessary to protect the secondary 
amide functions. cyclo-(L-Phe-L-Phe) (42) was treated with acetic 
anhydride under acidic conditions to give the diacetyl compound (157). 
Attempted sulphenylation of this compound in DMF with dimethyl disulph-: 
ide, methanesulphenyl chloride, or sulphur, using triethylamine or 
potassium t-butoxide as base, failed. Interestingly however, when 
potassium t-butoxide was used as the base, the unusual C-acetyl comp-
ounds (158) and (159) were obtained. It is not known whether the 
Ph P)y Ph A(N~O HNXfO KOtBu HN 0 
O~Nh DMF > o~NA( DB O~:: H" H Ph Ph 
( 158) (159) 
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acetyl group is transferred intramolecularly, but inspection of 
molecular models suggests that this would be difficult. 
The formation of these rearrangement products precluded the use 
of acetyl protecting groups in such reactions. An alternative was the 
methoxymethyl group, although if it were used, a much stronger base 
would be required to remove the ~ethine protons. (±)-Di(methoxymethyl)-
cis-cyclo-(Phe-Phe) (161,) was prepared in good yield by treatment of 
the racemic cis- cyclic dipeptide (16(j)111 with potassium i-but oxide 
and chloromethyl methyl ether in DMSO. Treatment of this compound 
with LDA in THF, in the presence of excess sulphur and a trace of DMF, 
gave a moderate yield of epitetrasulphide (162) which was readily 
obtained by crystallisation from the viscous reaction products. 
( 16(j) (162) 
Initially, elemental analysis suggested that this compound contained 
five sulphur atoms, but by t.l.c. purification a sample was obtained 
which gave an analysis corresponding to the tetrasulphide (162). An 
X-ray crystal analysis was carried out by Dr. A.A. Freer, and this 
confirmed that the compound was indeed the tetrasulphide (162). A 
. representation of the three-dimensional structure is given below 
(Figure 3, page 78). 
The necessity to add a small amount of DMF to the reaction mixture 
is difficult to explain. The original (±)_di(methoxymethyl)-cyclo-
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Figure 3 
(Phe-Phe) used for these experiments had been prepared in DMF, and very 
small amounts of the solvent remained In the product. When rigorous l y 
pure di(methoxymethyl) compound (161) was used without a dded DMF, t he 
yield of the sulphuration reaction dropped to zero, the only pr oduct 
be ing a viscous, polymer-like material. Other ami de so l vents , such as 
hexamethylphosphortriamide or ~,~'-dimethylimidazoli d in-2 - one had a 
similar bene fi c i a l ffect t o D~W. Whe n l arge r t ha n tra ce a mounts of 
these compounds (~ 1 mole equiva l ent ) were a dded to the r eacti on 
mixture , the yi e l d of t e trasu l phi de was onc e mor a dver s e ly a f f e ct e . 
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The reaction mixture was normally quenched with acetic acid at 
o 
-10 C. If it was allowed to warm to room temperature, the epimono-
sulphide (163) was obtained. This compound could be derived from a 
trans-dithiolate species by intramolecular attack: 
Other compounds were obtained from the reaction mixture after 
quenching at _10oC; the epidisulphide (164) was isolated, along with 
an unsymmetrical sulphur-containing compound, believed to have the 
structure (165), the number of sulphur atoms in the compound being 
unknown. This compound might have arisen by elimination at one end of 
an oligosulphide, and Michael-type addition to the unsaturated deriv-
ative formed. If x = 2, this compound is related to the system found 
( 164) 
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in gliovirin (166), a metabolite of Gliocladium virens. 4 
Mea 
MeO 
( 166) 
The rest of the starting material was converted in the sulphur-
ation reaction into a gummy substance with a very broad n.m.r. 
spectrum, and this was thought to be a polymer made up from mainly 
trans-sulphenylated units. 
Schmidt64 had obtained optically active epipolysulphide when 
cyclo-(L-Pro-L-Pro) (70) was treated with sulphur and sodamide in 
liquid ammonia (see Introduction, Section 1.3). To test whether reten-
tion of configuration occurred in our system, the optically active 
protected compound di(methoxymethyl)-cyclo-(L-Phe-L-Phe) (161a) was 
prepared by hydroxymethylation of cyclo-(L-Phe-L-Phe) (42) with form-
alin, and replacement of the hydroxy groups by methoxyls in methanol-
thionyl chloride. This alternative route was used to avoid epimeris-
ation of the chiral centres. However, on sulphuration, the tetrasulph-
ide (162) was optically inactive, and its melting point properties 
Ph Ph>y Ph >yo a HN HO~N ~ a 
~H )?( a "N"-./OH H~' ~\\ 
Ph Ph 
11.....,.\ (167) (161a) 
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Ph>yJl PhlY 
MeO./'"'N" a 8 8, LDA, DMF Mea./'" N a (±) ~) -~) w 
0- H"'~ "-../OM~ THE' 0- In '-./OMe 
Ph Ph 
( 161a) ( 162) 
were identical to those of the racemate. 
To test the general applicability of the sulphuration reaction, 
the N,N'-dimethyl and N,N'-dibenzyl derivatives of (±)-cis-cyclo-(Phe-
Phe) (168) and (169),were prepared, and reaction of these compounds 
under the same conditions as before gave the corresponding epitetra-
sulphides (170) and (171). The dimethyl epitetrasulphide (170) was 
formed in somewhat better yield (41%) than the di(methoxymethyl) 
compound. 
Ph 
RN
),,\H -0 /' L 88, LDA, DMF 
THF 
(168); R = Me 
(169); R = CH2Ph 
) 
Ph 
RN a 
a NR 
Ph 
(170); R = Me 
(171); R = CH2Ph 
The di(methoxymethyl) epitetrasulphide (162) was converted in 
high yield to the cis-di(methylthio)-dioxopiperazine (172) by reduction 
with sodium borohydride and methylation of the resultant cis-dithiolate 
with methyl iodide. Initially, attempts were made to reduce the 
epitetrasulphide (162) in the presence of methyl iodide,112 but these 
resulted in the compounds (173) and (174), containing methyldithio-
groups. 
Ph Me(Y""N~ (±) 1. NaBH4, EtOH 
o~--...AMe-2-. -M-el---~) 
Ph 
RT 
NaBH4 ,' Mel, 
MeOH, pyridine 
Ph l,~,,\SMe MeQ""N~O (±) 
O~N"-./OM e 
MeSS~"''''Ph 
( 173) 
Ph), ••• 5SMe 
MeO/"N ~O (±) 
o~~"""""-OMe Mes~t"'Ph 
To prepare the epidisulphide (164), the epitetrasulphide was 
reduced with sodium borohydride to the dithiol (175), which was not 
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purified because of its instability. This compound was interesting in 
that on heating a solution in methanol, a beautiful purple-red colour 
was produced, which disappeared on recooling. This might be due to 
transient formation of a thioketone, as was suggested by Ottenheijm 
113 for a related compound. 
( 162) ( 175) 
The dithiol (175) was readily oxidised to the epidisulphide (1642-
Ferric chloride solution in ethanol gave better yields in this reaction 
th . d" 'd' 60 an 10 1ne 1n pyr1 1ne. 
Ph 
),,$H (±) 
MeO ............. W .... "(0 FeC13 O~" "-"",,OMe -Et-O-":H~--4) 
H ~, 
S Ph 
( 175) 
Ph J;y (±) MeO/"'N ~ 0 ~s...S o ,: N"-./OMe Ph 
(164) 
The disulphide (164) could be reconverted into the epitetrasulph-
ide (162) by treatment with sulphur in basic conditions. Even when a 
deficiency of sulphur was used, no epitrisulphide was observed, 
contrary to what is found in similar systems. 8 Heating the epidi-
sulphide gave, besides sulphur, the epimonosulphide (163) and traces 
of epitetrasulphide (162). Similarly, heating the epitetrasulphide 
afforded epimonosulphide (163). 
Ph 
MeO./'-. N ~ s......:8_,_L_i_SH_e_X_yl_~) 
o~N"v"'OMe cs: 
Ph 
( 164) 
Ph 
o N'-./OMe 
Ph 
( 162) 
Attempts to remove the methoxymethyl protecting groups from the 
epidisulphide (164) with hydrochloric acid, in ethanol or trifluoro-
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t' . d 51,54 
ace lC aCl , were not successful; extensive decomposition occurred, 
and dibenzylidenepiperazinedione (140c) was one of the main products. 
Ph Ph~ 
MeO/"'..N S Hel HN ~ ) O~H o N .............. OMe EtOH + other products Ph Ph 
( 164) ( 140c) 
Treatment of the di(methoxymethy~)-epidisulphide (164) with boron 
tribromide at _4ooc gave, rather unexpectedly, the di(bromomethyl) 
compound (176) in very high yield. This parallels the research of 
114 Cherbuliez and Feer, who found that in derivatives of glycine 
anhydride ~ the N,N'-di(chloromethyl) compound (177) , the methyl-
ene position was especially susceptible to nucleophilic attack. 
Cl/'-~~ 
O~-...../Cl 
(164 ) ( 176) ( 177) 
The di(bromomethyl) compound (176), when stirred with water, was 
hydrolysed to the di(hydroxymethyl) epidisulphide (178). This comp-
ound was much more stable than expected, and neither heat nor basic 
conditions (sodium bicarbonate) effected the removal of the hydroxy-
methyl groups. With more strongly basic conditions, decomposition 
, l!~~-_ 
,lS!Ql l!£~6\~" 
occurred with the evolution of hydrogen sulphide. 
Ph ~ 
o .? N'-"'Br--E-t-20--~ 0 .~ N'-.,../OH 
Ph Ph 
( 176) ( 178) 
Another possible means of deprotection was to displace bromine 
with ammonia or a primary amine, and then the methylene group might be 
lost as an imine. Thus, treatment of a solution of the di(bromomethyl) 
compound (176) with ammonia in methylene chloride (ca. 10% saturated) 
for ca. 30 min gave the deprotected disulphide (152) on crystallisation 
from benzene, in moderate yield (ca. 50%), along with hexamethylene-
tetramine and hexamethylenetetramine hydrobromide (detected by n.m.r. 
spectroscopy only). The epidisulphide (152) was surprisingly soluble 
in re latively non-polar solvents (chloroform, carbon tetrachloride, 
) 
( 176) 
Ph 
HN ~ 
~)~ 
~ NH o ,:-
Ph 
(152) 
ether), whereas di(methylthio)-cyclo-(Phe-Phe) (131) was relatively 
insoluble in most solvents. It crystallised from benzene or toluene 
as a solvate, which by n.m.r. spectroscopy and elemental analysis 
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contained 0.75 benzene or toluene molecules for each epidisulphide 
molecule. Crystallisation also occurred from concentrated solutions 
in chloroform, but this material would not give a consistent analysis; 
this was attributed to residual traces of chloroform in the crystals. 
The compound was stable under neutral or slightly acidic conditions, 
but not under basic (potassium carbcnate, morpholine) conditions. 
When the di(bromorrethyl) compound (176) was treated with a 
saturated solution of ammonia in methylene chloride, no deprotected 
e~idisulphide was obtained; instead, the unusual bis(dithio)- compound 
(179) was isolated as a gum, along with dibenzylidenepiperazinedione 
Ph 
c?)? Br/',..N&O NH3 0 ~ ) N CH2C12 Obc) + o ! N"-/Br 0 Ph Ph S-S 
( 179) ( 140c) 
(140c). The structure of (179) was assigned on the basis of its 
spectroscopic properties only. The mechanism of its formation is not 
known. 
The yield of epidisulphide (152) from treatment with ammonia was 
probably diminished by decomposition because of the basic conditions. 
We therefore tried using ammonium acetate as a suspension in methylene 
"d t t" nt The salt should be chloride, as a weakly bas1c epro ec 10n reage • 
partially dissociated to free ammonia and acetic acid and, since it is 
used in excess as a suspension, it should provide a constant, reproduc-
" Indeed, deprotectioD proceeded almost ible concentration of ammon1a. 
quantitatively in 24h, with very little decomposition. 
) 
( 176) (152) 
The epidisulphide, on treatment with sodium borohydride ineth-
anol and methyl iodide at OOC, gave a reasonable ~ield (49%) of cis-
di(methylthio)-cyclo-(Phe-Phe) (131). Its spectral properties were 
identical to those of the natural product obtained from Aspergillus 
terreus. 
Ph 
NaBH4, Mel 
EtOH/THF 
Ph 
( 152) 
) 
Ph~~SMe 
.,' 0 
HN 
oA....NH 
MeS'''Ph 
(±)-cis-Di(methylthio)-cyclo-(Phe-Phe) (131) was also prepared 
from the di(methoxymethyl) compound (172). When this compound was 
treated with boron tribromide at _600 C, a mixture of products was 
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obtained, with the desired di(bromomethyl) derivative (180) as a minor 
component (~ 30% of the total material). The remainder of the 
mixture consisted of three compounds [(181), (182), and(183~, all of 
which had undergone intramolecular cyclisation onto the phenyl ring. 
Compound (181) was fully characterised; the structures of (182) and 
(183) were deduced from spectral data. 
( 180) 
( 172) 
( 182) 
N 
O~/NH MeS'~'''' 
Ph 
(181 ) 
It is interesting that this aromatic substitution occurs with the 
di(methylthio)- compound (172) but not with the epidisulphide (164). 
It could be that the epidisulphide has an unsuitable conformation for 
the reaction to take place. 
After boron tribromide treatment of (172), the total reaction 
products were stirred with aqueous sodium bicarbonate solution, and 
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this gave, on crystallisation from acetone, the racemic natural product 
(131) in 31% yield from the di(methoxymethyl) compound (172). The 
mother liquors from the crystallisation contained the cyclised comp-
ounds (181) and (183). Thus the natural product (131) was synthesised 
both by the above method, and by reductive methylation of the deprot-
ected epidisulphide (152). 
> 
2.5.3 Radio-labelled sulphur-containing dioxopiperazine synthesis 
and feeding experiments 
Having made the proposed biosynthetic intermediate (152), and the 
natural product (131), we then had to prepare them in radioactive form 
for feeding experiments. Two labels (3H and 35S ) were required to 
determine whether the precursors were incorporated intact. 
The [3H] - and [35SJ -di(bromomethyl)epidisulphides (176) were 
prepared separately, and combined in the final, deprotection step to 
give epidisulphide (152) with a suitable 3H:35S isotopic ratio. cyclo-
(DL-[4,_3H]Phe-DL-Phe) was prepared by heating L-[4,_3H]phenylalanine 
in ethylene glycol under reflux. Strangely, this reaction did not 
behave in the same way as with unlabelled L-phenylalanine. The mixt-
ure became very dark after a short time, so the reaction was stopped 
earlier than was usual in case all the product was destroyed. The 
reaction did, however, yield a reasonable amount of cyclic dipeptide. 
The reaction sequence to the di(bromomethyl) compound (176) was carried 
out as before, giving a 2.3% overall yield from L-phenylalanine. 
Similarly, 35S-labelled elemental sulphur was used to label the 
disulphide bridge, and the di(bromomethyl)-[35S]epidisulphide (176) 
9C 
was obtained in 15% yield from di(methoxymethyl)-cyclo-(Phe_Phe) (161). 
3 35 For the final step, the H- and S-labelled compounds were combined 
in suitable proportions, and deprotected with ammonium acetate in 89% 
yield. This material was then fed to ASpergillus terreus. 
In the first feeding experiment, after administration of the 
disulphide (152) (45 mg; 3H, 16.8 fCi; 35S , 3.3 fCi), the fungus was 
given its normal growth period (4 days) before extraction. The extract 
was separated by t.l.c. to give BDA (40) (10.0mg), di(methylthio)-
oyclo-(Phe-Phe) (131) (0.6 mg) and cyclo-(L-Phe-L-Phe) (42) (8mg). 
The incorporations into BDA were reasonable (3H,2.?%; 35S, 4.4%), and 
h d Ol 0 (3 . 35 ) t e 1 ut10n by endogenous material was low H,5.41, S, 3.40 , but 
the 3H:35S isotopic ratio had not remained constant (5.16~3.24). 
Substantially more sulphur activity than tritium ~ad been incorporated. 
Since no precursor was recovered in the extract, both optical isomers 
of the racemic compound fed had been consumed, and thus the discrep-
ancy in the ratio could have been caused by breakdown of the "wrong" 
(SS) optical isomer and incorporation of the fragments at different 
rates. Nevertheless, the incorporation of both labels at significant 
levels, with the low dilution of the precursor in the isolated BDA, 
did suggest that the epidisulphide (152) is a precursor of the aran-
otins. It was desirable, however, to demonstrate more fully that the 
precursor is incorporated intact, at least to some extent. 
The di(methylthio)-cyclo-(Phe-Phe) (131) isolated from this 
experiment was almost entirely derived from the disulphide fed, judging 
3 35 r.L) by the exceptionally low dilution figures ( H, 1.20; S, 1.uo , and 
accounted for ~ 1% of the activity fed. In this compound, the 
isotopic ratio (4.53) was much closer to that of the precursor (5.16). 
The cyclo-(L-Phe-L-Phe) isolated contained 0.3% of the tritium 
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activity of the precursor, with a dilution of 72.7, and this shows that 
there is some biological mechanism whereby the epidisulphide (152) can 
be reduced back to the cyclic dipeptide (42). 
In a separate experiment, [35S]-cis-di(methylthio)-cyclo-(Phe_Phe) 
(131) (5.5 mg, 0.36 }lCi), prepared by reductive methylation of the 
deprotected epidisulphide (152) was fed to A. terreus. The incorpor-
ation of activity into BDA was low (0.26%), and the dilution was high 
(306); this agrees with our proposed biosynthesis where this compound 
(131) does not lie on the main biosynthetic route. 
In an attempt to ascertain the causes of the alterations in 
isotopic ratio between the epidisulphide (152) and the metabolites, a 
second sample of doubly labelled precursor was synthesised, having 
higher specific activities than in the first run. This material was 
used for two feeding experiments run in parallel. In the first experi-
ment,. the cult1:U'e was harvest~d 5l h after feeding the epidisulphide 
«(4.8 mg; 3H, 2.06 fCi; 35S , 0.42 fCi; ratio, 4.86). The isolated EDA 
(3.2 mg) had incorporated tritium (1.2%) and 35S (2.7%), but the 3R:35S 
ratio (2.63) had changed even more than in the long-period experiment. 
Once again, there was no detectable epidisulphide remaining in the 
extract (by t.l.c., radioscanning, and autoradiography). Because the 
culture was harvested at an early stage, there was a significant 
amount of acetylaranotin (38) in the extract (1.2m~, and the precursor 
had been incorporated into this compound at a higher level (3R, 3.1%; 
35S, 3.4~, lower dilution (3R, 6.74; 35S , 5.91), and less distortion 
of the 3H:35S isotopic ratio (4.86~4.41) than in the case of BDA. 
The low dilution in acetylaranotin can be rationalised by proposing 
that, because it is being converted into BDA, a large proportion of the 
acetylaranotin present had been formed during the 5ih between feeding 
the radioactive epidisulphide and harvesting, whereas most of the EDA 
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was already present when feeding took place. It is difficult to 
1 · h th 3H 35S ' t' . exp aln w y e : lS0 OplC ratlo was lower in BDA than in acetyl-
aranotin. Assuming that all the BDA is derived from acetylaranotin, 
the activity in the isolated BDA should have been incorporated, in 
general, sooner after feeding than that in the acetylaranotin. Thus 
it is possible that a sulphur-containing product of degradation of the 
epidisulphide was absorbed into the cells more quickly than the 
precursor itself, and was therefore metabolised first, so that the 
acetylaranotin produced at this stage was high in sulphur activity; 
later, as the intact precursor was being metaboiised, the isotopic 
ratio in acetylaranotin would approach that of the epidisulphide, but 
the BDA ratio would take longer to reach a higher value. 
Also isolated from this extract was cis-di(methylthio)-cyclo-
(Phe-Phe) (131) (~0.2mg). In this material, the 3H:35S isotopic 
ratio was almost exactly that of the precursor (4.86~4.85). The good 
incorporation (~. 1.3%), and low dilution (3.54) strongly suggest 
that A. terreus can make this compound from the epidisulphide (152) 
without breakdown. 
In the second feeding experiment, after feeding the disulphide 
(3.2mg; 3H, 1.37pCi;35S , 0.28fCi; ratio, 4.86), the culture was grown 
for 24h before harvesting. BDA (3.9 mg) isolated from this culture had 
a 3H:35g isotopic ratio of 3.18, higher than in the previous experi-
ment but still substantially lower in tritium than the precursor. 
A further experiment was designed to determine whether the epidi-
sulphide (152) is produced by A. terreus. Autoradiography of chromat-
ograms from extracts of cultures fed radioactive aranotin precurscrs 
(~ 35s042- or L_[U_14~ phenylalanine) did not show any activity 
corresponding to this compound, but this might be due to its transient 
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nature and low concentration. Therefore, to test whether the epidi-
sulphide was present in the cultures, the compounds on the aranotin 
biosynthetic pathway were labelled by administration of L_[u_14CJ_ 
phenylalanine (50 f Ci) to. 2-day old cultures. After incubation for 3 h , 
(±)-epidithio-cyclo-(Phe-Phe) (152) (40mg) was added, and 30 min later 
the culture was harvested and the broth extracted. The epidisulphide 
was recovered by t.l.c., although there was very little of it left, 
(ca. 1 mg) and this was diluted with more epidisulphide (2 mg) to give 
.enough material for crystallisation to constant activity. The specific 
activity (1.08 ,uCimmol-1 ) represents an incorporation from L-phenyl-
alanine into the recovered material of 0.015%. This activity demonstr-
ates that the epidisulphide (152) can be biosynthesised from L-phenyl-
alanine by Aspergillus terreus. 
BDA and acetylaranotin were also isolated from this extract. The 
BDA contained 1.5% of the activity fed, and the acetylaranotin 3.0%. 
These incorporations after 3~ h parallel quite closely the incorpor-
ation of tritium from the epidisulphide (152) into the same metabolites 
(1.2 and 3.1%, respectively) after 5~ h. 
2.5.4 Conclusions 
In conducting this investigation we asked ourselves the question: 
Is epidithio-cyclo-(Phe-Phe) (152) an intermediate in the biosynthesis 
of the aranotins? Our experiments have provided strong evidence in 
favour of the affirmative; from doubly labelled (±)_[35S]epidithio-
cyclo-([4,_3H]Phe-Phe) (152), both isotopes were incorporated into 
aranotins'with reasonable efficiency, even after a very short time, 
and with very low dilution 
that the epidisulphide can 
by endogenous material. It was also shown 
be produced by A. terreus from L-[U_14~_ 
phenylalanine. The changes in isotopic ratio from the precursor to 
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the products lessens the certainty of our conclusions, but this change 
can be explained by breakdown of some of the precursor (for example the 
"wrong", SS-1' somer) to S1' 1 d d mp er compoun s, an re-incorporation of the 
sulphur label with greater efficiency than the tritium. In this 
respect it might be advantageous to resolve the epidisulphide (152) so 
that only one optical isomer was being fed. 
The situation is much clearer for di(methylthio)-cyclo-(Phe-Phe) 
(131). The epidisulphide (152) was converted into this compound with 
very low dilution by endogenous metabolite, and with no change in the 
3H:35S isotopic ratio (in the short term experiment). It can there-
fore be concluded with some certainty that this metabolite can be 
derived from the intact epidisulphide precursor (152). The low incorp-
oration of the di(methylthio)- compound into BDA suggests that it is 
not an intermediate in aranotin biosynthesis. 
If the biosynthesis of the aranotins is analogous to that of 
gliotoxin, the methylthio- groups in BDA should be formed by reductive 
methylation of the disulphide bridge in acetylaranotin. The data from 
the above experiments tend to support this hypothesis, since in the 
short-term feeding experiments much of the activity from precursors is 
found in acetylaranotin, with low dilution by endogenous metabolite, 
whereas incubation of the fungus for several days results in most of 
the activity reaching BDA. 
Although no apoaranotin metabolites ~.g.. BDAA (41) were isolated 
during this study, the results for acetylaranotin and BDA should also 
~pply to these compounds. 
Combining the results acquired in this project, including the 
experiments with fluorinated precursors, with previous research, a 
probable pathway for the biosynthesis of the aranotin metabolites can 
be outlined, as shown below. 
) 
a 
o 
OAc 
(38) 1 ~O 
OAc 
~ 0 
(40) 
Ph 
(42) 
Ph H~ a 
7 ~}r 
a (NH 
/ Ph / 1 (152) 
Ph 
OAc 
AcO 
(41 ) 
Many aspects of the pathway remain unclear, however. It has not 
yet been demonstrated conclusively that the di(methylthio)- compounds 
originate from the corresponding epidisulphides [except for the new 
metabolite (131) J, although there is much evidence in support of this 
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hypothesis. The detailed mechanism of sulphur introduction, and the 
source of the sulphur atoms, remain unknown. Also, the mechanism of 
oxygenation of the aromatic rings of the precursors to the aranotin 
and gliotoxin-type ring systems, and the order in which these oxid-
ations occur, are still unclear. Further experiments with this fungus 
might include feeding of other possible sulphur-containing precursors, 
such as dithiol and monothiol derivatives of cyclo-(L-Phe-L-Phe). 
Also, it would be interesting to feed the resolved epidisulphide (152) 
and thus perhaps establish conclusively that this compound is incorp-
orated intact into the aranotins. A further search of the broth 
extracts for new metabolites might be enlightening, since their struct-
ures might reveal the order of some of the biosynthetic steps. 
CHAPrER 3 
EXPERIMENTAL SECTION 
3.1 General procedures 
Melting points were recorded on a Reichert hot-stage apparatus, 
and are uncorrected. 
Optical rotations were measured at 5B9 nm (unless otherwise 
stated) using an Optical Activity Ltd AA-100 polarimeter. 
Elemental analyses were carried out by Mrs. W.Harkness and her 
staff. 
Ultraviolet spectra were recorded on a Pye-Unicam SP-Boo 
spectrometer. 
97 
Infrared spectra were recorded on a Perkin-Elmer 5Bo spectrometer 
by Mrs. F.Lawrie and her staff. Unless otherwise stated, the samples 
were prepared by dispersion in potassium bromide discs. 
Proton n.m.r. spectra were recorded on a Perkin-Elmer R 32 
(90 MHz) spectrometer, unless otherwise stated. 100 MHz spectra were 
obtained from a Varian XL-100 spectrometer in the pulsed Fourier 
Transform (FT) mode. 360 MHz spectra were recorded on a Brucker 
WH-360 instrument, by Dr. I.Sadler and his staff (University of 
Edinburgh). Unless otherwise stated, deuteriochloroform (CDC~) was 
used as the solvent, with tetramethylsilane (TMS) as internal 
reference. All proton spectra are quoted to the nearest 0.01 p. p. m. 
Carbon-13 n.m.r. spectra were recorded on a Varian XL-100 spectro-
meter, in CDCI
3
, with TMS as internal reference, at 25.2 MHz, unless 
otherwise stated. 
Fl · spectra were also recorded on the Varian XL-100 uorl.ne n. m.r. 
machine, in CDCl
3 
unless otherwise stated, at 94.1 MHz. Signals were 
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recorded in p.p.m. from trichlorofluoromethane, using a deuterium 
locking system. The offsets of CFCl3 from the deuterium signals were, 
for CDC13 , 49 661 Hz; for d6-DMSO, 50 019 Hz; and for CD3
0D, 49 827 Hz. 
The spectra from the Varian XL-100 were recorded by Dr. D.S.Rycroft, 
Mr. J .Gall, and Mr. R.Sharp. 
Radioactive samples were counted on a Philips liquid scintillation 
counter, model PW 4510 D649, in Packard scintillation vials. The 
samples were dissolved in scintillator solution (10 ml); this was 
AnalaR toluene containing 2,5-diphenyloxazole (4 gil) and 1,4-bis-
2-(4-methyl-5-phenyloxazolyl) benzene (0.1 gil). Materials contain-
. 35S t d . th 14 1ng were coun e uS1ng e same programme as for C. The results 
were found to be consistent if the quenching value was not signific-
antly altered. Activities of 35S (t~ = 88 days) have been adjusted to 
account for decay, so that incorporations, purities etc. can be 
evaluated directly from the quoted results. The scintillation counter 
was operated by Mrs. M.Tait and her staff. Autoradiograms were 
prepared using Ilford Red Seal 100FW film. A Panax Thin Layer Scanner, 
model RTLS-1A, was also used for detection of activity on t.l.c. 
plates. 
Analytical t.l.c. was carried out on precoated Kieselgel GF254 
plates of thickness 0.25 mm, available from Merck. Spots were located 
initially using u.v. light (254 nm). Cyclic dipeptides were detected 
by the method of Issaq and Barr; 115 after treatment of the dried, 
developed t.l.c. plates with chlorine gas for 5 min., the plates were 
sprayed with an aqueous solution of £-tolidine. Cyclic dipeptides 
with a secondary amide function gave blue spots, or yellow spots at 
higher concentrations. Tertiary amides gave cream-coloured spots. 
Later, a solution of tetramethylbenzidine was substituted to avoid the 
use of the carcinogenic o-tolidine. The solution was made by 
dissolving 2,2' ,6,6'-tetramethylbenzidine (200 mg) in acetic acid 
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(30 ml), then adding water (500 ml) and potassium iodide (1 g). The 
colours produced were the same. Sulphur-containing compounds were 
detected by spraying the plates with a 2% silver nitrate solution in 
aqueous acetone; compounds containing S-S bonds gave brown spots after 
ca. 1 min. Preparative t.l.c. separations were carried out on 
20 x 20 cm plates coated with a 1 mm-thick layer of silica gel GF254 
(Fluka). The solvent systems used for t.l.c. were: 
A; di-isopropyl ether: chloroform: acetic acid, 6:3:1 
B; chloroform: ethyl acetate, 1:1 
C; toluene: ethyl acetate, 3:1 
D; benzene: acetic acid, 9:1 
Organic solvents were removed on a Buchi rotary film evaporator 
at water-pump pressure. 
• 
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3.2 Preparation of fluorinated cyclic dipeptides 
cyclo-(Gly-L-Phe) (137)?5,100 To an ice-cooled suspension of 
L-phenylalanine methyl ester hydrochloride (5.39 g, 25 mmol) in dry 
methylene chloride (50 ml) was added triethylamine (2.78 g, 27.5 mmol), 
followed by N-benzyloxycarbonylglycine (5.22 g, 25 mmol), and dicyclo-
hexylcarbodiimide (5.67 g, 27.5 mmol). The mixture was left in the 
dark at room temperature for 12 h, with occasional swirling, and was 
then filtered through celite. The filtrate was washed with 1 ~ hydro-
chloric acid (2 x 10 ml), water (2 x 10 ml), saturated aqueous sodium 
bicarbonate solution (2 x 10 ml), water (1 x 10 ml), and brine (1 x 
10 ml), and evaporated to dryness. The resultant oil was dissolved in 
acetone (25 ml), filtered through celite, and the solvent was evapor-
ated. The oil was then dissolved in methanol (50 ml) and acetic acid 
(5 ml); 10% Pq/C catalyst (200 mg) was added, and the mixture was 
hydrogenated at atmospheric pressure for 14 h. After the catalyst had 
been filtered off, the solution was concentrated to a yellow oil which 
was dissolved in methanol (30 ml). To the solution was added saturated 
ammoniacal methanol (50 ml). After standing overnight at room temper-
ature, the solid was filtered off, washed with methanol and ether, and 
dried under vacuum, to give cyclo-(Gly-L-Phe) (137) (4.50 g, 88%), m.p. 
268-2700 C (lit.,100 265.5°C), [O(J~O +100.00 (.£ 2.7 in AcOH) (lit.,100 
+100.5 0 ); V 3 200 (NH), and 1 675 cm-1 (CO); &(TFA) 3·07 (1 H, d, 
max. 
J 18 Hz, Hpro_~ of CH2N), 3.35 (2 H, m, C!!2Ph), 3.99 (1 H, d, !L 18 Hz, 
H R of CH
2
N), 4.78 (1 H, m, C!!CH2Ph), 7.1-7.5 (5 H, m, Ph), 8.00 pro-_ 
( ) 8.33 (1 H, br s, NH); _rrl_z 204 (M+, 52%),161,91 , 1 H, br s, NH , and 
(100), 86, and 43. 
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N,N'-Diacetyl-cyclo-(Gly-L-Phe) (133).101_ cyclo-(Gly-L-Phe) (137) 
(700 mg, 3.43 mmol) was stirred with acetic anhydride (6 ml) and 
perchloric acid (2 drops) for 40 min. at n(5°c. T he mixture was cooled, 
poured into water (70 ml), and extracted with chloroform (3 x 15 ml). 
The solvents were removed and the residual oil was crystallised from 
ethanol-water to give diacetyl-cyclo-(Gly-L-Phe) (133) (830 mg, 83%), 
m.p. 103-104°C, [<xJ~20 + 76.4 (£ 1.0 in EtOH) (Found: C, 62.4; H, 5.5; 
N, 9.5. C15H16N204 requires C, 62.5; H, 5.6; N, 9.7%); V 1 720 
max. 
(2 COMe) and 1700 cm-1 (2 ring CO); &2.52 (3 H, s, Ac), 2.54 (3 H, s, 
Ac), 2.50 (1 H, d, ~ 19 Hz, H s of CH2N) , 3.28 (2 H, m, CH Ph), pro-_ -2 
4.48 (1 H, d, J 19 Hz, H R of CH N), 5.42 (1 H m CHCH Ph) and 
- pro-_ 2 ' , - 2 ' 
7.0 - 7.4 (5 H, m, Ph); mI~ 288 (M+, 100%), 203, 91, and 43. 
General method for the preparation of the cyclic dipeptides (136a-f) 
To an ice-cooled solution of diacetyl-cyclo-(Gly-L-Phe) (133) 
(288 mg, 1 mmol) and the relevant aromatic aldehyde (1.1 mmol) in DMF 
(2 ml) was added slowly with stirring a 0.5 M solution of potassium 
t-butoxide in t-butanol (2 ml). o The mixture was stirred at 0 C for 
1 h, when t.l.c. indicated that the reaction was completed. Acetic 
acid (0.2 ml) was added, the mixture was poured into water (20 ml), 
and the products were extracted with ethyl acetate; (3 x 10 ml). After 
removal of the solvent, the residual oil containing the monoacetyl-
arylidene derivative (134a - f) was dissolved in methanol (10 ml) and 
acetic acid (2 drops), 10% P~C catalyst (50 mg) was added, and the 
mixture was hydrogenated at atmospheric pressure for 24 h. The cata-
lyst was filtered off, the solvents were evaporated, and the residue 
containing the N-acetyl cyclic dipeptide was dissolved in DMF (2 ml). 
Hydrazine hydrate (30 fl) was added, and the mixture was left at room 
temperature for 1 h, then acidified with acetic acid (0.1 ml). The 
mixture was added to water (10 ml), the product was filtered off, 
washed with methanol and ether, and crystallised from acetic acid-
water • 
102 
. oyclo-(L-I'he-L-2' ,6'-Difluorophe) (136a), (215 mg, 65%), m.p. 287-
8 0 [J 21 0 ( . 2 9 C, ~ D -29.6 £ 0.5 ln AcOH) (Found: C, 65.55; H, 4.95; N, 8.5; 
F, 11.2. C18H16F2N202 requires C, 65.45; H, 4.9; N, 8.5; F, 11.5%); 
V
max
• 3 200 (NH), 1 680 (CO), and 1 670 cm-1 (co); 6 (TFA) 2.5 - 2.9 
(2 H, m, 2 C~ RHAr ) , 3.0 - 3.4 (2 H, m, 2 CH SHAr), 4.61 (2 H, pro-_ -wpro-_ 
m, 2 C~CH2Ar), 6.8 - 7.5 (8 H, m, Ar), 8.16 (1 H, br s, NH), and 8.35 
(1 H, br s, NH); ~F{1H} (CD30D) -113.2 (s); rrv'z 330 (M+, 100%),239, 
203, and 91. 
cyclo-(L-Phe-L-E-Fluorophe) (136b), (110 mg, 35%), m.p. 307 -
308°C, [a;JD20 -95.80 (£ 0.5 in AcOH) (Found: C, 69.4; H, 5.7; N, 9.0; 
F, 6.2. C18H17FN202 requires C, 69.4; H, 5.5; N, 8.95; F, 601%); 
~max. 3 210 (NH), 1 680 (CO), and 1 660 cm-1 (CO); b(TFA) 2.07 (1 H, 
dc;i., J 15 and 8 Hz, CH RHAr), 2.66 (1 H, dd, J 15 and 7 Hz, 
-pro-_ 
CH. RHPh ) , 3. 01 (1 H, dd, J 15 and 3 Hz, C!! SHAr), 3 • 17 (1 H, dd, 
-pro-_ - pro-_ 
J 15 and 4 Hz CH HPh) 4.40 - 4.75 (2 H, m, 2 CHCH2Ar), 7.0 - 7.6 
- '-pro-S' -
(9 H, m, Ar), 8.02 (1-H, br s, NH), and 8.14 (1 H, br s, NH); &F{1 H} 
-116.0; rrv'z 312 (M+, 100%), 221, 203, 109, and 91. 
cyclo-(L-Phe-L-o-Fluorophe) (136c), (200 mg, 64%), m.p. 300 -
3020 C, [aJD21 _74.6 0 (£ 0.5 in AcOH) (Found: C, 69.35; H, 5.4; N, 8.8; 
F 6 4 C H ~N 0 requires C, 69.2; H, 5.5; N, 8.95; F, 6.1%); 
, •• 18 1'/ 2 2 
3 310 (NH), 3 200 (NH), 1 675 (CO), and 1 665 cm-
1 (CO); &(TFA) 
'V rnax • 
1 ~7 • v.-J 
2.35 (1 H, dd, J 15 and 7 Hz, CH HAr) 2 49 (1 H 
-pro-g ,. , dd, J 14 and 8 H=, 
CHpro_BHPh), 3.04 - 3.38 (2 H, m, 2 C~pro_SHAr), 4.62 (2 H, m, 
2 CBCH2Ar), 7.0 - 7.5 (9 H, m, Ar), 8.14 (1 H, br s, NH), and 8.24 
(1 H, br s, NH); bF{1H} (d6-DMSO) -112.7; ~~ 312 (M+, 20%), 221, 203, 
109, and 91 (100). 
cyclo-(L-Phe-L-m-Fluorophe) (136d), (170 mg, 54%), m.p. 300 -
o [J 21 40 ( . 303 c, a D -74. ~ 0.5 ln AcOR) (Found: C, 69.2; H, 5.5; N, 9.0; 
F, 6.3. C18H1~N202 requires C, 69.2; H, 5.5; N, 8.95; F, 6.1%); 
V
max
• 3 200 (NH) , 1 680 (CO), and 1 670 cm-1 (CO); 5(TFA) 2.04 (1 H, 
dd,.!! 15 and 8 Hz, C!.!pro_!3.HAr), 2.62 (1 H, dd, J 15 and 8 Hz, 
CHpro_RHPh), 2·99 (1 H, dd, J 15 and 3 Hz, CH~_~HAr), 3.12 (1 H, dd, 
~ 15 and 4 Hz, cg~o_§HAr), 4.38 - 4.72 (2 H, m, 2 C~CH2Ar), 6.7 - 7.5 
(9 H, m, Ar), 8.01 (1 H, br s, NH), and 8.11 (1 H, br s, NH); bF{1H~ 
(d6-DMSO) -116.7; m1~ 312 (M+, 16%), 109, and 91 (100). 
cyclo-(L-Phe-L-Pentafluorophe) (136e), (crystallised from acetic 
. 0 [J 21 60 ( . aCld-ether), (290 mg, 76%), m.p. 309 - 311 C, ~ D -39. £ 0.5 ln 
AcOH) (Found: C, 56.0; H, 3.2; N, 7.0; F, 24.6. C18H13F5N202 requires 
-1 
c, 56.25; H, 3.4; N, 7.3; F, 24.7%); Y 3 200 (NH), and 1 680 cm 
max. 
(co); S(TFA) 2.17 (1 H, dd, J 15 and 9 Hz, C~pro_RHC6F5)' 2.92 (1 H, 
dd, J 15 and 4 Hz, CH HC6F) 3.22 - 3.41 (2 H, m, C!!2Ph ) , 4.40 -pro-~ 5' 
(1 H, m, CHCH
2
Ph), 4.78 (1 H, m, CHCH2C6F5), 7·1 - 7.6 (5 H, m, Ph), 
8.30 (1 H, br s, NH), and 8.39 (1 H, br s, NH); 6F{1H} (d6-DMSO) 
( m)·, _/ Z 384 (M+, 
-141.0 (2 F, m), -157.6 (1 F, t), and -163.5 2 F, rrv 
6%),265,203,181, and 91 (100). 
cyclo-(L-Phe-L-Phe) (136f) = (42), (185 mg, 63%), m.p. 307 -
104 
31 00 C , ( 1 . t 1 02 308 0) [l 21 0 1 ., - 310 C, ~JD -123.6 (£ 0.5 in AcOH); 
[N] D21 0 J V\ -237 (.Q 0.06 in pyridine) lit., 103 [ex D25 _242 0 (£ 0.059 In 
pyridine) ; Vmax • 3 210 (NH), 1675 (CO), and 1665 cm-1 (CO); 6 (TFA) 
2.34 (2 H, dd, J 15 and 8 Hz, CH HPh) 3 09 (2 H dd J 1 4 l2.!:..Q-B ,. "_ 5 and Hz , 
CBpro_SHPh), 4.58 (2 H, m, CHCH2Ph), 7.0 - 7.6 (10 H, m, Ph), and 8.07 
(2 H, br s, NH); m/z 294 (M+, 33%), 203, 175, and 91 (100). 
Although the intermediate arylidene compounds (134a - f) were not 
isolated in pure form, their n.m.r. spectra were recorded, and are 
given in Table 1. 
Determination of the optical purity of (134a) 
After carrying out the condensation of diacetyl-cyclo-(Gly-L-Phe) 
(133) with 2,6-difluorobenzaldehyde as described above, a sample of 
tpe oil obtained was purified by preparative t.l.c. (solvent system B) 
to give the pure arylidene compound (134a) as an oil, A (EtOH) 
max. 
307 nm (E 16 000); V 3 400 (NH), 1 710 (CO), and 1 695 cm-1 (CO); 
max. 
[ 2.59 (3 H, s, Ac), 3.22 (2 H, d, !Z 5 Hz, C!!2Ph ) , 5.33 (1 H, t, ~ 
5 Hz, CECH2Ph), 6.52 (1 H, s, C~), 6.8 - 7.5 (8 H, m, Ar), and 7.81 
(1 H, br s, NH); !VZ 370 (M+, 77%), 328, 237~(100), 209, 91, and 43. 
On addition of the chiral shift reagent tris[3-(trifluoromethylhydrOxy-
methylene)-~-camphoratoJeuropium(III) [Eu(tfC)3] (0.2 mol eq) to the 
n.m.r. sample, the spectrum became; 02.82 (3 H, s, Ac), 3.84 (1 H, dd, 
J 14 and 6 Hz, C!!ffPh), 4.18 (1 H, dd, J 14 and 3 Hz, CH!!Ph) , 6.6 - 7.8 
(10 H, m, Ar, CHAr, and CBCH2Ph), and 8.90 (1 H, br s, NH). The 
spectrum of a partially racemic sample (prepared using triethylamine 
as base _ see Discussion) contained an additional ABX system ~. 0.1 
p.p.m. upfield, and an additional NH signal 0.2 p.p.m. upfield of the 
CH3CO CH2 CHCH2 C=CHAr Ax NH 
-
COMPOUND (s) (d, J 5 Hz) (t, J 5 Hz) (br s) (m) (bI' s) 
(134a); Ar = C6H3F2 2.58 3.22 5.35 6.52 6.8 - 7.5 7.74 
(134b); AI' = £-F-Ph 2.56 3.19 5.30 6.55 6.8 - 7.35 I 8.60 
(134c); Ar = £-F-Ph 2.58 3.23 5.34 6.62 6.95 - 7.5 7.95 
(134d); Ax = ~-F-Ph 2".58 3.19 5.27 6.53 6.7 - 7.5 8.56 
(1~4e)' Ar - C F 
...J , - 6 5 2.60 3.20 5.25 6.40 6.9 - 7.4 8.83 
( 134f); Ar = Ph 2.57 3.24 5.36 6.62 7.0 - 7.7 8.4 (br) 
TABLE 1 N.m.r. data for arylidene compounds (134a - f) 
~ 
~ 
1~ 
corresponding signals from the S-enantiomer. These signals were not 
detectable in the first sample. 
cyclo-(L-Phe-L~(3R)-[3-DJ-~-Fluorophe) (136h). - This compound was 
prepared by the general method, using [formyl-D]-£-fluorobenzaldehyde 
(preparation given below). Diacetyl-cyclo-(Gly-L-Phe) (133) (200 mg, 
0.69 mmol) gave the deuteriated cyclic dipeptide (136h) (130 mg, 60%), 
m.p. 306 - 309°C, ~ 3 210 (NH), 1 680 (CO), and 1 660 cm-1 (CO)., 
max. 
~ (TFA) 2.63 (1 H, dd, J 15 and 7 Hz, CtIpro_RHPh), 2.98 (1 H, br d, 
J 4 Hz, CBpro_.§DAr), 3.12 (1 H, dd, J 15 and 4 Hz, C!!pro_~HPh), 4.46 
(1 H, m, CHCHDAr), 4.62 (1 H, m, CliCH2Ph), 7.0 - 7.5 (9 H, m, Ar), 
7·97 (1 H, br s, NH of B-Fluorophe), and 8.09 (1 H, br s, NH of Phe); 
also small signals at 3.33 (m), 4.82 (m), 7.25 (m), and 8.42 (br s), 
due to a small amount (ca. 15%) of the arylidene compound (138h); ~~ 
313 (M+, 70%), 312 (11), 311 (28), 203 (41), 110 (76), and 91 (100). 
a-Morpholino-~-(~-fluorophenyl)acetonitrile (184). - This compound 
was prepared by the method of Bennett et al., 116 substituting ~-fluoro­
benzaldehyde for benzaldehyde, on a 6 millimolar scale, giving (184) 
(1.07 g, 81%), m.p. 67 - 68°C, (Found: C, 65.25; H, 5.8; N, 12.75. 
C12H13FN20 requires C, 65.45; H, 5.95; N, 12.7%); ~~ax. 2 870, 2 830, 
2 230 (CN), 1 610, 1 600, 1 505, 1 110, and 860 cm-1 ; £ 2.57 (4 H, m, 
NCH2), 3.71 (4 H, In, OCH2 ) , 4.80 (1 H, m, CH), 7.09 (2 H, t, J 9 Hz, 
£- to F), and 7.52 (2 H, dd, J 9 and 6 Hz, ~- to F); ~~ 220 (M+, 43%), 
189, 134 (100), 109, and 86. 
[Formyl-D]-B-fluorobenzaldehyde. - ~-Morpholino~-£-fluorophenyl)-
acetonitrile (184) (1.0 g, 4.55 mmol) was dissolved in dry ether (5 ml). 
The solution was cooled to oOe in a flask equipped with a rubber septum, 
and a 1.5 M solution of Q-butyllithium in hexane (4 ml) was added with 
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stirring. After 10 min., D20 (0.2 ml) was added dropwise, then thionyl 
chloride was added until the mixture gave an acid reaction on wet 
litmus paper. The mixture was then added to water (50 ml) and extrac-
ted with ether (3 x 10 ml). The brown oil so obtained was heated under 
reflux with 2 M hydrochloric acid (50 ml) for 1 h, the crude deuterio-
fluorobenzaldehyde was extracted with ether (3 x 10 ml), and was 
purified using a Kugelrohr ball-to-ball distillation apparatus. Pure 
[formyl-DJ-~-fluorobenzaldehyde was thus obtained (200 mg, 35%), 
&7. 13 (2 H, t, ~ 8 Hz, £-H to F), 7.82 (2 H, dd, J 8 and 5 Hz, o-H 
to CDO), and 9.84 (residual CHO, s, ~ 3% of 1 H). 
was prepared by the general method, except that the reduction step was 
carried out using deuterium gas, with methanol-OD as the solvent. The 
deuterium was generated by addition of D20 via a pressure-compensated 
dropping funnel to lithium metal contained in a three-necked flask 
attached to the evacuated hydrogenation apparatus~ When atmospheric 
pressure was reached (indicated by inflation of a rubber teat attached 
to one arm of the three-necked flask), the reservoir was allowed to 
fill, and the three-necked flask was detached. The diacetyl compound 
(133) (144 mg, 0.5 mmol) gave the deuteriated cyclic dipeptide (136g) 
(60 mg, 38%), m.p. 304 - 307°C; v
max
• 3 210 (NH), 1 680 (CO), and 
1660 cm-1 (CO); b (TFA) 2.06 (1 H, br s, C.tlpro_SDAr), 2.63 (1 H, dd, 
J 15 and 7 Hz, CH RHPh), 3.13 (1 H, dd, J 15 and 4 Hz, C~pro_S_HPh), 
-:eEE-_ 
4.43 (~. 0.1 H, m, residual CHCHDAr), 4.63 (1 H, m, C~CH2Ph), 7.0 -
7.6 (9 H, m, Ar), 8.00 (1 H, br s, NH of E-Fluorophe), and 8.12 (1 H, 
br s, NH of Phe); ~/z 314 (M+, 46%), 313 (12), 223 (7), 204 (36), 203 
(6), 110 (91), 109 (8), and 91 (100). 
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2,6-Difluorobenzaldehyde. - 2,6-Difluorobenzoic acid (6.5 g, 
41 mmol) was added to thionyl chloride (10 ml) containing pyridine 
(1 drop), and the mixture was heated under reflux for 3 h. Excess 
thionyl chloride was removed under reduced pressure to give crude 
2,6-difluorobenzoyl chloride as an oily liquid, which was used without 
further purification. V
max
• (thin film) 1 780 (co) and 1 740 cm-1 (CO). 
To a solution of the crude acid chloride (7.2 g, ca. 40 mmol) and 
triphenylphosphine (21.6 g, 82 mmol) in acetone (100 ml) was added 
bis-( triphenylphosphine) copper(I) borohydride (24.8 g, 40 mmol). 117 
The mixture was stirred for 45 min., and the solids were removed by 
filtration. The filter cake was washed with ether, and the solvents 
were evaporated from the combined filtrate and washings. The residue 
was treated with ether (100 ml) and filtered; the filtrate was evapor-
ated, and the residue was dissolved in chloroform (100 ml). The 
solution was stirred with finely powdered copper(I) chloride (10 g) 
for 2 h, the mixture was filtered, and the filtrate was evaporated. 
The residue was treated with methanol (50 ml) and filtered. After 
evaporation of the methanol from the filtrate, the remaining oil was 
distilled at water-pump pressure to give 2,6-difluorobenzaldehyde 
o . 118 8 0 /' ) (3.8 g, 65%), b.p. 104 - 105 C/40 Torr (llt., 85 - 7 C 20 Torr; 
" (thin film) 
V max • 
(3 H, m, Ar), and 
(M+ - H). 
-1 2 870, 2 770 (CHO), and 1 700 cm 
10.33 (1 H, s, CHO); &F{1 H} -115·2 
(co); S 6.8 - 7.8 
(s); .!!V'z 141 
3 ,6-Di-(..E-fluorobenzylidene )piperazine-2 ,5-dione (140a). 96 
Glycine anhydride (300 mg, 2.63 mmol), E-fluorobenzaldehyde (820 mg, 
6.61 mmol) , sodium acetate (870 mg, 10.61 mmol) , and acetic anhydride 
(3 ml) were heated together at 1200 C for 4 h. The mixture was then 
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shaken with water (25 ml), the precipitate was filtered off , and was 
washed with methanol and ether to give (140a) (530 mg, 62%), m.p. 
> 328°C, \Jmax • 3 220 (NH), 1685 (CO), 1630 (C=C), 1510,1410, 
1230 cm-1 ; S(TFA) 7.1 - 7.6 (m); ~~ 326 (M+, 100%), 136, 135, 
and 
109, 108, and 107 (Found: ~z 326.0878. C18H12F2N202 requires 
326.0867) • 
134, 
(±)-3,6-Di-(£-fluorobenzyl)piperazine-2,5-dione (139a). - The 
diarylidene compound (140a) (60 mg, 0.18 mmol) was suspended in meth-
anol (60 ml) and acetic acid (0.5 ml), 1CJ}6 pdlc catalyst (30 mg) was 
added, and the mixture was hydrogenated for 70 h at atmospheric 
pressure. The catalyst was filtered off and washed with acetic acid 
(10 ml), and the filtrates were evaporated to dryness. The residue 
was crystallised from acetic acid-water to give (139a) (35 mg, 58%), 
m.p. 291 - 293°C (Found: C, 65.25; H, 4.95; N, 8.55; F, 11.6. 
C18H16F2N202 requires C, 65.45; H, 4.9; N, 8.5; F, 11.5%); Ymax . 3 210 
(NH), and 1 670 cm-1 (CO); S (TFA) 2.44 (2 H, dd, ~ 15 and 8 Hz, 
CH RHAr in SS-enantiomer), 3.13 (2 H, dd, J_ 15 and 4 Hz, CH SHAr 
-pro-_ - -pro-_ 
in SS-enantiomer), 4.60 (2 H, m, CHCH2Ar), 7.12 (8 H, d, ~ 7 Hz, Ar), 
and 8.1 (2 H br s NH)' b. {1H} -116.3; m/z 330 (M+, 7%), 221, and 109 
, , 'F --
(100) • 
3,6_Di_(pentafluorobenzylidene)piperazine-2,5-dione (139b). 97 -
Triethylamine (220 mg, 2.18 mmol) was added to a solution of 1,4-di-
acetylpiperazine-2,5-dione (200 mg, 1.01 mmol) and pentafluorobenz-
aldehyde (400 mg, 2.04 mmol) in DMF (2 ml), and the mixture was stirred 
at 1000 C for 2 h. The dark-coloured mixture was then shaken with 
water (10 ml), the solid was filtered off, and was washed with methanel 
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and ether to give ( 14ob) (170 mg, 36%), lm. p. > 322°C (Found: C, 45.9; 
H, 0.75; N, 6.0; F, 40.4. C18H4F 10N202 requires C, 46.0; H, 0.85; 
N, 5·95; F, 40.4%); \I max. 3 200 (NH), 1 690 (CO), 1 660, and 1 645 cm 
(C=C); ~~ 470 (M+, 96%) , 208 (100), 207, and 180. 
(±)-cis-3,6-Di-(pentafluorobenzyl)piperazine-2,5-dione (139b). -
The diarylidene compound (140b) (140 mg, 0.30 mmol) was suspended in 
methanol (100 ml) and acetic acid (10 ml), with 10% P~C catalyst 
-1 
(100 mg), and the mjxture was hydrogenated at atmospheric pressure for 
50 h. The catalyst was filtered off, the filtrate was evaporated to 
dryness, and the residue was crystallised from methanol-water to give 
( 139b) (130 mg, 92%), m.p. 292 - 2940 C (Found: C, 45 . 7; H, 1.4; N, 
5.65; F, 39.85. C18HBF10N202 requires C, 45.6; H, 1.7; N, 5.9; F, 
40.05%) ; » 3 200 (NH) , 1 680 (CO), 1520, and 1 510 cm -1 ~ (TFA) max. , 
3.01 - 3.72 (4 H, m, C~~r), 4.71 (2 H, m, C~CHZAr), and 8.48 (2 H, 
br s, NH); SF{1H1 (d6-DMSO) -141.6 (2 F, m), -156.9 (1 F, t), and 
-163.2 (2 F, m); ~~ 474 (M+, 7%), 293, 265 (100), 181, and 163. 
(+)-cis-cyclo-([2,3-D2]-Phe-[2,3-DJPhe) (139c). - 3,6-Dibenzyl-
idenepiperazine-2,5-dione (140c)96 (97 mg, 0.33 mmol) was suspended 
in methanol-OD (8 ml) with 10% P~C catalyst (30 mg)" and the mixture 
was treated with deuterium gas (preparation given above) at atmosph-
eric pressure for 20 h. The catalyst was filtered off and washed with 
acetic acid (10 ml). The combined filtrates were evaporated to 
dryness, and the residue was crystallised from acetic acid-water to 
o 
give tetradeuterio-cis-cyclo-(Phe-Phe) (139c) (38 mg, 39%), m.p. 325 C 
(sublimed), V 3 210 (NH), 1 675 (CO), and 1 450 cm-1 ; S(TFA) 2.50 
max. 
(2 H, br s, CHDPh), 7.0 - 7.5 (10 H, m, Ph), and 8.06 (2 H, br s, NH); 
111 
+ 
.0/ ~ 299 ( 5 • 7%), 298 ( M , 18), 297 (7), 294 (15), 2 ~, 202, 178 , 174 , 
116, 93, 92 (100), and 91. 
14 Preparation of C-labelled cyclic dipeptides 
~-BenZyloxycarbonYl-[1-14CJ-glycine. - This compound was prepared 
by the method of Greenstein and Winitz,119 using G_14cJglycine (250 
pCi, 51.2 nC:i/mmol) which was diluted by the addition of unlabel]ed 
,glycine (225 mg, 3 mmol) to the aqueous solution. This procedure gave 
• 
the !!-protected derivative (562 mg, 90%), m.p. 122 - 123°C (lit.,11 9 
120oC), specific activity 83.4 fCi/mmol. 
cyclo-( [1_14C ]Gly-L-Phe) (137). - The cyclic dipeptide was prepared 
by the method described previously for unlabelled material. N-Benzyl-
oxycarbonyl-[1-14C]glycine (510 mg, 2.44 mmol) , gave the cyclic dipep-
tide (137) (250 mg, 50%), m.p. 270 - 272°C. 
N,NI-Diacetyl-cyclo-([1-14C]Gly-L-Phe) (133). - This compound was 
prepared as described earlier for unlabelled material. CJClo-([1-14C]-
Gly-L-Phe) (137) (250 mg, 1.23 mmol) gave the diacetyl derivative 
(133) (240 mg, 68%), m.p. 102 - 103°C, specific activity 84.4 fCi!mmol. 
This material was used to prepare the labelled fluorinated cyclic 
dipeptides (136a - e) (data given in Table 2). 
COMPOUND 
(136a); Ar = C6H3F2 
( 136b); Ar = ,E-F -Ph 
(136c); Ar = Q-F-Ph 
(136d); Ar = ~-F-Ph 
(136e); Ar = C6F5 
From (133) Yield Yield m.p. Specific activity 
(mg) (mg) (%) (oC) (!lCi! mmol) 
50 28.5 50 280 - 282 83.2 
40 20.9 48 312 - 314 83.6 
40 20.3 47 299 - 302 83.5 
45 24.3 50 300 - 302 83.0 
45 36.5 61 300 - 303 82.7 
TABLE 2 Experimental data for radio-labelled fluorinated dipeptides 
~ 
~ 
I\.) 
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3.3 Synthesis of sulphur-containing dioxopiperazines 
!i,!!' -Diacetyl-cyclo-(L-Phe-L-Phe) (157). 101 - A mixture of cyclo-
(L-Phe-L-Phe) (294 mg, 1 mmol) , acetic anhydride (2 ml), and perchloric 
acid (1 drop) was stirred at 90°C for 1 h. The acetic anhydride was 
evaporated under reduced pressure, and the residue was crystallised 
from acetone-water, giving the diacetyl derivative (157) (240 mg,64%), 
6 0 [J 21 0 m.p. 17 - 177 c, ~ D +177·5 (£ 1.0 in CHC1-); ~ 1 715 (CO), 5 max. 
( ) -1 (" 1 705 CO, and 1 220 cm ; 0 2.47 (6 H, s, Ac), 2.5 - 2.91 (4 H, m, 
CB2Ph), 5.30 (2 H, dd, ~ 7 and 5 Hz. C~CH2Ph), and 7.02 - 7.45 (10 H, 
+ 
m, Ph); ~~ 378 (M , 20%), 336, 245, 203, 131, 91 (100), and 43. 
Reaction of (157) with potassium l-butoxide 
i) To diacetyl-cyclo-(L-Phe-L-Phe) (157) (126 mg, 0.33 mmol) in 
DMF (1 ml) was added dimethyl disulphide (0.15 ml). The mixture was 
cooled to OoC, and a 0.5 M solution of potassium l-butoxide in 
t-butanol (0.67 ml) was added with stirring. After 25 min., acetic 
acid (0.2 ml) was added, the mixture was poured into water, (25 ml), 
and the products were extracted with chloroform (3 x 10 ml). The 
extract was ~ashed with water (2 x 10 ml) and evaporated to dryness. 
The residual gum was a 1:1 mixture of cis- and trans- isomers of the 
rearranged compound (158); V
max
• (CHC13) 3 440 (NH), 3 005, 1 780, 
1 740 (C-Ac), 1 710 (~-Ac), 1 675 (CONR2 ), 1 495, and 1 265 cm 
-1 
61.20 (1 H, dd, J 16 and? Hz, cis-CHHPh), 1.82 (3 H, s, trans-
CCOMe), 2.01 (3 H, s, cis-CCOMe), 2.41 (3 H, s, N-Ac), 2.63 (3 H, s, 
~-Ac), 2.7 - 3.3 (7 H, m, cis- and trans- C~2Ph), 3.67 (1 H, dd, J 10 
and 6 Hz, trans-CHCH
2
Ph), 4.95 (1 H, dd, J 7 and 3 Hz, cis-C~CH2Ph), 
6 8 1 ) 68 (20H Ph) d7.57(1H,brs,NH)j .2 ',1 H, br s, NH, • - 7.5 , m, ,an 
+ ~~ 378 (M , 24%), 277, 245, 203, 186, 131, 120, 91 (100), and 43. 
ii) To an ice-cooled solution of diacetyl-cyclo-(L-Phe_L_Phe) 
(90 mg, 0.24 mmol) , in DMF (1 ml) was added a 0.5 M solution of 
potassium t-butoxide in i-butanol (1 ml) with stirring. Af ter 1 h, 
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acetic acid (0.1 ml) was added, the mixture was added to water ,(15 ml), 
and the products were extracted with ethyl acetate (3 x 5 ml). The 
solvent was evaporated and the residue was crystallised from ethyl 
acetate to give (159) (31 mg, 39%), m.p. 243 - 244°c V 3 280 (NH) 
, max. ' 
1 770~ 1 705 (CO), 1 670 (CONH), 1 660 (CONH), and 700 cm-1 ; 5 0.86 
(1 H, dd, ~ 14 and 11 Hz, CHCHHPh), 1.92 (3 H, s, CONe), 2.63 (1 H, dd, 
J 14 and 4 Hz, CHCHHPh), 2.93 and 3.23 (2 H, ABq, ~ 13 Hz, CAcC!!2Ph), 
4.32 (1 H, dd, ~ 11 and 4 Hz, CHCH2Ph), 6.35 (1 H, br s, exchangeable 
with D20, NH), 6.8 (2 H, m, Ar), 7.0 - 7.4 (8 H, m, Ar), and 7.45 (1 H, 
br s, exchangeable with D20, NH); ~~ 336 (M+, 27,%), 319, 245, 203, 
186, 120, 119, 118, 91 (100), and 43. 
Addition of methanethiol to 3,6-dibenzylidenepiperazine-2,5-dione. 
Zinc metal (25 mg) was suspended in dry methylene chloride (30 ml), and 
dry hydrogen chloride was bubbled through the suspension until satur-
ation was reached. After stirring for a further 2 h, most of the zinc 
had dissolved, and dibenzylidenepiperazine-2,5-dione (140c) (580 mg, 
2.0 mmol) was added, followed by methanethiol (0.6 ml; cooled to ca. 
OOC). The mixture was stirred at ca. 100 C for 24 h. After removal of 
the volatile components by evaporation under reduced pressure, the 
residual solid was treated with chloroform (50 ml), and the insoluble 
material was filtered off (this was nearly all starting material). 
Evaporation of the chloroform gave a solid (45 mg) which was purified 
by t.l.c. (solvent system B) to give a white solid (156) (ca. 10 mg), 
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m.p. 300 - 3030 C (decomp.); &(100MHz) 2.26 (3 H, s, SMe), 3.19 and 
3.60 (2 H, ABq, CH2Ph), 6.35 (1 H, br s, exchangeable with D20, NH), 
6.87 (1 H, s, CHPh), 7.0 - 7.6 (~ 18 H, m, Ar), and 7.89 (1 H, br s, 
exchangeable with D20, NH); ~~ 292 (24%), 291 (M+-SMe, 87), 290 (100), 
118 (73), 117 (53), 91 (58), 90 (31), 48 (MeSH: 10), and 47 (MeS+, 13). 
Sulphur. - The sulphur used in the reactions given below was 
heated to increase its solubility; technical grade flowers of sulphur 
was heated in an oven at 110°C overnight. 
Lithium di-isopropylamide (LDA). - LDA was prepared by the addition 
of a 1.5 M solution of Q-butyllithium in hexane (1.0 equivalents) to a 
stirred solution of di-isopropylamine in THF, at OOC. 
(±)-1,4-Di(methoxymethyl)-3,6-cis-dibenzylpiperazine-2,5-dione 
(161). - Potassium l-butoxide (7.6 g, 68 mmol) was added slowly to a 
stirred suspension of (±)-3,6-cis-dibenzylpiperazine-2,5-dione (160)"111 
(9.1 g, 31 mmol) in DMSO (50 ml). When all the solids had dissolved 
(~. 30 min.), chloromethyl methyl ether (5.0 ml, 66 mmol) was added 
dropwise over 20 min. After stirring for a further 10 min., the 
mixture was poured into water (300 ml), the products were extracted 
with methylene chloride (3 x 50 ml), and the extract was washed with 
water (2 x 50 ml). The solvent was evaporated and the residual oil was 
purified by passing it through a short column of silica gel H, with 
ether as the eluent. This gave reasonably pure protected compound 
as an oil (8.7 g, 74%), V (CHC13 ) 1 675 (CO), 1 460, 1 090, max. 
and 710 cm-1 ; S 2.47 (2 H, dd, ~ 14 and 6 Hz, C!!HPh), 2.85 (2 H, dd, 
~ 14 and 4 Hz, CHHPh), 3.23 (6 H, s, Me), 4.14 and 5·13 (4 H, ABq, 
116 
..l 10Hz, CH20Me) ,4.42 
(10 H, m, Ar); .!!V~ 382 
(2 H, dd, J 6 and 4 Hz, CHCH Ph) and 7 0 
- 2' • - 7.4 
+ (M , 0.6%), 350, 91, and 45 (100); (Found: ~~ 
(±)-Di(methQxymethyl)-3,6-epitetrathio-3,6-dibenzylpiperazine-
2,5-dione (162). - A solution of the protected dipeptide (161) (2.10 g, 
5.50 mmol), and sulphur (1.72 g, 5.50 mmol of S8) in THF (60 ml) and 
DMF (0.02 ml) was cooled to -78°c. LDA (12.1 mmol) in THF (15 ml) was 
added by syringe via a rubber septum, whereupon the mixture became 
orange-red. The mixture was stirred at -78°c for 30 min., then allowed 
t t _10oC o warm up 0 Over ca. 90 min. At this point the colour was a 
deep red, a~d there were no suspended solids remaining. Acetic acid 
(2 ml) was added, the mixture was poured into water (300 ml), and the 
products were extracted with methylene chloride (3 x 50 ml). The 
solvent was evaporated off, and excess sulphur was removed by treating 
the residue with ethyl acetate (25 ml) and filtering off the insoluble 
solids. After evaporation of the solvent, the syrupy residue was 
crystallised from acetone to give the tetrasulphide (162) (1.04 g, 
o 35%; calculated for C22H24N204S5 - see Discussion), m.p. 160 - 162 C. 
An analytical sample, purified by t.l.c. (solvent system C), followed 
by crystallisation from acetone, had m.p. 165 - 167°C (Found: C, 51.7; 
H, 4.5; N, 5.7; S, 25.3. 
N, 5.5; S, 25.2%); V 
C22H24N204S4 requires C, 51.95; H, 4.75; 
1 680 cm -1 (CO); 5 3.10 (6 H, s, Me), 3.45 
max. 
and 3.63 (4 H, ABq, J 15 Hz, CH2Ph), 4.89 and 5.45 (4 H, ABq,:I. 10 Hz, 
CH OMe), and 7.10 (10 H, br s, Ph); 0c 41.0 (t), 
-2 
79.2 (s), 127.0 (d), 128.2 (d), 130.5 (d), 134.1 
!!(z 380 (M+-S4 , o/Jy), 325, 91,64, and 45 (100). 
57.8 (q), 75.8 (t), 
(s), and 169.3 (s); 
I h Od (162) (200 mg) by t.l.c. Separation of the crude tetrasu p 1 e 
(solvent system C) afforded as a minor product, the bridged sulphide 
(165) (5 mg), m.p. 140 - 142°C (from acetone); ~max. 1 685 (CO), 
-1 1 455, 1 365, 745, and 700 cm ; 63.02 (3 H, s, Me), 3.36 (3 H, s, 
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Me), 3.45 and 3.67 (2 H, ABq, J 15 Hz, CH2Ph), 4.47 and 4.71 (2 H, ABq, 
~ 6 Hz, CHCHPh), 4.90 and 5.43 (2 H, ABq, J 10 Hz, C!!20Me), 4.95 and 
5.65 (2 H, ABq, ~ 10 Hz, CH20Me), and 7.0 - 7.2 (10 H, br s, 2 Ph); 
~z 410, 380, 378, 325, 117, 116, 91, 64, and 45 (100%). 
The mother liquors from crystallisation of the tetrasulphide (162) 
were evaporated to a viscous oil. This was separated by column chrom-
atography using silica gel H and toluene-ethyl acetate as eluent, and 
crystallisation of one of the fractions from methanol gave the epidi-
sulphide (164) (90 mg, 3.7%), m.p. 110 - 112°C. Spectral data were 
identical to those given below. 
(±)-1,4-Di(methoxymethyl)-3,6-epidithio-3,6-dibenzylpiperazine-
2,5-dione (164). - To a stirred, ice-cooled solution of tetrasulphide 
(162) (540 mg, 1 mmol) in THF (4 ml) and ethanol (4 ml) was added 
slowly a suspension of sodium borohydride (200 mg, 5.26 mmol) in 
ethanol (3 ml). After 20 min. the solution was carefully acidified 
with acetic acid and added to water (30 ml). On extraction with 
methylene chloride (3 x 5 ml) and evaporation, the crude dithiol (175) 
was obtained as a foul-smelling oil, 0 3.30 (6 H, s, Me), 3.55 and 
3.93 (4 H ABq J 14 Hz, CH Ph), 3.74 (2 H, s, exchangeable with D20, , , - -2 
SH), 5.03 and 5.32 (4 H, ABq, J 10 Hz, CH20Me), and 6.8 - 7.5 (10 H, 
m, Ph). A solution of the dithiol in ethanol gave a purple-red colour 
on heating which disappeared on cooling. The oil was dissolved ln 
ethanol (10 ml), and a solution of ferric chloride \800 mg, 4.03 mmol) 
in ethanol (5 ml) was added. The mixture was stirred for 1 h, water 
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(60 ml) was added, and the product was extracted with methylene chlor-
ide (3 x 10 ml). After removal of the solvent, the epidisulphide (164) 
was crystallised from methanol; (400 mg, 90%), m.p. 108 _ 1100 C 
(Found: C, 59.6; H, 5.55; N, 6.1; S, 14.6. C22H24N204S2 requires 
C, 59.45; H, 5.45; N, 6.3; S, 14.45%);)} 1 695 cm-1 (CO); S 3.40 
max. 
(6 H, s, Me), 3.96 and 4.13 (4 H, ABq, J 14 Hz, C~2Ph), 4.82 and 5.42 
(4 H, ABq, ~ 10 Hz, CH20Me), and 7.2 - 7.5 (10 H, m, Ph); bC 35.8 (t), 
56.9 (q), 73.8 (s), 74.1 (t), 127.6 (d), 128.4 (d), 130.4 (d), 134.3 
(5), and 166.3 (s); ~~ 380 (M+- S2' 5%), 325, 91, 64, and 45 (100). 
(±)-1,4-Di(methoxymethyl)-3,6-epithio-3,6-dibenzylpiperazine-
2,5-dione (163). - A solution of protected dipeptide (161) (0.38 g, 
1.0 mmol) and sulphur (0.26. g, 1 mmol of S8) in THF (10 ml) and DMF 
(5 jJ-I) was cooled to -78°C, and LDA (2.2 mmol) in THF (5 ml) was added 
by syringe via a rubber septum. The stirred mixture was allowed to 
warm to room temperature over 1 h, then acetic acid (0.5 ml) was added 
and the mixture was poured into water (50 ml). Extraction with 
methylene chloride (3 x 10 ml), followed by evaporation of the solvent, 
gave a viscous oil, which was dissolved in ethyl acetate (5 ml) and 
filtered. The ethyl acetate was evaporated off, and the residue was 
separated by column chromatography (silica gel H, with toluene-ethyl 
acetate as the eluent). Crystallisation of one of the fractions from 
ethyl acetate-hexane gave the epimonosulphide (163) (110 mg, 27%), 
m.p. 129 - 131 0 C (Found: C, 64.15; H, 6.1; N, 6.75; S, 7.9· 
C22H24N204S requires C, 64.05; H, 5.85; N, 6.8; S, 7.75%); ~max. 1 725 
(CO), and 1 090 cm-1 ; 5 3.23 (6 H, s, Me), 3.31 and 3.86 (4 H, ABq, 
~ 14 Hz, CH
2
Ph), 4.70 and 4.85 (4 H, ABq, ~ 11 Hz, C~20Me), and 7.25 
( 1 0 H, s, Ph); 6 C 31.8 (t), 56.3 (q), 72.8 (t), 76.9 (s), 127.7 (d), 
128.6 (d), 130.0 (d), 134.3 (s), and 173.8 (s); mV& 412 (M+, 0.3%), 
380, 91, and 45 (100). 
(±)-1,4-Di(bromomethyl)-3,6-epidithio-3,6-dibenzylpiperazine-
2,5-dione (176). - The epidisulphide (164) (222 mg, 0.5 mmol) was 
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dissolved in methylene chloride (5 ml), and the solution was cooled to 
_78°C. A solution of boron tribromide (260 mg, 1.04 mmol) in methylene 
chloride (1 ml) was added with stirring. The mixture was allowed to 
warm to _40oc over 40 min., at which point wet ether (10 ml) and 5% 
aqueous sodium bicarbonate (5 ml) were added. The mixture was poured 
into water (30 ml), extracted with ether (3 x 10 ml), and the ether 
extract was washed with 20% glucose solution (10 ml) and water (2 x 
10 ml). After evaporation of the solvent, the residue was crystallised 
from carbon tetrachloride to give the di(bromomethyl) derivative (176), 
(260 mg, 96%), m.p. 167 - 168°c (decomp.). A satisfactory analysis 
was not obtained. V 1 710 cm-1 (CO); b 4.03 and 4.17 (4 H, ABq, 
ma.x. 
~ :5 Hz, CH2Ph), 5.04 and 5.81 (4 H, ABq, { 11 Hz, Cg2Br), and 7.38 
(10 H, br s, Ph); m/z 480, 478, and 476 (M+-S2 , 4, 9, and 4%), 91 
79 81 (100), 82, 81, 80, 79, and 64; (Found: 541.9190. C20H18 Br BrN202S2 
81 
requires 541.9156. Found: 479.9673. C20H18 Br2N202 requires 
479.9650) • 
(±)_1,4_Di(hydroxymethyl)-3,6-epidithio-3,6-dibenzylpiperazine-
2,5-dione (178). - A solution of the di(bromomethyl) compound (176) 
(80 mg, 0.15 mmol) in ether (10 ml) was stirred vigorously with water 
(30 ml) for 18 h. The water was decanted and replaced with a further 
d . f 20 h The ether layer 30 ml, and the mixture was stirre agaln or . 
and the residue was crystall-was separated and evaporated to dryness, 
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ised from acetone to give (178) (50 mg, 81%), m.p. 263 _ 280°C 
(decomp.); Vmax • 3 420 (OH) , 1 680 (CO), and 1 030 cm-1 ; & (100 MHz) 
(d6-DMSO) 3.88 and 4.11 (4 H, ABq, J 15 Hz, C~2Ph), 4.83 (2 H, dd, 
~ 12 and 8 Hz, CHHOH), 5·30 (2 H, dd,.i. 12 and 8 Hz, C~OH), 6.49 (2 H, 
t, ~ 8 Hz, exchangeable with D20, OH), and 7.2 - 7.5 (10 H, m, Ph); 
.!!I~ 292 (M+-S2-(CH20)2' 35%),290 (100),201,118,117,116, and 91. 
(±)-3,6-Epidithio-3,6-dibenzylpiperazine-2,5-dione (152). - The 
di(bromomethyl) epidisulphide (176) (27 mg, 0.05 mmol) was stirred 
with powdered ammonium acetate (100 mg, 1.30 mmol) in methylene chlor-
ide (3 ml) for 20 h. The mixture was washed with water (3 x 1 ml), 
and evaporated to dryness. The residue crystallised from benzene to 
give the deprotected disulphide (152) (19.5 mg, 94%), m.p. 246 - 249°C 
(decomp.) (Found: C, 65.0; H, 4.9; N, 6.85; S, 16.4. C18H16N202S2. 
0.75 C6H6 requires C, 65.1; H, 5.0; N, 6.75; S, 15.45%); [A sample was 
also crystallised from toluene; m.p. 251 - 253°C (decomp,) (Found: 
c, 65.9; H, 5.25; N, 6.55; S, 14.9. C1SH16N202S2. 0.75 C7HS requires 
C, 65.6; H, 5 • 2; N, 6 • 6; S, 15 • 05%) ; ] ; ))rnax. (CHC13 ) 3 360 (NH), 
1 710 (CO), 1 455, 1 335, and 705 cm -1 Vrnax • (KBr) 3 360 (NH), 3 200 . , 
(NH), 1 690 (CO), 1 425, 1 340, and 700 cm-1 ; 63. 42 and 3.70 (4 H, 
ABq, l. 16 Hz, CH
2
Ph), 6.55 (2 H, br s, exchangeable with D20, NH), 
7.36 (4.5 H, s, benzene), and 7.40 (10 H, s, Ph); bC 37.7 (t), 71.1 
(s), 128.5 (d), 129.0 (d, benzene), 129.3 (d), 130.9 (d), 132.4 (s), 
and 165.0 (s); .!¥~ 292 (M+- S2' 28%), 290, 201, 173, 91 (100), 65, and 
64. 
Bis(dithio)- compound (179). - To a solution of di(bromomethyl) 
( 6) ( 4 026 mmol) lOn methylene chlorjde (1 ml) epidisulphide 17 1 mg, O. 
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was added a saturated solution of ammonia in methylene chloride (1 ml). 
After 10 min., the mixture was evaporated to dryness, d an to the residue 
was added methylene chloride (2 ml). The mixture was filtered, and the 
filtrate was evaporated to dryness. Separ t" f th a lon 0 e residue by t.l.c. 
(solvent system B) gave the bis(dithio)- compound (179) as an oil (4 mg, 
35%); ~max. (CHC13 ) 1 720 (CO), 1 665, and 1 365 cm-1 ; ~ 2.63 and 3.34 
(4 H, ABq, 1. 14 Hz, CH2Ph), 4.43 and 5.65 (4 H, ABq, ~ 11 Hz, C!!2S), 
and 7.0 - 7.5 (10 H, m, Ph); ~~ 446 (~+, 3.5%), 382, 117, 116, 91 
(100), and 64; (Found: ~z 446.0249. C20H18N202S4 requires 446.0251). 
The material collected on the filter was washed with water and 
methanol to give 3,6-dibenzylidenepiperazinedione (140c) (2.4 mg, 32%), 
m.p. 302 - 306°C (lit., 96 298 - 3000 C); V 3 200 (NH), 1 680 (CO), 
max. 
1630 (C=C), 1 400, and 690 cm-1 ; ~z 290 (~+, 21%), 118, 117, 116, 
90 (100), and 89. 
(±)-Di(methoxymethyl)-cis-3,6-di(methylthio)-3,6-dibenzylpiperaz-
ine-2,5-dione (172). - The tetrasulphide (162) (27 mg, 0.05 mmol) was 
o dissolved in THF (0.5 ml) and ethanol (0.5 ml), cooled to 0 C, and 
sodium borohydride (15 mg, 0.39 mmol) in ethanol (1 ml) was added 
slowly with stirring. After 5 min., methyl iodide (1 ml) was added. 
The reaction mixture was stirred for 30 min., then allowed to warm to 
room temperature, and acetic acid (0.1 ml) was added. The mixture was 
poured into water (20 ml) and the products were extracted with methyl-
ene chloride (3 x 5 ml). After evaporation of the solvent, the residue 
was crystallised from methanol to give (172) (21 mg, 89%), m.p. 117 -
119°C (Found: C, 60.75; H, 6.5; N, 5.75; S, 13·7· C24H30N204S2 
requires C, 60.75; H, 6.35; N, 5.9; S, 13.5%); 
and 700 cm-1 ; 6 2.14 (6 H, s, SMe), 2.96 (4 H, 
V 1 675 (CO), 1 (:90, 
max. 
s CH Ph), 3.38 (6 H, 
, -2 
s, OMe) , 4.72 and 5.14 (~ H, ABq, J 10 Hz, C~20Me), and 7.0 _ 7.3 
(10 H, m, Ph); C 13.8 (q), 44.6 (t), 57.8 (q), 74.5 (s), 76.6 (t), 
127·5 (d), 128.4 (d), 131.0 (d), 134.2 (s), and 166.8 (s); ~~ 474 
(M+, 2%), 427, 390, and 91 (100). 
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(±)-Di(methoxymethyl)-cis-3,6-di(methYldithiO)_3,6_dibenzyl-
piperazine-2,5-dione (174). - To an ice-cooled solution of epitetra-
sulphide (162) (100 mg, 0.19 mmol) , in pyridine (1 ml) and methyl 
iodid~ (5 ml) was added a suspension of sodium borohydride (100 mg) in 
methanol (2 ml). The mixture was stirred for 40 min., then carefully 
acidified with acetic acid and evaporated to dryness. The residue was 
extracted with ether (3 x 5 ml), and after evaporation of the solvent 
the extract was separated by t.l.c. (solvent system C), giving the 
di(methyldithio)- compound (174) (50 mg, 5ryfo) , which was crystallised 
from methanol; m.p. 88 - 89°C (Found: C, 53.75; H, 5.55; N, 5.15; S, 
23.4. C24H30N204S4 requires C, 53.5; H, 5.6; N, 5.2; S, 23.8%) ; 
1 680 (CO), 1 360, and 1 290 cm -1 6 2.48 (6 H, SMe),3.20 Vmax • . s, , 
(6 H, s, OMe) , 3,20 and 3.92 (4 H, ABq, J 16 Hz, C~2Ph), 5.02 (4 H, s, 
C~20Me), and 7.10 (10 H, br s, Ph);.mI~ 459 (M+-SSMe, 0.44%),380, 
130, 91, 79, 64, 47, and 45 (100). 
(~)-1,4-Di(methoxymethyl)-cis-3-methyldithio-6-methylthio-3,6-di­
benzylpiperazine-2,5-dione (173). - To an ice-cooled solution of epi-
tetrasulphide (162) (55 mg, 0.1 mmol) in methyl iodide (2 ml) and 
pyridine (0.5 ml) was added a suspension of sodium borohydride (50 mg) 
in methanol (1 ml). The mixture was allowed to warm up to room 
temperature, and it was stirred for a further 1 h, then evaporated to 
dryness under reduced pressure. The residue was extracted with ether 
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(3 x 5 ml), and on evaporation the extract gave the compound (173) as 
a gum; & 2.22 (3 H, s, SMe), 2.42 (3 H, s, SSMe), 2.97 (2 H. s. C~2Ph), 
3.12 and 3.63 (2 H, ABq, J 15 Hz, CH2Ph), 3.25 (3 H, s, OMe), 3.39 
(3 H, s, OMe) , 4.62 and 5.02 (2 H, ABq, J 9 Hz, Cg20Me), 5.07 (2 H, s, 
C!!2°Me ), and 6.80 - 7.35 (10 H, m, Ph); !!V'~ 458 qt-MeSH, 0.1%),427 
(M+- MeSS, 14), 381, 380, 379 (100), 303, 130, 91, and 45. 
(±)-cis-3,6-Di(methylthio)-3,6-dibenzylpiperazine-2,5-dione (131). 
- A solution of the di(methoxymethyl) compound (172) (24 mg, 0.05 
mmol) in methylene chloride (1 ml) was cooled to -78°c, then boron 
tribromide (25 mg, 0.1 mmol) in methylene chloride (0.1 ml) was added 
with stirring. The mixture was allowed to warm to _40oC over 30 min., 
then wet ether was added (2 ml), and the mixture was poured into 5% 
aqueous sodium bicarbonate (5 ml). After extraction with ether (3 x 
3 ml), the extract was washed with 20% glucose solution (3 ml) and 
water (2 x 5 ml). The oil obtained on evaporation of the solvent was 
a mixture of the desired di(bromomethyl) derivative (180) and various 
by-products (see Discussion). The oil was dissolved in acetone (5 ml) 
and water (3 ml), 5% aqueous sodium bicarbonate (1 ml) was added, and 
the mixture was stirred for 18 h. The mixture was then added to water 
(20 ml) and extracted with chloroform (3 x 5 ml). The solvent was 
evaporated and the residue crystallised from chloroform to give the 
deprotected compound (131) (6 mg, 31%), m.p. 302 - 304°C (decomp.). 
A satisfactory analysis was not obtained. y 3 180 (NH), 1 670 max. 
(CO), 1 410, 765, 700, and 485 cm-1 ; & (100 MHz) 2.25 (6 H, s, Me), 
2.67 and 3.02 (4 H, ABq, ~ 14 Hz, Cg2Ph), 5.83 (2 H, br s, exchange-
+ 
able with D
2
0, NH), and 7.04 - 7.5 (10 H, ro, Ph); rrv'z 339 (~-SMe, 
1.8%),292,291 ,290 (100),212,118,117,91,90 ,89, and 47; (FOULC: 
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m/z 386.1142 (0.16%). C20H22N202S2 requires 386.1123. Found: 339.1166 
(13%). C19H19N202S requires 339.1168). 
The supernatants from the crystallisation were evaporated to 
dryness, and the residue was crystallised from methanol, giving the 
cyclised compound (181) (6.5 mg, 3~fo), m.p. 193 - 197°C (decomp.) 
(Found: C, 63.3; H, 5.7; N, 7.1; S, 16.25. C21H22N202S2 requires 
C, 63.3; H, 5.55; N, 7.05; S, 16.1%); V 3 200 (NH), 1 670 (CO), 
max. 
1 660 (CO), and 1 390 cm-1 ; & 1.93 and 3.08 (2 H, ABq, ~ 17 Hz, 
CC~2Ar), 2.09 (3 H, s, Me), 2.42 (3 H, s, Me), 3.06 and 3.73 (2 H, ABq, 
J 15 Hz, CH2Ph), 4.46 and 5'.22 (2 H, ABq, ~ 18 Hz, NC~2Ar), and 6.8 -
7.3 (10 H, m, 1 H exchangeable with D20, ,Ph, Ar, and NH); &C (50.3 MHz) 
14.0 (q), 36.6 (t), 43.2 (t), 47.0 Ct), 66.1 (s), 67.6 (s), 125.5 (d), 
126.7 (d), 126.9 (d), 127.6 (d), 128.3 (d), 128.5 Cd), 130.5 Cd), 133.6 
(d), 164.1 (s), and 166.5 (s); !!V'~ 351 qt-SMe, 60)6),304,303,130, 
129, 128, 91 (100), and 47. 
A sample of the di(bromomethyl) compound (180) was obtained by 
preparative t.l.c. (solvent system C) of the products of boron trjbrom-
ide treatment; m.p. 151 - 1530 C (decomp.); )) 1 680 (CO), 1 350, 
max. 
and 1 240 cm-1 ; ~ 2.24 (6 H, s, Me), 2.63 and 2.93 (4 H, ABq, ~ 15 Hz, 
CH
2
Ph) , 4.99 and 5.62 (4 H, ABq, ~ 8 Hz, CH2Br), and 6.9 - 7.4 (10 H, 
m, Ar);!rI~ 445 and 443 (M+-SMe-HBr, 0.8%), 411, 91, 90, 77, 61 
(100), and 47. 
Alternative synthesis of (131). - The deprotected epidisulphide 
(152) (20.7 mg, 0.05 mmol) was dissolved in methyl iodide (2 ml), and 
sodium borohydride (15 mg, 0.39 mmol) in ethanol (1 ml) was added with 
stirring to the ice-cooled solution. After 20 min., acetic acid 
(0.1 m]) was added, and the ~ixture was evaporated to dryness. The 
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residue was dissolved in acetone (1 ml), water (10 ml) was added, and 
the precipitate was filtered off. Crystallisation from acetone gave 
the deprotected di(methylthio)- compound (131) (9.8 mg, 52%), m.p. 
301 - 303°C (decomp.); spectral data identical to those of the sample 
prepared by the first method. 
~,~'-Di(methoxymethyl)-cyclo-(L-Phe_L_Phe) (161a). - cyclo-(L-Phe-
L-P~e) (42)39(441 mg, 1.5 mmol), DMSO (5 ml), 40% formalin (10 ml), 
and sodium bicarbonate (50 mg) were heated together under reflux for 
90 min. The mixture was then poured into water (50 ml) and extracted 
with methylene chloride (3 x 10 ml). Evaporation of the solvent gave 
crude di(hydroxymethyl)-cyclo-(L-Phe-L-Phe) (167) (480 mg); & 2.35 
(2 H, dd, J 14 and 7 Hz, CHHPh) , 2.79 (2 H, dd, ~ 14 and 4 Hz, CH!!Ph) , 
4.13 and 5.03 (4 H, ABq, J 10 Hz, CH20H), 4.39 (2 H, m, C1!CH2Ph), 
4.45 (2 H, br s, OH), and 6.9 - 7.4 (10 H, m, Ph). This oil was 
dissolved in methanol (5 ml) and thionyl chloride (0.5 ml) was added. 
After 1 h, the solvents were evaporated off, and the residue was 
purified by precipitation of the impurities from ethyl acetate-pet. 
ether (60 - 800 C). The supernatants were evaporated to give the di-
(methoxymethyl) derivative (161a) as a colourless oil (220 mg, 38%), 
having spectral data identical with those of the racemic material (161); 
[~JD20 +26.6 0 (£ 2.2 in CHC1
3
). 
Formation of the tetrasulphide (162) from (161a). - The reaction 
of the protected cyclic dipeptide (161a) with sulphur was carried out 
as before: (161a) (220 mg, 0.58 mmol) and sulphur (148 mg, 0.58 mmol 
of S8) in THF (10 ml) and DMF (2 fl), were treated with LDA (1.3 mmol) 
in THF (4 ml). After work-up, crystallisation from acetone gave the 
126 
tetrasulphide (162) (28 mg, 9%), m.p. 161 - 163°C, which was purified 
by t.l.c. (solvent system C) to give pure epitetrasulphide (162), 
6 0 [] 22 0 m.p. 164 - 1 7 C, ~ D 0 (£ 0.5 in CHC1
3
). 
Equilibration of the disulphide (164) and tetrasulphide (162) 
in basic conditions. - To a solution of epidisulphide (164) (22 mg, 
0.05 mmol) in carbon disulphide (0.5 ml) was added sulphur (3.2 mg, 
0.1 mmol of S) in carbon disulphide (32 fl). A catalytic amount of 
lithium hexane-1-thiolate in carbon disulphide [prepared by the 
addition of n-butyllithium (1 equivalent) to a solution of hexane-1-
thiol in carbon disulphide] was added. N.m.r. spectroscopy of the 
solution after 30 min. indicated that ~ 70% of the epidisulphide had 
been converted to the epitetrasulphide, and no signals attributable to 
other oligosulphides were observed. After 24 h"the n.m.r. spectrum 
showed that ca. 95% of the disulphide (164) had been converted into 
the tetrasulphide (162), and once again no evidence for other oligo-
sulphides was observed. Addition of more sulphur increased further 
the proportion of tetrasulphide, but no other changes in the spectrum 
were observed. 
Action of heat on the disulphide (164) and tetrasulphide (162). -
The tetrasulphide (162) (27 mg, 0.5 mmol calculated from C22H24N204S5) 
was heated at 1300 C for 2 h, at 0.1 Torr. The products, examined by 
t.l.c. and n.m.r. spectroscopy, along with elemental sulphur (sublimed), 
were the epimonosulphide (163), epidisulphide (164), and epitetrasulph-
ide (162), in the ratio 2 : trace: 3· 
The disulphide (164) (22 mg, 0.05 mmol) was heated for 2 h at 
0.06 Torr, up to 120oC. The product, apart from sublimed sulphur, was 
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the epimonosulphide (163), together with a smll 
amount of epitetrasul-
phide (162) (by t.l.c. and n.m.r. spectroscopy). 
(±)-1,4-Dimethyl-3,6-cis-dibenzylpiperazine_2,5_dione (168). _ 
To a stirred suspension of (±)-cis-3,6-dibenzylpiperazine-2,5_dione 
(160)111 (2.50 ~, 8.5 mmol) in DMSO (40 ml) ~ was added potassium 1-
butoxide (2.10 g, 18.7 mmol). When all the solids had dissolved (ca. 
30 min.), methyl iodide (2 ml, 32 mmol) was added slowly, and the 
mixture was stirred for a further 1 h, then added to water (200 ml). 
Extraction with methylene chloride (3 x 20 ml), followed by evapor-
ation of the solvent, gave an oil which was crystallised from ethyl 
acetate to give the dimethyl derivative (168) (2.22 g, 81%), m.p. 138 _ 
141
0
C (Found: C, 74.45; H, 6.65; N, 8.6. C20H22N202 requires C, 74.5; 
H, 6.9; N, 8.7%); V 1 650 cm-1 (co); ~ 2.16 (2 H, dd, J 15 and 
max. 
7 Hz, CHHPh), 2.68 (6 H, s, Me), 2.78 (2 H, dd, J 15 and 4 Hz, C~Ph), 
4.00 (2 H, dd, J 7 and 4 Hz, CHCH2Ph)" and 6095 - 7.40 (10 H, m, Ph); 
mI~ 322 (M+, 19%), 231, 203, and 91 (100). 
(±)-1,4-Dimethyl-3,6-epitetrathio-3,6-dibenzylpiperazine-2,5-
dione (170). - A solution of the dimethyl cyclic dipeptide (16S) 
(644 mg, 2.0 mmol) and sulphur (512 mg, 2.0 mmol of SS) in THF (30 ml) 
and DMF (10 fl) was cooled to -78°C in a round-bottomed flask sealed 
with a rubber septum. LDA (4.4 mmol) in THF (10 ml) was added by 
o 
syringe, and the stirred mixture was allowed to warm to -10 Cover 
90 min. Acetic acid (0.5 ml) was added, the mixture was poured into 
water (250 ml), and the products were extracted with methylene chloride 
(3 x 30 ml). After evaporation cf the solvent, the residue was rreated 
with ethyl acetate (10 ml) and the mixture was filterFd. The solvent 
was evaporated and the viscous residue was crystallised from acetone 
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giving crude epitetrasulphide (170) (370 mg, 41%), m.p. 184 _ 186°c. 
An analytical sample was purified by t.l.c. and crystallised from 
acetone; m.p. 192 - 194°C (Found: C, 53.6; H, 4.4; N, 6.2; S, 28.25. 
C20H20N202S4 requires C, 53·55; H, 4.5; N, 6.25; S, 28.6%); V 
max. 
1 675 cm-1 (CO); 6 3.15 and 3.85 (4 H, ABq 6 ) , ~ 1 Hz, C!!2Ph , 3. 15 (6 H, 
s, Me), and 6.73 - 7.25 (10 H, m, Ph); rzV~ 320 qt -S4' 33%), 229, 
201, 116, 91, and 64 (100). 
(±)-1,4-Dibenzyl-3,6-cis-dibenzylpiperazine-2,5-dione (169). -
To a stirred suspension of (±)-cis-3,6-dibenzylpiperazine-2,5-dione 
(160)111 (1.18 g, 4.0 mmol) in DMSO (15 ml) was added potassium !-
butoxide (0.95 g, 8.5 mmol). After 1 h, a clear orange solution 
resulted, to which was added benzyl bro~ide (1.5 ml, 12 mmol). After 
a further 1 h, the mixture was acidified with acetic acid, added to 
water (300 ml), and extracted with methylene chloride (3 x 50 ml). 
The solvent was evaporated, the residue was dissolved in ethyl acetate 
(10 ml), and the solution was filtered. After evaporation of the 
solvent, the residual oil was crystallised from ethyl acetate-pet. 
ether (60 - 80°C) to give the dibenzyl derivative (169) (1.40 g, 74%), 
m.p. 142 - 144°C (Found: C, 81.0; H, 6.65; N, 5.7· C32H3~N202 requires 
-1 
C, 81.0; H, 6.35; N, 5.9%); V
max
• 1 660 (CO), 1 450, and 700 cm ; 
b 2.36 (2 H, dd, J 15 and 8 Hz, CHCHHPh), 2.91 (2 H, dd, ~ 15 and 5 Hz, 
CHCHHPh), 3.43 and 5.34 (4 H, ABq, ~ 16 Hz, NCg2Ph), 4.12 (2 H, dd, 
+ 
J 8 and 5 Hz, CHCH
2
Ph), and 6.8 - 7.4 (20 H, m, Ph); ~~ 383 (!:! - C.fi7' 
69%), 355, and 91 (100). 
(±)-1,4 Dibenzyl 3,6 epitetrathio-3,6-dibenzylpiperazine-2,5-
dione (171). _ A solution of the dibenzyl derivative (169) (474 ~h, 
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1.0 mmol) and sulphur (384 mg, 1.5 mmol of S8) in THF (15 ml) with DMF 
(20 ~l) was cooled to -78°c in a flask sealed with a rubber septum. 
LDA (2.2 mmol) in THF (5 ml) was added by syringe, and the stirred 
mixture was allowed to warm up to ooc over 90 min. Acetic acid 
(0.2 ml) was added, the mixture was poured into water (200 ml), and 
the products were extracted with methylene chloride (3 x 20 ml). The 
solvent was evaporated off, the residue was treated with ethyl acetate 
(5 ml), and the excess sulphur was filtered off. The solvent was 
evaporated, and the viscous residue was crystallised from acetone, to 
give tetrasulphide (171) (120 mg, 20%), m.p. 192 - 1940 C (decomp.) 
(Found: C, 63.95 ; H, 4.65; N, 4.55; S, 21.3. C32H28N202S4 requires 
C, 63.95; H, 4.7; N, 4.65; S, 21.35%) ; 'Y 1 670 (CO), and 700 cm -1 
max. , 
& 3.46 and 3.64 (4 H, ABq, J 16 Hz, CCH2Ph) , 4.46 and 5.43 (4 H, ABq, 
1:: 15 Hz, NCH2Ph), 6.50 (4 H, m, £-H of 2 Ph), and 6.8 - 7.4 (16 H, In, 
+ 
other Ph); .!!V'~ 472 (.!:!. - S4' 2.5%), 470, 381, 199, 91 (100), 65, and 64. 
Synthesis of radio-labelled sulphur-containing compounds 
A) .i) (±)-1 ,4-Di(bromomethyl)-3,6-epidithio-3,6-di [4 _3H]benzylpiper-
azine-2,5-dione (176). - L-[4,_3H]Phenylalanine (1 mCi) in water (1 ml) 
was added to unlabelled L-phenylalanine (660 mg, 4 mmol), and the 
water was evaporated under reduced pressure. To the solid was added 
ethylene glycol (technical grade; 3 ml), and the mixture was heated 
under reflux for 4 h. The reaction mixture had grown very dark-
coloured, so heating was not continued (the normal reaction time was 
24 h). After cooling, the mixture was filtered, and the crystals were 
washed with methanol and ether, giving a mixture of cis- and trans-
isomers of cyclo-([4,_3H]Phe-Phe) (160) (320 mg, 54%), m.p. 305 -
308°c. The cyclic dipeptide was suspended in DMSO (3 ml), and 
potassium t-butoxide (270 mg, 2.41 mmol) was added with stirring. 
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When the solids had dissolved, chloromethyl methyl ether (0.2 ml, 
2.5 mmol) was added dropwise. After 20 min., the mixture was poured 
into 5% aqueous sodium bicarbonate (20 ml) and the products were 
extracted with methylene chloride (3 x 5 ml). The solvent was evapor-
ated, and the residue was purified by passing it through silica gel H 
(~. 2 g), using ether as the eluent, to give the di(methoxymethyl) 
derivative (161) (300 mg, 72%v. The protected cyclic dipeptide was 
converted into the tetrasulphide as described earlier. Crystallisation 
from acetone gave 65 mg (15%), and a further crop was obtained by 
adding non-radioactive tetrasulphide (162) (40 mg) to the mother 
liquors and recrystallising, giving a combined total of 110 mg, m.p. 
(for first crop) 158 - 161 0 C (decomp.). The tetrasulphide was con-
verted into the epidisulphide (164), and thence to the di(bromomethyl) 
derivative (176) as described previously, giving (176) (33 mg, 29% 
from epitetrasulphide), m.p. 164 - 166°C (decomp.); specific activity 
368 fACi/ mmol. 
ii) (~)-1,4-Di(bromomethyl)-3,6-[35SJepidithio-3,6-dibenzylpiperaz­
ine-2,5-dione (176). - N.B. All reactions involving 35S-labelled 
compounds were performed in a well-ventilated fume cupboard. 
The protected cyclic dipeptide (161) (1.00 g, 2.62 mmol) was 
sulphurated, converted to the epidisulphide, and cleaved with boron 
tribromide, as described for the unlabelled compounds, using sulphur 
(675 mg, 2.6 mmol) to which was added [35sJsulphur (rhombic; nominal 
2 mCi). 
Tetrasulphide (162) (357 mg, 25%), m.p. 161 - 163°C (decomp.) 
o 
Disulphide (164) (215 mg, 73%), m.p. 108 - 110 C 
o 
Di(bromomethyl) disulphide (176) (219 mg, 83%), m.p. 167 - 166 C 
(decomp.); specific activity 41.6 fCi/mmol. 
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razine-2 5-dione 
(152). - ThepH]di(bromomethyl) epidisulphide (176) (33 mg, 0.061 mmol) 
and [35S]di(bromomethyl) epidisulphide (54 mg, 0.1 mmol) were combined, 
dissolved in methylene chloride, and deprotected with ammonium acetate 
as described for the unlabelled compound. The deprotected epidisulph-
ide (152) was crystallised from chloroform-hexane to constant activity 
(51 mg, 89%), 
activity (3H) 
m.p. 249 - 252 0 C (decomp.)·, one spot btl °fO Y •• c.; SpeCl lC 
133 fCi/mmol, (35S ) 25.8 fCi/mmol. 
lli-3,6-Di([35S]methylthio)-3,6-dibenzylpiperazine-2,5-dione 
(131). - The [35S]di(bromomethyl) disulphide (176) (60 mg, 0.11 mmol) 
was converted to the deprotected disulphide (152) as before. Without 
crystallisation, the disulphide was dissolved in methyl iodide (1 ml) 
and ethanol (0.5 ml), and reductively methylated with sodium borohyd-
ride as before. The product was crystallised from chloroform and 
acetone. At this point the di(methylthio)- derivative was found to 
contain some unreacted disulphide (152), so the mixture was separated 
by t.l.c. (solvent system A), and the [35S]di(methylthio)-cyclic 
dipeptide (131) was crystallised from acetone (6 mg, 14%), m.p. 292 -
2950 C, specific activity 25.1 fCi/mmol. 
B) i) (±) -1 ,4-Di (bromomethyl) -3 ,6-epidi thio-3 ,6-di [4':ij ] benzylpiper-
azine-2,5-dione (176). - The preparation of cyclo-(Phe-Phe) (cis- and 
trans- mixture) (160) was carried out as in A) above, starting with 
1-[4 - 3H] phenylalanine (250 pCi) diluted with unlabelled 1-phenylala-
nine (330 mg, 2.0 mmol). 
o 75%), m.p. 304 - 306 C. 
This gave the cyclic dipeptide (160) (220 mg, 
The di(methoxymethyl) derivative (161) was 
prepared by the method used in the preparation of ~,~'-di(methoxy-
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methyl)-cyclo-(L-Phe-~-Phe) (161a). This procedure gave (161) (170 mg, 
60%). The protected cyclic dipeptide was carried through to the 
di(bromomethyl) epidisulphide (176) as before. 
Epitetrasulphide (162) (27 mg, 11%), m.p. 160 - 163°C (decomp.) 
Epidisulphide (164) (18 mg, 81%), m.p. 107 - 1100 C 
Di(bromomethyl) epidisulphide (176) (18 mg, 82%), m.p. 164 - 166°c 
(decomp.), specific activity 238 ~Ci/mmol. 
ii) (±)-1,4-Di(bromomethyl)-3,6-[35S]epidithio-3,6-dibenzylpiper-
azine-2,5-dione (176). - The reaction sequence was carried out as in 
A) above, using protected cyclic dipeptide (161) (0.28 g, 0.73 mmol) 
and sulphur (180 mg, 0.7 mmol) containing [35sJsulphur (nominal 
activity 2.2 mCi), giving; 
Epitetrasulphide (162) (25 mg, 6%), m.p. 158 - 161°C (decomp.) 
Epidisulphide (164) (19 mg, 92%), m.p. 109 - 111°C 
Di(bromomethyl) epidisulphide (176) (19.5 mg, 84%), m.p. 166 -
168°C (decomp.), specific activity 343 ~Ci/mmol. 
0.033 mmol) 
and P5S]di(bromomethyl) disulphide (3 mg, 0.006 mmol) were combined, 
and deprotected as for the unlabelled material. Crystallisation from 
o 
benzene gave epidisulphide (152) (9 mg, 56%), m.p. 245 - 249 C 
(decomp.); one spot on t.l.c.; specific activity (3H) 178 fCi/mmol, 
(35S) 36.6 fCi/mmol. 
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~ Biosynthetic experiments 
Fermentation conditions 
Aspergillus terreus (NRRL 3319) was obtained from Lilly Research 
Laboratories, Indiana, U.S.A. Cultures were started on Czapek-Dox 
agar slants, made from: 
Glucose 50 g Magnesium sulphate (anhydrous) 1 g 
Agar 20 g Dipotassium hydrogen phosphate 0.5 g 
Sodium nitrate 2 g Ferrous sulphate (anhydrous) 0.01 g 
Potassium chloride 1 g Deionised water 1 litre 
After incubation for 7 days, the slants were used to inoculate 
500 ml wide-necked conical flasks containing 100 ml each of the 
nutrient medium: 
Glucose 15 g Magnesium sulphate heptahydrate 0·5 g 
Sucrose 15 g Potassium dihydrogen phosphate 1 g 
Sodium nitrate 2 g Ferrous sulphate heptahydrate 0.01 g 
Potassium chloride 0.5 g Beef extract (Oxoid "Lab-Lemco" ) 0.5 g 
Yeast extract 0.125 g Deionised water 1 litre 
o The medium was sterilised by autoclaving at 121 C for 20 min. 
The seed flasks were grown at 28°c for 2 days, when aliquots 
(10 ml) from them were used to inoculate similar flasks containing the 
same medium (100ml). These flasks were normally grown for 7 days at 
28°c; feeding was carried out after 48 h. Both the seed flasks and 
the main culture flasks were agitated on an orbital shaker at 160 r.p.m. 
Natural daylight provided the only illumination. 
All operations concerning the growth and propagation of the fungus 
were carried out by Mrs. M.Tait and her staff. 
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Extraction procedure 
The cultures were harvested by filtration and washing of the 
mycelium with methanol. The combined broth and washings were adjusted 
to pH 2.5 with concentrated hydrochloric acid, and extracted with 
methylene chloride or chloroform (5 x 10% of the broth volume). The 
extracts were concentrated to ~ 100 ml, washed with water (3 x 10 ml) 
and evaporated to dryness. 
Isolation of metabolites 
The extracts were separated by preparative t.l.c. (solvent system 
A) • 
i) BDA (40). - The t.l.c. separation gave two u.v.-active bands 
at Rf ~. 0.5, the lower of which contained BDA, which was crystallised 
o from methanol, (ca. 20 mg per litre of broth), m.p. 200 - 203 C 
(decomp.) [(lit.,43 213 - 217°C (decomp.»); & (360 MHz) (see Figure 1 
for assignment) 2.06 (6 H, s" H
a
), 2.25 (6 H, s, Hb), 2.9 - 3.1 (4 H, 
Figure 1 
c' 
J' 
I (F)e' 
f' 
a,' AcO 0 
complex, Hh , 
8 H ), J Hz, g 
" 
" bMeS h,j 
HJ, 4.68 (2 H, 
J 
5.80 (2 H, ddd, 
o 
c 
dd, ~ 8 
~ 8, 2, 
J 8 and 2 Hz, Hd), and 6.56 (2 H, br 
Assignments for BDA and 
acetylaranotin refer to the 
aranotin ring only. 
and 2 Hz, H ), 5.17 (2 H, br d, e 
and 2 Hz, Hf ) , 6.28 (2 H, dd, 
s, H ). 
c 
135 
BDAA (41). - The upper band of the two at R
f 
~ 0.5 in the 
t.l.c. separation described above contained BDAA. This was purified 
further byt.l.c. (solvent system B) and crystallised from ether-
hexane (ca. 15 mg per litre of broth), m.p. 131 - 134°C (decomp.) 
(lit.~3 105 - 107°C (decomp.); 6 (360 MHz) 2.07 (3 H, s, H ), 2.10 
a 
(3 H, s, Ha ,), ~.22 (3 H, s, Hb), 2.30 (3 H, s, ~,), 2.86 (1 H, br d, 
~ 16 Hz, Hh ) , 2.9 - 3.1 (3 H, complex, Hh " H., H.,), 4.68 (1 H, dd, J J 
J 8 and 2 Hz, H ), 5.16 (1 H, m, H ), 5.19 (1 H, br d, J 14 Hz H) e g -, e' 
5.58 (1 H, br d, J 8 Hz, H ,)" 5. 79 (1 H, ddd, J 8, 2, and 2 Hz, Hf ), e 
5.94 (1 H, m, Hc ')' 5.96 (1 H, m, Hd ,), 6.15 (1 H, br d, J 14 Hz, Hf ,), 
6~28 (1 H, dd, ~ 8 and 2 Hz, Hd), and 6.55 (1 H, br s, Hc)' 
iii) Acetylaranotin (38). - Thjs compound was occasionally "found in 
extracts, especially those where the fungus was harvested at an early 
stage. The band containing BDAA (41) from the t.l.c. separation, when 
further se:parated (solvent system B) gave, besides BDAA, a band at 
higher Rf • This was extracted and crystallised from methanol to give 
acetylaranotin (ca. 2 mg per litre of broth harvested after 3 days of 
growth), m.p. 212 - 215°C (decomp.) [lit., 210 - 215°C (decomp.)]; 
& (100 MHz) 2.03 (6 H, s, H
a
), 3.00 (2 H, ddd, J 18, 2, and 2 Hz, Hh), 
4.06 (2 H, ddd, J 18, 2, and 2 Hz, Hj ), 4.64 (2 H, dd,J 8 and 2 Hz, 
H ), 5.14 (2 H, dd J 8 and 2 Hz H), 5.72 (2 H, ddd, i!. 8, 2, and , - , g e 
2 Hz, Hf ), 6.35 (2 H, dd, ~ 8 and 2 Hz, Hd), and 6.66 (2 H, dd, J 3 
and 2 Hz, Hc); ,!!V'z 440 (M+- 82 , 1.a~D, 291 
64 (5), 60 (5), 45 (10), 44 (12), 43 (28), 
(3), 115 (4), 106 (4), 
and 32 (1 00) . 
iv) ~ 3,6 Di(methylthio) 3,6_dibenzylpiperazine-2,5-dione (131). 
_ The t.l.c. separation of the total extract gave a u.v.-active band 
Extraction of this band afforded a gum containing 
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several compounds, which was crystall' d f ~se rom methanol and recryst-
allised from acetone to give the di(methylthio)-cyclic dipeptide (131) 
(~. 0.5 mg per litre of broth), m.p. 291 - 293°C (decomp.), [~JHg21 
_122° (.£ 0.019 in CHC13 ), [orJD21 -52.1 0 (.£ 0.28 in AcOH)· V 3 180 , max. 
(NH) , 1 670 (CO), 1 420, 700, and 485 cm-1 ; ~ (100 MHz) 2.25 (6 H, s, Me), 
2.67 and 3.01 (4 H, ABq, ~ 14 Hz, CH2Ph), 5.77 (2 H, br s, exchangeable 
with D20, NH), and 7.04 - 7.5 (10 H, m, Ph); !!y'z 339 (!:t-SMe, 96%), 
292 (61), 291 (49), 119 (30), 118 (39), 117 (18), 91 (100), 90 (10), 
48 (8), and 47 (13). 
v) cyclo-(L-Phe-L-Phe) (42). - The bands near the baseline in the 
t,l.c. separation of the total extract (solvent system A) (Rf ca. 0.2) 
were cut off and extracted with methanol. Crystallisation of the 
extracted material from methanol gave cyclo-{L-Phe-L-Phe) (ca. 5 mg 
per litre of broth), m.p. 312 - 315°C (lit. ,102 308 - 3100 C) ,[C(J n20 
-1250 (Q 0.5 in AcOH) , having spectral data as for the synthesised 
material (136f). 
Non-dioxopiperazine metabolites isolated from extracts 
i) Orsellinic acid. - This metabolite was isola.ted on one occasion 
from an extract of cultures fed DL-£-fluorophenylalanine. After t.l.c. 
separation of the total extract (solvent system A), the band at Rf 0.75 
(containing di(methylthio)-cyclo-(Phe-Phe) was subjected to a second 
t.l.c. separation (solvent system B). A band at Rf ca. 0.5 was cut 
off and extracted, giving crude orsellinic acid (3 mg), identified by 
its mass spectrum and proton n.m.r. spectrum; S (100 MHz) (CD30D) 2.48 
(3 H, br s, Me), 6.18 (2 H, ABq, J 2 Hz, Ar), and 7.2 (1 H. br s, OH); 
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+ !V~ 168 (~ , 44%), 150, 122 (100), 94, 69, and 66. 
ii) Ergosterol,(129). - This compound was occasionally isolated 
from extracts; t.l.c. (solvent system A) gave a u.v.-active band at R
f 
~. 0.8, which was extracted and crystallised from acetone to give 
ergosterol (129) (~ 3 mg per litre of broth), m.p. 162 _ 1640c 
120 0 l (lit., ' 163 C), <:) (100 MHz) 0.63 (3 H, s, Me), 0.84 (3 H, d, ~ 7 Hz, 
Me), 0.85 (3 H, d, ~ 7 Hz, Me), 0.92 (3 H, d, J 7Hz, Me), 0.96 (3 H, 
s, Me), 1.05 (3 H, d, J 6 Hz, Me), 1.05 - 2.6 (~ 20 H, complex), 
3.63 (1 H, m, CHOH), 5.24 (2 H, m, side-chain olefinic CH), and 5.34 _ 
5.65 (2 H, In, ring olefinic CH); ,gV~ 396 (M+, 14%), 394, 378, 363, 
337, 267, 251, and 69. 
iii) Ergosterol endo-peroxide (130). - This compound was isolated 
from an extract of 1.5 litres of culture which had been fed cyclo-
(E-Fluorophe-~-Fluorophe) (139a). Separation by t.l.c. (solvent 
system A) and, extraction of a band at high Rf (ca. 0.8) gave a gum 
which was tentatively identified as the peroxide (130) from its proton 
n.m.r. spectrum and mass spectrum; & 0.8 - 2.3 (ca. 40 H, complex), 
3,99 (1 H, m, CHOH) , 5.23 (2 H, m, side-chain olefinic CH), 6.39 and 
6.56 (2 H" ABq,J 9 Hz, ring olefinic CH); rrv'z 428 (M+, 3%),396,266, 
249, 109, 107, 105, 95, 69, and 55· 
iv) Phenolic metabolite (127).93 - The supernatants from crystall-
isation of di(methylthio)-cyclo-(Phe-Phe) (131) were evaporated to 
dryness, and separated further by t.l.c. (solvent system A or B), 
giving the metabolite (127) as an oil (ca. 3 mg per litre of breth); 
)J (CHC1
3
) 3 590, 3 500, 3 600 - 3 150 (br), 3 030 eCH), 1 755 (CO), 
max. 
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1 740 (co), 1 610 (C=C), 1 520, 1 390, 1 265, and 1 180 cm-1 & (100 
MHz) 1.70 (3 H, br s, C-Me) , 1.74 (3 H, br s, C-Me) , 3.18 (2 H, br d, 
~ 7 Hz, CH2 of dimethylallyl), 3.55 (2 H, br s, CH2Ar), 3:80 (3 H, s, 
OMe), 5.1 (2 H, br s, 2 OH), 5.16 (1 H, br t, ~ 7 Hz, CH of dimethyl-
allyl), 5.8 (1 H, br s, OH), 6.52 - 6.65 (3 H, m, CH of trisubstituted 
aromatic ring), 6.96 and 7.65 (4 H, ABq, J 9 Hz, CH of disubstituted 
aromatic ring); !!I~ 396 (M+ - co, 6%), 394, 380, 378, 175 (100), 131, 
91, and 78. 
Feeding of fluorinated compounds 
The fluorinated dipeptides were fed to A. terreus after 48 h of 
growth, as solutions in DMSO; the total volume of DMSO was <.0.5% of 
the volume of the medium. The concentration of dipeptide in the medium 
was ca. 0.1 mM. Fluorinated amino-acids were fed as solutions in DMSO-
water mixtures; the concentration of amino-acid in the medium was 
normally ca. 0.05 mM. 
After extraction, the 19F n.m.r. spectrum (proton-noise decoupled) 
of a representative sample of the total extract was recorded (in CDC13 ), 
and the most significant signals in these spectra are given below (s = 
strong signal, m = medium, w = weak). 
Total extract from cultures fed: 
DL-..2-Fluorophenylalanine; ~F {1.H} -106.9 (m), -115.7 (s), -117.3 (m), 
-118.0 (m), -130.1 (w). 
DL-!-Fluorophenylalanine; bF{1H~ -113.7·(s), -114.1 (s), -123.1 (w), 
-137.3 (m). 
DL F h 11 · cF
{1Hl -115.1 (m), -115.4 (m), -115·5 (m), 
-p- luorop eny a anlne; 0 5 
-116.5 (m), -122. 1 ( w ), -122.2 (s). 
cyclo-(L-Phe-L-£-Fluorophe) (136c); 6F \1H} -115.6 (s), -117.0 (w), 
-117.3 (w). 
cyclo-(L-Phe-L-m-Fluorophe) (136d); bF{1H} -113.2 (s), -114.1 (w), 
-114.3 (w). 
cyclo-(L-Phe-L-~-Fluorophe) (136b); ~t1H} -115.3 (m), -115.6 (m), 
-116.8 (m), -122.3 (s). 
cyclo-(L-Phe-L-2', 6'-Difluorophe) (136a}, 6F{1H) -108.0 (m), -108.1 
(m), -110.2 (m), -111.1 (s), -113.8 (s),. -114.5 (m), -115.1 (.w) 
- , 
-116.7 (s). 
cyclo-(L-~he-L-Pentafluorophe) (136e); ~F{1H}-140.0 - -142.8 (several 
. signals, s), -144.5 (s), -156.0 (s), -156.5 (s), -157.4 (s), -158.6 
(w), -162.4. - -164.3 (several signals, s). 
(±)-cis-cyclo-(~-Fluorophe-E-Fluorophe) (139a); bF{1H} -115.3 (s), 
-115.6 (s), -115.8 (s). 
(±)-cis-cyclo-(Pentafluorophe-Pentafluorophe) (139b); 5F tH} -142.6 
(m), -156.6 (m), -163.0 (m). 
The extracts were then separated by t.l.c. or column chromato-
graphy (solvent system A). When cyclo-(L-Phe-L-Phe) (42) and cis-
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3,6-di(methylthio)-3,6-dibenzylpiperazine-2,5-dione (131) were isolated 
as described above, the mono- and di-fluoro analogues tended to co-
crystallise. These fluorinated analogues were detected using mass 
spectrometry and 19F n.m.r. spectroscopy on the mixtures. 
i) From cultures fed DL-E-fluorophenylalanine (112): 
Mixture of cyclo-(L-Phe-L-Phe) (42), cyclo-(L-Phe-L-E-Fluorophe) (1)6b), 
and cis-cyclo-(~-Fluorophe-12-Fluorophe) (139a); bF t 1H} -115·3 (136b), 
and -115.6 (139a); mI~330 [(139a), 2%J, 312 [(136b ), 6J, 294 [(42), 
17], 109 [C7H6F, 35], and 91 [Cr;H7' 100]; (Found: 330.1 187. 
Calc. for 
ii) Di(methylthio)-cyclo-(Phe-Phe) analogues 
a) From cultures fed DL-B-fluorophenylalanine (112); 
Mixture of (131) with .E-fluoro- and .E ,,E '--difluoro-analogues (142) and 
(143); 6F PH} -114.3;!!Y'~ 375 [( 143), M+-SMe, 1.5%J ,357 [(142), 
M+-SMe, 11J, 339 [(131 ), M+-SMe, 100J, 309 [(142), M+-SMe-MeSB, 
140 
14], 291 ~131), M+-MeSH-SMe, 94J, 109 [C~6F+, 7J and 91 [c~;, 50]; 
(Found: ~z 357.1077. C19H1SFN202S requires 357.1073. Found: 309.1035. 
C18H14FN202 requires 309.1039. 
b) From cultures fed cyclo-(L-Phe-L-,E-Fluorophe) (136b); 
Mixture of (131) with,E-fluoro-analogue (142); ~F{1H} -114.3; nYz 357 
[(142), M+- SMe, 7)b], 339 [78J, 309 [(142), M+-MeSH-SMe, 6], 292 
[72J, 291 [1ooJ, 109 [Cf6F+, 6J, and 91 [94J. 
c) From-cultures fed cyclo-(L-Phe-L-£-Fluorophe) (136c); 
Mixture of (131) with o-fluoro-analogue (144); 5F {1H1 -115.4; ~z 357 
[(144),M+-SMe, 776], 339 [78J, 310 [(144), M~2 SMe, 10J, 309 [(144), 
M+ - MeSH - SMe, 1 oJ, 292 [57], 291 [62], 109 [8 J, and 91 [100]. 
d) From cultures fed cyclo-(L-Phe-L-!-Fluorophe) (136d); 
Mixture of (131)- with m-fluoro-analogue (145); &F{1H} -112.5; nY~ 357 
[(145), M+-SMe, 3%], 339 [37J, 291 [27J, 290 [24J, 109 [13J, and 91 
[100J • 
e) From cultures fed cyclo-CL-Phe-L-2',6'-Difluorophe) C136a); 
Mixture of (131) with 2' ,6' -difluoro-analo~e -(146); SFtH5 -110.6; 
yz 375 [(146), J:t-SMe, ?%], 339 [42J, 328 [4J, 327 [4J, 292 [27J, 
291 [29J,_127 [C7H5F2+' 4J, 91 [71J, and 57 [100J. 
f) From cultures fed C+)_cis_cyclo-C,E-Fluorophe-,E-Fluorophe) 
C 139a) ; 
141 
Mixture of (131) with 4,4 ' -difluoro-analogue (143); ~z375 [(1 43), 
M+ - SMe, 1.5%J, 339 (36), 292 (22), 291 (16), 109 (30), and 91 (100). 
Fluoro-BDAA (141). 
DL-£-Fluorophenylalanine (112) (13.7 mg) was fed to A. terreus 
(1.5 litres of medium) and extracted as described above, after 5 days. 
The extract was separated by preparative t.l.c. (solvent system B), 
and a band at Rf ~. 0.5, containing a mixture of aranotin metabolites, 
was cut off and extracted. This material was further separated 
(solvent system A), and the band containing BDAA (and· fluoro-BDAA) was 
cut off and extracted. A third separation (solvent system D) on anal-
ytical t.l.c. plates (25 mg of mixture per 20 x 20 cm plate) gave 
fluoro-BDAA (141) as a narrow band just above the strong BDAA band. 
This was further purified by another t.l.c. separation on analytical 
plates (solvent system B) to give fluoro-BDAA as an oil, which was 
crystallised from ether-hexane (2.4 mg after crystallisation), m.p. 
131 - 134°C (decomp.), [C(JD20 _123 0 (£ 0.03 in CHC13 ); Amax. (EtOH) 
266 nm (£ 3350); ~max. 3 080 (olefinic CH), 2 930 (saturated CH), 
1 745 (COCH
3
), 1 675 (CON), 1 375, 1 230, and 1 040 cm-\ 6 (360 MHz) 
(see Fig. 1 for assignments) 2.07 (3 H, s, Ha ), 2.15 (3 H, s, Ha ,), 
2.20 (3 H, s, H
b
), 2.29 (3 H, s, Hb, ), 2.83 (1 H, br d, J 15 Hz, ~), 
06 ( ~ H H ) 4 68 ( 1 H, dd, _J 8 and 2 Hz, 2.97 - 3. 3 H, complex, " ., '1' • J J 
H ), 5.14 (1 H, m, H ), 5.38 (1 H, very br d, ~ ca. 15 Hz, Hg ,), 5·61 
e g 
(1 H, br ddd, J 11, 5,5, and 2 Hz, Hd ,), 5.79 (1 H, ddd, J 8, 2, and 
2 H H) 5 85 (1 H H) 6 28 (1 H dd, ~ 8 and 2 Hz, Hd), z, f'. ,m, c"· , 
6 32 (1 H br H ) and 6.55 (1 H, br s, Hc); SF (55°C) ca.. ,very, f' , 
-121.9 (m); from selective proton decoupling ~H ,F = 5 Hz, ~Hd,F = 
c + 
J = 4 Hz·, ~/_z 536 (11 , 0.8%), 489, 429, 11 Hz, lH F = 2 Hz, and -H F ~ 
f' g' 
381, 321, 162, 160, 13·4, 132, and 43 (100) j (Found: EY.t! 536.1089. 
C24H25FN207S2 requires 536.1087. 
142 
Feeding experiments with radio-labelled fluorinated compounds 
14 The results of feeding the C-labelled fluor'inated cyclic dipep-
tides (136a - e) are summarised in Table 3. 
The incorporation of cyClo-(L-Phe-L-[1-14C]-£-FluoroPhe) (136b) 
into fluoro-BDAA waa measured by n.m.r. spectroscopy: To the total 
extract was added ~-fluorobenzoic acid (1.5480 mg), and the proton-
decoupled 19F n.m.r. spectrum integral was used to give an approximate 
incorporation. Integral heights; fluoro-BDAA (0.-123) 408 cm
t 
~-fluorobenzoic acid (& -107) 51.1 cm, other fluorinated compounds 
(& -114 - -117) 12.0 cm. Incorporation into fluoro-BDAA = 1.8%. 
Total recovery of fluorinated compounds = 6.2% (cf. incorporation of 
14C into the total extract = 8.0%). 
Feeding of the deuteriated cyclic dipeptides (136g) and (136h) 
cyclo-(L-Phe-L-(3R)-[3-D] -~-Fluorophe) (136h) (85 mg, 0.27 mmol) 
and cyclo-(L-Phe-L-(3S)-[2,3-D2]-E-FluoroPhe) (136g) (85 mg, 0.27 mmol) 
were each fed to 1.4 litres of A. terreus culture medium. The cultures 
were harvested 5 days later, and the mixtures of di(methylthio)-clclo-
(Phe-Phe) (131) and its fluorinated, deuteriated analogues (142) were 
isolated as described previously. The two samples were analysed by 
mass spectrometry. 
i) From the culture fed cyclo_(L_Phe-L-(3~)-[3-D]-£-FluoroPhe) 
(136h)j mI~ 358 [(142), M+- SMe, 3.6%J, 357 [0.47J, 339 [(131), M+-
SMe, 34J, and 91 [100J. 
ii) From the culture fed cyclo-( L-Phe-L-(3S) - [2, 3-D2] -12-.Fluorophe) 
Radioactive compounds in extract 
Activity Weight Medium Activity in I Corresp. I Di(SMe) 
COMPOUND FED fed (fJ-Ci) fed (mg) vol. (1) extract (fCi)1 cyclic dip.\ cpd. Other compounds 
DL- G·_14C] -,E-Fluorophenyl- 50 0.46 0.5 22.0 (,E-F) + + I Fluoro-BDAA +++ 
alanine (112) (,E2) + 
DL- [3_14c] -,E-Fluorophenyl- 10 32.4 1.4 0.9.3 (,E-F) + + I Fluoro-BDAA ++ 
alanine (112) (,E2) + 
(136b)j Ar = ,E-F-Ph 5.00 18.7 0.6 0.40 + + I Fluoro-BDAA ++ 
(136c)j Ar = o-F-Ph 5.08 19.0 0.8 0.66 ++ + 
(136d)j Ar = m-F-Ph 6.36 23.9 1.0 0.78 ++ + 
(136a)j Ar = 2,6-di-F-Ph 6.83 27.1 0.8 1.38 ++ ++ Several unidentified 
compounds 
(136e)j Ar = penta-F-Ph 4.32 16.3 0.5 1.12 ++ ? I Several unidentified 
compounds 
TABLE 3 Experimental data for feeding experiments + = small amount present ++ = moderate amou~t 
with radio-labelled fluorinated compounds +++ = substantial amount 
~ 
~ 
(136g); ~~ 358 [(142), M+- SMe, 0.93%J, 357 [0.17J, 339 [(131), M+ 
SMe, 6.3], and 91 [1 00] • 
Feeding of sodium [35S1sulphate 
14!-t 
A solution of sodium [35sJ sulphate (298 rCi, <: 1 mg) in sterile 
water (5 ml) was fed to 0.8 litres of A. terreus culture. On extrac-
tion 4 days later, the total extract contained 75 fCi, an incorporation 
of 35S into organic metabolites of 25%. Radioscanning and autoradio-
grams of t.l.c. plates showed that most of the activity was in EDA and 
EDAA, with lesser amounts in di(methylthio)-cyclo-(Phe-Phe) (131) and 
some other, unidentified metabolites. 
Feeding of 3,6-[35S]epidithio-3,6-[4-3H]dibenzylpiperazine-2,5-
dione (152) 
A) The doubly labelled deprotected epidisulphide (152) (45 mg, 
0.126 mmol; specific activity (3H) 133 fCi/mmol, (35S) 25.8 ~Ci/mmol; 
total activity (3H) 16.8 ~Ci, (35S ) 3.3 ~Ci; 3H:35S ratio 5.16) was 
dissolved in DMSO (1.5 ml) and fed to A. terreus (0.6 litres of 
cUlture). After 4 days, the cultures were harvested, extracted, and 
the extract separated by t.l.c. to give: 
EDA (40) (10.0 mg), crystallised from methanol to constant activity; 
specific activity (3H) 24.6 fCi/mmol, (35S) 7.6 fCi/mmol; 3H:35S ratio 
3.24; incorporation (3H) 2.7.%, (35S ) 4.4%; dilution (3H) 5.41, (35S) 
3.40. 
Di(methylthio)-cyclo-(Phe-Phe) (131) (0.6 mg), crystallised from 
chloroform and recrystallised from acetone; specific activity (3H) 
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110.5 pCi/mmol, (35S ) 24.4 fCi/mmol; 
(3H) 1.0%, (35S) 1.1%; dilution (3H) 
3H·35S t· 4 
. ra 1.0 .53; incorporation 
cyclo-(L-Phe-L-Phe) (42) 
water, specific activity 
dilution 72.7. 
(35 1.20, S) 1.06. 
(8 mg), crystallised twice from acetic acid-
3 ' ( H) 1.83 fCi/mmol; incorporation 0.3%; 
B) The disulphide (152) (4.8 mg, 0.012 mmol; specific activity 
(3H) 178 fCi/mmol, (35S) 36.6 fCi/mmol; total activity (3H) 2.06 f Ci , 
(35S) 0.42 fCi; 3H:35S ratio 4.86) was fed to 0.6 litres of culture, 
and the cultures were harvested after 5i h. Preparative t.l.c. of the 
extract gave: 
BDA (40) (3.2 mg), crystallised twice from methanol; specific activity 
(3H) 4.21 fCi/mmol, (35S) 1.93 fCi!mmol; incorporation (3H) 1.2%, 
(35S) 2.7.%; dilution (3H) 42.3, (35S) 19.0. To obtain a constant 
ratio on successive crystallisations, it was necessary to add unlabel-
led BDA (5 mg) (due to lack of material); 3H:35S ratio 2.63. 
Acetylaranotin (38) (1.2 mg), crystallised twice from methanol; 
specific activity (3H) 26.4 flCi/mmol, (35S) 6.20 fCi!mmolj 3H:35S 
ratio 4.26; incorporation (3H) 3.1%, (35S) 3.4%; dilution (3H) 6.74, 
(35S) 5.91. A sample was diluted with unlabelled acetylaranotin and 
crystallised to constant ratio; 3H:35S ratio 4.41. 
Di(methylthio)-cyclo-(Phe-Phe) (131) (~ 0.2 mg), crystallised from 
chloroform and recrystallised from acetone; specific activity (3H) 
50.3 fCi/mmol, (35S ) 10.4 fCi/mmol; 3H:35S ratio 4.85; incorporation 
(3H and 35S ) 1.3%; dilution (3H and 35S) 3.54. 
c) The disulphide (152) (3.2 mg, 0.008 mmol, specific activities 
etc. as in B), total activity (3H) 1.37 rCi, (35S) 0.28 f Ci ) \vas fed 
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to 0.4 litres of culture, and harvested after 24 h. T .1. c. gave BDA 
(3.9 mg), crystallised to constant activity from methanol; specific 
activity (3H) 3.28 fCi/mmol, (35S) 1.03 pCi/mmol; 3H:35S ratio 3.18; 
incorporation (3H) 1.7%, (35S) 2.6%; dilution (3H) 54.3, (358 ) 35.5. 
Feedin of [35S di(meth lthio)-cyclo-(Phe-Phe) (131) 
The above compound, prepared from the [35S]epidisulphid~ (152), 
(5.5 mg, 0.014 mmol; specific activity 25.1 fCi/mm~l; total activity 
0.36 f Ci) was dissolved in DMSO (1 ml) and fed to 0.3 Ii tres of 
culture. The culture was harvested 5 days later, BDA (6.0 mg) was 
isolated by t.l.c., and crystallised to constant activity from meth-
anol; specific activity 0.082 fCi/mmol; incorporation 0.26%; dilution 
306. 
Intermediate trapping experiment 
To 0.5 litres of culture was fed L-[u_14C]phenylalanine (50 fCi; 
specific activity 10 mCi/mmol) in water (1 ml). After 3 h, epidi-
sulphide (152) (40 mg, 0.097 mmol) in DMSO (1 ml) was added, and after 
a further 30 min., the culture was harvested and the broth extracted. 
T.I.c. (solvent systems A and C) recovered some of the disulphide (152) 
(ca. 1 mg). This was diluted with unlabelled disulphide (2 mg), and 
crystallised from toluene to constant activity; specific activity 1.08 
fC~mmol; incorporation into recovered (152) 0.015%. BDA (40) and 
acetylaranotin (38) were also isolated: 
BDA (40) (4.5 mg), crystallised to constant activity from methanol; 
specific activity 89.6 fC~mmol; incorporation 1.5%· 
Acetylaranotin (38) (1.8 mg), crystallised to constant activity from 
methanol; specific activity 422 rCi/mmol; incorporation 3.0%· 
1. 
2. 
REFERENCES 
R.Weindling and O.Emerson, Phytopathology, 1936, 26, 1068. 
M.R.Bell, J.R.Johnson, B.S.Wildi, and R.B.Woodward, J. Am. Chern. 
Soc., 1958, 80, 1001. 
147 
3. C.Miyamoto, K.Yokose, T.Furumai, and H.B.Maruyama, J. Antibiotics, 
1982, 35, 374. 
4. R.D.Stipanovic and C.R.Howell, J. Antibiotics, 1982, 35, 1326. 
5· K.Sakata, M.Masago, A.Sakurai, and N.Takahishi, Tetrahedron Lett., 
1982 ,.23, 2095. 
6. P.G.Sammes, 'Progress in the Chemistry of Organic Natural Products,' 
1975, 32, 51. 
7. S.Johne and D.Groger, Pharmazie, 1977, 32, 1. 
8. C.Leigh and A.Taylor, in 'Mycotoxins and other fungal-related food 
problems,' Ed. J.V.Rodricks, Adv. in Chem. series 149, Amer. Chern. 
Soc., Washington, D.C., 1976, pp 228 - 275. 
9. G.W.Kirby and D.J.Robins, in 'The biosynthesis of rnycotoxins - a 
study in secondary metabolism,' Ed. P.S.Steyn, Academic Press, New 
York, 1980, p~ 301 - 326. 
10. T.Kikuchi, S.Kadota, K.Nakamura, A.Nishi, T.Taga, T.Kaji, K.Osaki, 
and K.Tubaki, Chem. Pharm. Bull. (Japan), 1982, 30, 3846. 
11. A.Taylor, in 'Microbial toxins,' Eds. S.Kadis, A.Ciegler, and 
S.J.Ajl, Vol. VII, chap. 10, Academic Press, London and New York, 
19'71, PP. 337 - 377. 
12. R.J.Suhadolnik and R.G.Chenoweth, J. Am. Chern. Soc., 1958, 80, 
4391. 
13. J.A.Winstead and R.J.Suhadolnik, J. Am. Chern. Soc., 1960, 82, 
1644. 
14. 
15· 
16. 
J.D.Bu'Lock and A.P.Ryles, J. Chern. Soc., Chern. Commun., 1970, 
1404. 
N.Johns and G.W.Kirby, J. Chern. Soc., Chern. Commun., 1971, 163. 
D.R.Brannon, J.A.Mabe, B.B.Molloy, and W.A.Day, Biochern. Biophys. 
Res. Commun., 1971, 43, 588. 
17. A.K.Bose, K.G.Das, P.T.Funke, I.Kugajevsky, O!P.Shukla, K.S. 
Khanchandani, and R.J.Suhadolnik, J. Am. Chern. Soc., 1968, 90, 
1038. 
18. A.K.Bose, K.S.Khanchandani, R.Tavares, and P.T.Funke, J. Am. Chern. 
Soc., 1968, 90, 1038. 
19. J.C.MacDonald and G.P.Slater, Can. J. Biochern., 1975, 53, 475. 
20. J.D.Bu'Lock and C.Leigh, J. Chern. Soc., Che~. Commun., 1975, 628. 
21. G.W.Kirby, G.L.Patrick, and D.J.Robins, J. Chern. Soc., Perkin 
Trans. 1, 1978, 1336. 
22. W.H.Rastetter and L.J.Nummy, J. Org. Chern., 1980, 45, 3149· 
23. M.S.Ali, Ph.D. Thesis, University of Dalhousie, 1968; cited in 
Ref. 8. 
24. W.H.Rastetter, T.Chancellor, and T.J.Richard, J. Org. Chern., 1982, 
47, 1509· 
25. J.R.Hanson and M.A.O'Leary, ~. Chern. Soc., Perkin Trans. 1, 1981, 
218. 
26. N.Neuss, L.D.Boeck, D.R.Brannon, J.C.Cline, D.C.De Long, M.Gorman, 
L.L.Huckstep, D.H.Lively, J.Mabe, M.M.Marsh, B.B.Molloy, 
J D N 1 and W.M.Stark, Antirnicrob. Agents Cherno-R.Nagarajan, .' e son, -
ther., 1968, 213· 
27. K J D B 'L k and A.P.Ryles, J. Chern. Soc., N.Johns, G.W. irby, •• u oc, 
Perkin Trans. 1, 1975, 383· 
28. J Chern. Soc., Chern. Commun., 19'?b, 354. G.W.Kirby and D.J.Robins, ~.~~~~~~~------------
29. G.W.Kirby, Pure Appl. Chem., 1979, 51, 705. 
30. G.W.Kirby, W.Losel, P.S.Rao, D.J.Robins, M.A.Sefton, and 
R.R.Talekar, J. Chem. Soc., Chem. Commun., 1983, 810. 
31. 
149 
G.W.Kirby, D.J.Robins, M.A.Sefton, and R.R.Talekar, J. Ch S ern. oc., 
Perkin Trans. 1, 1980, 119. 
32. G.Lowe, A.Taylor, and L.C.Vining, J. Chem. Soc. C, 1966, 1799. 
33. G.M.Strunz, M.Kakushima, M.A.Stillwell, and C.J.Heissner, J. Chern. 
Soc., Perkin Trans. 1, 1973, 2600. 
34. G.M.Strunz, C.J.Heissner, M.Kakushima, and M.A.Stillwell, 
Can. J. Chern., 1974, 52, 325. 
35. F.Dorn and D.Arigoni, Experientia, 1974, 30, 134. 
36. K.H.Michel, M.O.Chaney, N.D.Jones, M.M.Hoehn, and R.Nagarajan, 
J. Antibiotics, 1974, 27, 57. 
37. G.M.Strunz, M.Kakushima, and M.A.Stillwell, Can. J. Chern., 1975, 
53, 295. 
38. G.L.Patrick, Ph.D. Thesis, University of Glasgow, 1979. 
39. M.I.Pita Boente, Ph.D. Thesis, University of Glasgow, 1981. 
40. N.R.Towers and D.E.Wright, New Zealand J. Agric. Res., 1969, 12, 
275· 
41. G.W.Kirby and M.J.Varley, J. Chem. Soc., Chern. Commun., 1974, 833. 
42. J.P.Ferezou, A.Quesneau-Thierry, C.Servy, E.Zissmann, and 
M.Barbier, J. Chem. Soc., Perkin Trans. 1, 1980, 1739. 
43. N.Neuss, R.Nagarajan, B.B.Molloy, and L.L.Huckstep, Tetrahedron 
Lett., 1968, 4467. 
44 R N . L L H k t D.H.Lively, D.C.De Long, M.M.Marsh, • • agaraJan, .• UC 5 ep, 
and N.Neuss, J. Am. Chern. Soc., 1968, 90, 2980. 
4 P W T W.Fulmor, G.O.Morton, and J . Karliner , 5. P.A.Miller, •. rown, 
Biochem. Biophys. Res. Commun., 1968, 90, 2980. 
150 
46. D.B.Cosulich, N.R.Nelson, and J.H.Van den Hende, J. Am. Chem. 
47. 
48. 
Soc., 1968, 90, 6519. 
- -
R.Nagarajan, N.Neuss, and M.M.Marsh, J. Am. Chem. Soc., 1968, 90, 
6518. 
M.l.Pita Boente, G.W.Kirby, and D.J.Robins, J. Chern. Soc., Chem. 
Commun., 1981, 619. 
49. G.M.Strunz, M.Kakushima, and M.A.S~illwell, Can. J. Chem., 1975, 
53, 295· 
50. P.W.Trown, Biochem. Biophys. Res. Commun., 1968, 33, 402. 
51. T • Fukuyama , S.-l.Nakatsuka, and Y.Kishi, Tetrahedron, 1981, 37, 
2045. 
52. T.Fukuyama and Y.Kishi, J. Am. Chern. Soc., 1976, 98, 6723. 
53. Y.Kishi, T.Fukuyama, and S.-I.Nakatsuka, J. Am. Chern. Soc., 1973, 
95, 6492. 
54. Y.Kishi, S.-l.Nakatsuka, T.Fukuyama, and M.Havel, J. Am. Chern. 
Soc., 1973, 95, 6493. 
55. G.M.Strunz and M.Kakushima, Experientia, 1974, 30, 719· 
56. H.Poisel and U.Schmidt, Chern. Ber., 1971, 104, 1714. 
57. A. Srinivasan , A.J.Kolar, and R.K.Olsen, J. Heterocycl. Chem., 
1981, 18, 1545· 
E.Ohler, F.Tataruch, and U.Schrnidt, Chern. Ber., 1973, 106, 165. 
59· J.Yoshimura , H. Nakamura , and K.Matsunaki, Bull. Chern. Soc. Japan, 
1975, 48, 605· 
60. H.C.J.Ottenheijm, J.D.M.Herscheid, G.P.C.Kerkhoff, and T.F.Spande, 
J. Org. Chern., 1976, 41, 3433. 
61. P.J.Machin and P.G.Sammes, J. Che~. Soc., Perkin Trans. 1, 1974, 
62. J.Yoshimura, Y.Sugiyama, K.Matsunari, and H.Nakamura, Bull. Chern. 
Soc. Jpn., 1974, 47, 1215· 
63. 
64. 
H.Poisel and U.Schmidt, Chern. Ber., 1972, 105, 625 • 
.. 
E.Ohler, H.Poisel, F.Tataruch, and U.Schmidt, Chern. Be 
__ ~~~r~., 1972, 
105, 635. 
65. R.M.Williams and W.H.Rastetter, Tetrahedron Lett., 1979, 1187. 
66. R.M.Williams and W.H.Rastetter, J. Org. Chern., 1980, 45, 2625. 
67. D.L.Coffen, D.A.Katonak, N.R.Nelson, and F.D.Sancilio, J. Drg. 
Chem., 1977, 42, 948. 
68. T.Sato and T.Hino, Chem. Pharrn. Bull., 1976, 24, 285. 
69. T.Hino and T.Sato, Chern. Pharm. Bull., 1974, 22, 2866. 
70. R.A.Peters, Adv. Enzymology, 1957, 18, 113. 
71. E.Kirsten, M.L.Sharma, and E.Kun, Molec. Pharmacol., 1978, 14, 
172. 
72. G.D.Prestwich and S.Phirwa, Tetrahedron Lett., 1983,2461. 
73. K.Kieslich, in 'Microbial transformations of non-steroid cyclic 
compounds,' Georg Thie~, Stuttgart, 1976, p.233. 
74. P.F.Pilch and R.L.Somerville, Biochemistry, 1976, 15, 5315· 
75. C.D.Poulter and H.C.Rilling, Acc. Chern. Res., 1978, 12, 307. 
151 
76. B.E.Cross and A.Erasmuson, J. Chern. Soc., Perkin Trans. 1, 19~1, 
1918, and references cited therein. 
77. H.D.Hollingworth, B.P. 916 488/1959; Chern. Abs., 1963, 58, 9600a· 
78. P.Goldman, G.W.A,Milne, and M.Pignataro, Arch. Biochern. Biophys., 
1967, 118, 178. 
79. A.M.Reiner and G.D.Hegeman, Biochemistry, 1971, 10, 2530. 
80. 
81. 
82. 
D.B.Harper and E.R.Blakley, Can. J. Microbiol. , 1971, 17, 1015· 
D.B.Harper and E.R.Blakley, Can. J. Microbiol. , 1971, 17, 635. 
J.E.Watkin and D.S.Magrill, 4th International Symposium on the 
d t Stockholm, June 26th - July end Chemistry of natural pro uc s, 
1966, Abstracts P. 146. 
152 
83. M. Gorman , R.L.Harnill, R.P.Elander, and J.Mabe, Biochem. Biophys. 
Res. Commun., 1968, 31, 294. 
84. W.A.Skinner, J.J.Morris, and J.V.Stevenson, J. Pharm. Sci., 1967, 
56, 396. 
85. E.Leete, G.B.Boden, and M.F.Manuel, Phytochemistry, 1971, 10, 
2687. 
86. E.Leete, J. Org. Chern., 1979, 44, 165. 
87. T.G.C.Bird, P.M.Fredericks, E.R.H.Jones, and G.D.Meakins, J. Chern. 
Soc., Perkin Trans. 1, 1980, 750. 
88. A.A.Gottlieb, Y.Fujita, S.Udenfriend, and B.Witkop, Biochemistry, 
1965,.i, 2507. 
89. J.Renson and V.Bourdon, Arch. Int. Pharmacodyn. Ther., 1968, 171, 
240. 
90. J.W.Daly, G.Guroff, S.Udenfriend, and B.Witkop, Biochem. 
Pharmacol., 1968, 17, 31. 
91. V.Ullrich, J.Wolf, E.Amadori, and H.Staudinger, Hoppe-Seylers Z. 
Physiol. Chern., 1968, 349, 85. 
92. P.A.Miller and P.W.Trown, U.S. Patent 3,701,774/1972; Chern. Abstr., 
78, 56432v. 
93. N.Kiriyama, K.Nitta, Y.Sakaguchi, Y.Taguchi, and Y.Yamarnoto, 
Chern. Pharrn. Bull., 1977, 25, 2593. 
94. G.W.Kirby, D.J.Robins, and W.M.Stark, J. Chern. Soc., Chern. Comnrun." 
95. 
96. 
97. 
98. 
1983, 812. 
K.Blaha, Collect. Czech. Chern. Commun., 1969, 34, 4000. 
T.Sasaki, Chern. Ber., 1921, 54B, 163· 
C.Gallina and A.Liberatori, Tetrahedron, 1974, 30, 667. 
. and N.lzumiya, Tetrahedron Lett., T.Kanmera, S.Lee, H.Aoyag1, 
1979, 4483. 
153 
99. H.Poisel and U.Schmidt, Chern. Ber., 1973, 106, 3416. 
100. E.Fischer and H.Schoeller, Annalen, 1907, 357, 22. 
101.. P.J.Machin and P.G.Sammes, J. Chern. Soc., Perkin Trans. 1, 1976, 
624. 
102. D.E.Nitecki, B.Halpern, and J.M.Westley, J. Org. Chern., 1968, 
33, 864. 
103. R.Brown, C.Kelley, and S.E.Wiberley, J. Org. Chern., 1965, 30, 
277. 
104. B.Liberek and M.Bednarek, Pol. J. Chern., 1978, 52, 1099. 
105. W.Radding, B.Donzel, N.Ueyama, and M.Goodman, J. Arn. Chern. Soc., 
1 980, 1 02 , 5999 . 
106. I.J.Frigerio, l.D.Rae, and M.G.Wong, Aust. J. Chern., 1982, 35, 
1609. 
107. C.Shin, M.Hayakawa, H.Kato, and K.Mikami, J. Chern. Soc., Perkin 
Trans. 1, 1980, 419. 
108. H.Hsu, G.W.Kirby, and D.J.Robins, unpublished results. 
109. D.H.Berg, R.P.Massing, M.N.Hoehn, L.D.Boeck, and R.L.Harnill, 
J. Antibiotics, 1976, 29, 394. 
110. H.C.J.Ottenheijm, J.D.M.Herscheid, M.W.Tijhuis, and M.Oosterbaan, 
J. Med. Chern., 1978, 21, 796. 
111. C.Sannie, Bull. Soc. Chim. Fr., 1942, 9, 487. 
112 E F . R Rahma S.Safe, and A.Taylor, J. Chern. Soc., Perkin • . ranC1S,. n, 
Trans. 1, 1972, 470. 
113. J.D.M.Herscheid, M.W.Tijhuis, J.H.Noordik, and H.C.J.Ottenheijm, 
J. Arn. Chern. Soc., 1979, 101, 1159· 
114. E.Cherbuliez and E.Feer, Helv. Chim. Acta, 1922, 5, 678. 
115. H.J.lssaq and E.W.Barr, J. Chromatogr., 1977, 132, 121. 
116 D J B tt G W Ko band V.A.Moss, J. Chern. Soc. (C), 1Y~G, • •• e nne , •• lr y, 
2049. 
154 
117. G.W.J.Fleet, C.J.Fuller, and P.J.C.Harding, Tetrahedron Lett., 
1978,1437. 
118. A.R.Burton and A.M.Roe, B.P. 1,080,167/1968. 
119. J.P.Greenstein and M.Winitz, in 'Chemistry of the Amino-acids,' 
Vol. 2, p. 891 (Wiley, 1961). 
120. J.C.Eck and B.H.Thomas, J. BioI. Chern., 1939, 128, 257. 
~ .. '--.---- ' - ,-.--'GLASGJW UNIVERSITY UB ARY 
